No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4ltcO_, 1.0000, 0.00, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2, d4ltcA_, 0.9996, 0.11, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3, d5l6aO_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4, d5l6aA_, 0.9991, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
5, d5l5hO_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
6, d5l5hA_, 0.9991, 0.17, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
7, d4qv5O_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45I MUTANT
8, d4qv5A_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45I MUTANT
9, d4qv4O_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45T MUTANT
10, d4qv4A_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45T MUTANT
11, d4qv1O_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45A MUTANT
12, d4qv1A_, 0.9991, 0.17, 1.000, 250, 250, YCP BETA5-M45A MUTANT
13, d5m2bO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
14, d5m2bA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
15, d5l6cO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
16, d5l6cA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
17, d5l6bO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
18, d5l6bA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
19, d5l67O_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
20, d5l67A_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
21, d5l66O_, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
22, d5l65O_, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
23, d5l63O_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
24, d5l63A_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
25, d5l61O_, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
26, d5l5wO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
27, d5l5wA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
28, d5l5uO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
29, d5l5uA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
30, d5l5sO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
31, d5l5sA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
32, d5l5rO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
33, d5l5rA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
34, d5l5qO_, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
35, d5l5qA_, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
36, d5l5pO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
37, d5l5pA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
38, d5l5oO_, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
39, d5l5dO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
40, d5l5dA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
41, d5l5bO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
42, d5l5bA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
43, d5l5aO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
44, d5l5aA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
45, d5czaO_, 0.9990, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT
46, d5cz6O_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
47, d5cz6A_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
48, d5bxnO_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
49, d5bxnA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
50, d5bxlA_, 0.9990, 0.18, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT
51, d4qvlO_, 0.9990, 0.18, 1.000, 250, 250, YCP IN COMPLEX WITH BORTEZOMIB
52, d4qvlA_, 0.9990, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH BORTEZOMIB
53, d4qv8O_, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-C52F MUTANT
54, d4qv8A_, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-C52F MUTANT
55, d4qv7O_, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A50V MUTANT
56, d4qv7A_, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A50V MUTANT
57, d4qv0O_, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT
58, d4qv0A_, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT
59, d4quyO_, 0.9990, 0.18, 1.000, 250, 250, YCP BETA5-A49S-MUTANT
60, d4quyA_, 0.9990, 0.19, 1.000, 250, 250, YCP BETA5-A49S-MUTANT
61, d3nzwO_, 0.9990, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
62, d3nzjO_, 0.9990, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
63, p6gopO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
64, d5lttO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
65, d5lttA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
66, d5l69O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
67, d5l69A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
68, d5l68O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
69, d5l68A_, 0.9989, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
70, d5l66A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
71, d5l65A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
72, d5l64O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
73, d5l64A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
74, d5l62O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
75, d5l62A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
76, d5l61A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
77, d5l5tO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
78, d5l5tA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
79, d5l5oA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
80, d5l5jO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
81, d5l5jA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
82, d5l5iO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
83, d5l5iA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
84, d5l5fO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
85, d5l5fA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
86, d5fgaO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
87, d5fgaA_, 0.9989, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
88, d5d0wO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT
89, d5d0wA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT
90, d5czaA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT
91, d4ya4O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT
92, d4ya4A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT
93, d4ya1O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT
94, d4ya1A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT
95, d4y9yO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT
96, d4y9yA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT
97, p4y8tO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
98, d4qzzO_, 0.9989, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH OMURALIDE
99, d4qzzA_, 0.9989, 0.19, 1.000, 250, 250, YCP IN COMPLEX WITH OMURALIDE
100, d4qw1O_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
101, d4qw1A_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
102, d4qvyO_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
103, d4qvyA_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
104, d4qvwO_, 0.9989, 0.20, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
105, d4qvwA_, 0.9989, 0.20, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
106, d4qvnO_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
107, d4qvnA_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
108, d4qv3O_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-M45V MUTANT
109, d4qv3A_, 0.9989, 0.19, 1.000, 250, 250, YCP BETA5-M45V MUTANT
110, d4jt0O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
111, d4jt0A_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
112, d4jsuO_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
113, d4jsuA_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
114, p3un4O_, 0.9989, 0.19, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
115, d3nzxO_, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
116, d3nzwA_, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
117, d3nzjA_, 0.9989, 0.19, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
118, d5l5zO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
119, d5l5zA_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
120, d5l5yO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
121, d5l5yA_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
122, d5l5xO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
123, d5l5xA_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
124, d5l5vO_, 0.9988, 0.20, 1.000, 250, 250,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
125, d5l5vA_, 0.9988, 0.20, 1.000, 250, 250,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
126, d5fg9O_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
127, d5fg9A_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
128, d5fg7O_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T1A MUTANT
129, d5fg7A_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-T1A MUTANT
130, d5bouO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
131, d4y8rO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT
132, d4y8rA_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT
133, d4y8mO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
134, d4y8mA_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
135, d4r18O_, 0.9988, 0.20, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
136, d4r18A_, 0.9988, 0.20, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
137, d4r02O_, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
138, d4qvpO_, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
139, d4qvpA_, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
140, d4qv9O_, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-C63F MUTANT
141, d4qv9A_, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-C63F MUTANT
142, d4quxO_, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-A49T-MUTANT
143, d4quxA_, 0.9988, 0.20, 1.000, 250, 250, YCP BETA5-A49T-MUTANT
144, d4qltO_, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
145, d4qltA_, 0.9988, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
146, d4no8O_, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
147, d4no8A_, 0.9988, 0.20, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
148, d4lqiO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
149, d4lqiA_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
150, d4jsqO_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
151, d4jsqA_, 0.9988, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
152, d3nzxA_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
153, d3mg0O_, 0.9988, 0.20, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
154, d3hyeO_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
155, d3hyeA_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
156, d3gpwO_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
157, d3gpwA_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
158, d3gptO_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
159, d3gptA_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
160, d2fakO_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
161, d2fakA_, 0.9988, 0.20, 1.000, 250, 250, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
162, d5l60O_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
163, d5l60A_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
164, d5l5eO_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
165, d5l5eA_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
166, d5l54O_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
167, d5l54A_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
168, d5cz7O_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
169, d5cz7A_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
170, d5cgfO_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT
171, d5cgfA_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT
172, d5bouA_, 0.9987, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
173, p4y6vO_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
174, d4r00O_, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
175, d4r00A_, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
176, d4qwuO_, 0.9987, 0.20, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
177, d4qwuA_, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
178, d4qv6O_, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-A49V MUTANT
179, d4qv6A_, 0.9987, 0.21, 1.000, 250, 250, YCP BETA5-A49V MUTANT
180, d4qluO_, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
181, d4qluA_, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
182, d4no1O_, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
183, d4no1A_, 0.9987, 0.21, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
184, d4intO_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
185, d4inrO_, 0.9987, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
186, d4inrA_, 0.9987, 0.20, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
187, d3un8O_, 0.9987, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
188, d3shjO_, 0.9987, 0.21, 1.000, 250, 250, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
189, d3shjA_, 0.9987, 0.21, 1.000, 250, 250, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
190, d5lajO_, 0.9986, 0.21, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
191, d5lajA_, 0.9986, 0.21, 1.000, 250, 250, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
192, p5cghO_, 0.9986, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
193, d4z1lO_, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
194, d4z1lA_, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
195, p4y75O_, 0.9986, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
196, d4rurO_, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
197, d4rurA_, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
198, d4qz7O_, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
199, d4qz7A_, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
200, d4qvqO_, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
201, d4qvqA_, 0.9986, 0.22, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
202, d4qlsO_, 0.9986, 0.22, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
203, d4qlsA_, 0.9986, 0.22, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
204, d4inuO_, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
205, d4intA_, 0.9986, 0.21, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
206, d3un8A_, 0.9986, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
207, d3tddO_, 0.9986, 0.22, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
208, d3tddA_, 0.9986, 0.22, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
209, d2gplO_, 0.9986, 0.22, 1.000, 250, 250, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
210, d2gplA_, 0.9986, 0.22, 1.000, 250, 250, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
211, d2fnyO_, 0.9986, 0.22, 1.000, 250, 250,  
212, d2fnyA_, 0.9986, 0.22, 1.000, 250, 250,  
213, d5l55O_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
214, d5l55A_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
215, d5dkjO_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
216, d5dkjA_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
217, p5cggO_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
218, d5bxlO_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-G170A MUTANT
219, p4ya2O_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
220, p4y8pO_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
221, p4y8nO_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
222, d4qz4O_, 0.9985, 0.23, 1.000, 250, 250, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
223, d4qz4A_, 0.9985, 0.23, 1.000, 250, 250, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
224, d4qlqO_, 0.9985, 0.23, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
225, d4qlqA_, 0.9985, 0.23, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
226, d4j70O_, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
227, d4j70A_, 0.9985, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
228, d4inuA_, 0.9985, 0.22, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
229, d3okjO_, 0.9985, 0.23, 1.000, 250, 250, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
230, d3okjA_, 0.9985, 0.23, 1.000, 250, 250, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
231, d3mg0A_, 0.9985, 0.22, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
232, d3e47O_, 0.9985, 0.22, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
233, d3e47A_, 0.9985, 0.22, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
234, d5jhrO_, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
235, d5jhrA_, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
236, d5d0tO_, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
237, d5d0tA_, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
238, p4ya9O_, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
239, p4ya7O_, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
240, p4y9zO_, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
241, p4y8sO_, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
242, p4y8gO_, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
243, p4y77O_, 0.9984, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
244, p4y69O_, 0.9984, 0.23, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
245, d4qwxO_, 0.9984, 0.24, 1.000, 250, 250, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
246, d4qwxA_, 0.9984, 0.24, 1.000, 250, 250, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
247, d4qwlO_, 0.9984, 0.24, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
248, d4qwlA_, 0.9984, 0.24, 1.000, 250, 250, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
249, d4qvmO_, 0.9984, 0.23, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
250, d4qvmA_, 0.9984, 0.23, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
251, d2f16O_, 0.9984, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
252, d2f16A_, 0.9984, 0.23, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
253, d5laiO_, 0.9983, 0.24, 1.000, 250, 250, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
254, d5laiA_, 0.9983, 0.24, 1.000, 250, 250, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
255, d5l52O_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
256, d5l52A_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
257, d5fggO_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
258, d5fggA_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
259, d5d0xO_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
260, d5d0xA_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
261, d5d0vO_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
262, d5d0vA_, 0.9983, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
263, d5d0sO_, 0.9983, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
264, d5d0sA_, 0.9983, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
265, d5ahjO_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
266, d5ahjA_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
267, p4y8uO_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
268, p4y8hO_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
269, p4y84O_, 0.9983, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
270, p4y6aO_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
271, d4qz6O_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
272, d4qz6A_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
273, d4qz5O_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
274, d4qz5A_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
275, d4qz3O_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
276, d4qz3A_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
277, d4qz0O_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
278, d4qz0A_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
279, d4qw6O_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
280, d4qw6A_, 0.9983, 0.25, 1.000, 250, 250, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
281, d4qw0O_, 0.9983, 0.24, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
282, d4qw0A_, 0.9983, 0.24, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
283, d4q1sA_, 0.9983, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
284, d4nnnO_, 0.9983, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH MG132
285, d4nnnA_, 0.9983, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH MG132
286, d3dy3O_, 0.9983, 0.24, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
287, d3dy3A_, 0.9983, 0.24, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
288, d3d29O_, 0.9983, 0.24, 1.000, 250, 250, PROTEASOME INHIBITION BY FELLUTAMIDE B
289, d3d29A_, 0.9983, 0.24, 1.000, 250, 250, PROTEASOME INHIBITION BY FELLUTAMIDE B
290, d5d0zO_, 0.9982, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
291, d5d0zA_, 0.9982, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
292, p4ya5O_, 0.9982, 0.24, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
293, p4y8kO_, 0.9982, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
294, d4qwfO_, 0.9982, 0.26, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
295, d4qwfA_, 0.9982, 0.26, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
296, d4qw7O_, 0.9982, 0.26, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
297, d4qw7A_, 0.9982, 0.26, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
298, d4qw5O_, 0.9982, 0.25, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
299, d4qw5A_, 0.9982, 0.25, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
300, d4qlvO_, 0.9982, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
301, d4qlvA_, 0.9982, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
302, d4no6O_, 0.9982, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
303, d4no6A_, 0.9982, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
304, d5jhsO_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
305, d5jhsA_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
306, p5fghO_, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
307, d5cz9O_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
308, d5cz9A_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
309, p5cgiO_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
310, p4y8lO_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
311, p4y8jO_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
312, p4y82O_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
313, p4y74O_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
314, p4y70O_, 0.9981, 0.26, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
315, d4r02A_, 0.9981, 0.25, 1.000, 250, 250, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
316, d4qzwO_, 0.9981, 0.26, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
317, d4qzwA_, 0.9981, 0.27, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
318, d4q1sO_, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
319, p4gk7O_, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
320, d4fzcO_, 0.9981, 0.25, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
321, d4fzcA_, 0.9981, 0.25, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
322, d3mg4A_, 0.9981, 0.25, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
323, d3gpjO_, 0.9981, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
324, d3gpjA_, 0.9981, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
325, d3dy4A_, 0.9981, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
326, d2zcyO_, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
327, d2zcyA_, 0.9981, 0.25, 1.000, 250, 250, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
328, d5fgfO_, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
329, d5fgfA_, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
330, p4y8qO_, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
331, p4y7wO_, 0.9980, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
332, d4qz2O_, 0.9980, 0.27, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
333, d4qz2A_, 0.9980, 0.27, 1.000, 250, 250, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
334, d4qwrO_, 0.9980, 0.27, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
335, d4qwrA_, 0.9980, 0.27, 1.000, 250, 250, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
336, d4qw4O_, 0.9980, 0.27, 1.000, 250, 250, YCP IN COMPLEX WITH CARFILZOMIB
337, d4qw4A_, 0.9980, 0.27, 1.000, 250, 250, YCP IN COMPLEX WITH CARFILZOMIB
338, d4no9O_, 0.9980, 0.26, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
339, d4no9A_, 0.9980, 0.26, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
340, d4nnwO_, 0.9980, 0.27, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
341, d4nnwA_, 0.9980, 0.27, 1.000, 250, 250, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
342, d3dy4O_, 0.9980, 0.26, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
343, d5fgeO_, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
344, d5fgeA_, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
345, d5dkiO_, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
346, d5dkiA_, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
347, d5cz4O_, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
348, d5cz4A_, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
349, p4y8oO_, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
350, p4y8iO_, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
351, p4y81O_, 0.9979, 0.27, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
352, p4y7xO_, 0.9979, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
353, d4hnpO_, 0.9979, 0.27, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
354, d4fzgO_, 0.9979, 0.27, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
355, d4fzgA_, 0.9979, 0.27, 1.000, 250, 250, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
356, d5fhsO_, 0.9978, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
357, d5fhsA_, 0.9978, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
358, d5cz8O_, 0.9978, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
359, d5cz8A_, 0.9978, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
360, p4y80O_, 0.9978, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
361, p4y7yO_, 0.9978, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
362, d4qz1O_, 0.9978, 0.28, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
363, d4qz1A_, 0.9978, 0.28, 1.000, 250, 250, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
364, d4qvvO_, 0.9978, 0.27, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
365, d4qvvA_, 0.9978, 0.27, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
366, d4hnpA_, 0.9978, 0.27, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
367, p5nifP_, 0.9977, 0.28, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
368, p4y6zO_, 0.9977, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
369, d4qzxO_, 0.9977, 0.29, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
370, d4qzxA_, 0.9977, 0.29, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
371, d4qwiO_, 0.9977, 0.29, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
372, d4qwiA_, 0.9977, 0.29, 1.000, 250, 250, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
373, d3sdkO_, 0.9977, 0.28, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
374, d5fgdO_, 0.9976, 0.30, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
375, d5fgdA_, 0.9976, 0.30, 1.000, 250, 250, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
376, d5cz5O_, 0.9976, 0.30, 1.000, 250, 250, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
377, d5cz5A_, 0.9976, 0.30, 1.000, 250, 250, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
378, p4ya3O_, 0.9976, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
379, d4qxjO_, 0.9976, 0.30, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
380, d4qxjA_, 0.9976, 0.30, 1.000, 250, 250, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
381, d4qw3O_, 0.9976, 0.29, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
382, d4qw3A_, 0.9976, 0.29, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
383, d3oeuO_, 0.9976, 0.29, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
384, d3mg8O_, 0.9976, 0.29, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
385, d3mg7O_, 0.9976, 0.29, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
386, d3bdmO_, 0.9976, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
387, d3bdmA_, 0.9976, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
388, p4zzgP_, 0.9975, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
389, p4ya0O_, 0.9975, 0.29, 1.000, 250, 250, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
390, d4qwkO_, 0.9975, 0.30, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
391, d4qwkA_, 0.9975, 0.30, 1.000, 250, 250, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
392, d4hrdO_, 0.9975, 0.29, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
393, d4hrdA_, 0.9975, 0.29, 1.000, 250, 250, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
394, p4y78O_, 0.9974, 0.31, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
395, p4qbyO_, 0.9974, 0.31, 1.000, 250, 250, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
396, d3oevO_, 0.9973, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
397, d3mg6O_, 0.9973, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
398, d3mg6A_, 0.9973, 0.30, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
399, d4qwjO_, 0.9972, 0.32, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
400, d4qwjA_, 0.9972, 0.32, 1.000, 250, 250, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
401, d3oevA_, 0.9972, 0.31, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
402, d4qwsO_, 0.9970, 0.34, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
403, d4qwsA_, 0.9970, 0.34, 1.000, 250, 250, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
404, d3sdkA_, 0.9970, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
405, d3oeuA_, 0.9970, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
406, d3mg8A_, 0.9970, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
407, d3mg7A_, 0.9969, 0.33, 1.000, 250, 250, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
408, d1rypP_, 0.9969, 0.33, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
409, d3mg4O_, 0.9968, 0.34, 1.000, 250, 250, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
410, d1rypB_, 0.9968, 0.34, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
411, p5nifB_, 0.9966, 0.34, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
412, p4zzgB_, 0.9966, 0.35, 1.000, 250, 250, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
413, d4qwgO_, 0.9966, 0.35, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
414, d4qwgA_, 0.9966, 0.35, 1.000, 250, 250, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
415, d1g65A_, 0.9964, 0.36, 1.000, 250, 250, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
416, d1g65O_, 0.9963, 0.36, 1.000, 250, 250, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
417, d1jd2A_, 0.9951, 0.41, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
418, d4r17O_, 0.9950, 0.18, 1.000, 249, 249, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
419, d4r17A_, 0.9950, 0.18, 1.000, 249, 249, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
420, d1jd2V_, 0.9948, 0.42, 1.000, 250, 250, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
421, d5fgiO_, 0.9946, 0.22, 1.000, 249, 249, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
422, d5fgiA_, 0.9945, 0.22, 1.000, 249, 249, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
423, d3wxrB_, 0.9940, 0.26, 1.000, 249, 249, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
424, d4hrcO_, 0.9937, 0.28, 1.000, 249, 249, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
425, d4hrcA_, 0.9933, 0.31, 1.000, 249, 249, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
426, p4x6zP_, 0.9931, 0.32, 1.000, 249, 249, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
427, d4eu2B_, 0.9929, 0.33, 1.000, 249, 249, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
428, d3wxrP_, 0.9925, 0.35, 1.000, 249, 249, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
429, d4eu2P_, 0.9916, 0.40, 0.996, 249, 249, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
430, p4x6zB_, 0.9890, 0.33, 1.000, 248, 248, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
431, p3jcpKA_, 0.9887, 0.63, 1.000, 250, 250, 
432, p3jcpK_, 0.9887, 0.63, 1.000, 250, 250, 
433, p5mp9B_, 0.9852, 0.72, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S1)
434, d3sdiA_, 0.9824, 0.24, 1.000, 246, 246, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
435, d3sdiO_, 0.9822, 0.25, 1.000, 246, 246, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
436, p3jcoKA_, 0.9817, 0.81, 1.000, 250, 250, 
437, p3jcoK_, 0.9817, 0.81, 1.000, 250, 250, 
438, d1g0uA_, 0.9810, 0.32, 1.000, 246, 246, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
439, d1g0uO_, 0.9807, 0.34, 1.000, 246, 246, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
440, p5mp9b_, 0.9805, 0.94, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S1)
441, d4g4sB_, 0.9798, 0.39, 1.000, 246, 246, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
442, p5mpab_, 0.9753, 1.06, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S2)
443, p5mpaB_, 0.9748, 0.96, 1.000, 250, 250, 26S PROTEASOME IN PRESENCE OF ATP (S2)
444, p5wvkW_, 0.9720, 1.02, 1.000, 250, 250, 
445, p5wvkP_, 0.9698, 1.05, 1.000, 250, 250, 
446, d4cr2B_, 0.9591, 1.30, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
447, p5mpbB_, 0.9551, 1.37, 1.000, 250, 250, 
448, p5wviOA_, 0.9547, 1.32, 1.000, 250, 250, 
449, p5wviDA_, 0.9530, 1.34, 1.000, 250, 250, 
450, p5mpbP_, 0.9530, 1.36, 1.000, 250, 250, 
451, d1z7qP1, 0.9524, 0.94, 1.000, 249, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
452, d1z7qB1, 0.9523, 0.94, 1.000, 249, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
453, p1fntP_, 0.9512, 1.08, 1.000, 247, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
454, p1fntB_, 0.9512, 1.08, 1.000, 247, 243, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
455, p4cr4B_, 0.9464, 1.52, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
456, p5a5bB_, 0.9415, 1.55, 1.000, 250, 250, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
457, p4cr3B_, 0.9415, 1.55, 1.000, 250, 250, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
458, p5mpcB_, 0.9342, 1.42, 1.000, 250, 244, 
459, p5mpcP_, 0.9329, 1.48, 1.000, 250, 244, 
460, p6gopA_, 0.9190, 0.19, 1.000, 230, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
461, p4v7oB_, 0.9171, 0.53, 1.000, 231, 231, 
462, d3l5qG_, 0.9171, 0.53, 1.000, 231, 231,  
463, p4v7oXA_, 0.9170, 0.53, 1.000, 231, 231, 
464, p4v7oP_, 0.9170, 0.53, 1.000, 231, 231, 
465, p4v7oJA_, 0.9170, 0.53, 1.000, 231, 231, 
466, d3l5qS_, 0.9170, 0.53, 1.000, 231, 231,  
467, d1vsyP_, 0.9170, 0.53, 1.000, 231, 231,  
468, d1vsyB_, 0.9170, 0.53, 1.000, 231, 231,  
469, p4y8tA_, 0.9151, 0.18, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
470, p4y8gA_, 0.9147, 0.22, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
471, p4y75A_, 0.9147, 0.22, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
472, p4y6vA_, 0.9147, 0.22, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
473, p5cghA_, 0.9146, 0.23, 1.000, 229, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
474, p5cggA_, 0.9146, 0.24, 1.000, 229, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
475, p4ya9A_, 0.9146, 0.23, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
476, p4ya7A_, 0.9146, 0.23, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
477, p4ya2A_, 0.9146, 0.23, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
478, p4y8hA_, 0.9146, 0.23, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
479, p4y77A_, 0.9146, 0.24, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
480, p4y9zA_, 0.9145, 0.24, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
481, p4y8sA_, 0.9145, 0.24, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
482, p4y8nA_, 0.9145, 0.23, 1.000, 229, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
483, p4y84A_, 0.9145, 0.24, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
484, p4y69A_, 0.9145, 0.24, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
485, p4y8uA_, 0.9144, 0.24, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
486, p5cgiA_, 0.9143, 0.26, 1.000, 229, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
487, p4ya5A_, 0.9143, 0.25, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
488, p5fghA_, 0.9142, 0.26, 1.000, 229, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
489, p4y8lA_, 0.9142, 0.27, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
490, p4y8jA_, 0.9142, 0.27, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
491, p4y70A_, 0.9142, 0.26, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
492, p4y7wA_, 0.9141, 0.27, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
493, p4y8oA_, 0.9140, 0.28, 1.000, 229, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
494, p4y8iA_, 0.9140, 0.28, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
495, p4y7yA_, 0.9139, 0.29, 1.000, 229, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
496, p4ya3A_, 0.9137, 0.29, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
497, p4ya0A_, 0.9136, 0.30, 1.000, 229, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
498, p4qbyA_, 0.9136, 0.32, 1.000, 229, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
499, p3un4A_, 0.9110, 0.19, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
500, p4y8pA_, 0.9106, 0.23, 1.000, 228, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
501, p4y6aA_, 0.9105, 0.24, 1.000, 228, 228, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
502, p4gk7A_, 0.9104, 0.24, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
503, p4y8kA_, 0.9103, 0.26, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
504, p4y74A_, 0.9103, 0.26, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
505, p4y82A_, 0.9102, 0.26, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
506, p4y8qA_, 0.9101, 0.28, 1.000, 228, 228, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
507, p4y81A_, 0.9101, 0.28, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
508, p4y80A_, 0.9100, 0.28, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
509, p4y7xA_, 0.9100, 0.28, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
510, p4y6zA_, 0.9099, 0.29, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
511, p4y78A_, 0.9095, 0.32, 1.000, 228, 228, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
512, d4r3oB_, 0.9048, 1.02, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
513, d4r3oP_, 0.9047, 1.02, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
514, d4r67r_, 0.9039, 1.04, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
515, d4r67P_, 0.9039, 1.04, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
516, d4r67d_, 0.9039, 1.04, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
517, d4r67B_, 0.9037, 1.04, 0.608, 233, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
518, p5gjqC_, 0.9025, 1.08, 0.608, 233, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
519, p5gjrHA_, 0.9021, 0.99, 0.606, 231, 231, 
520, p5gjrT_, 0.9020, 0.99, 0.606, 231, 231, 
521, p5l4gP_, 0.9017, 1.08, 0.608, 233, 232, 
522, p5l4gB_, 0.9015, 1.14, 0.608, 233, 232, 
523, p3uneO_, 0.9014, 1.10, 0.608, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
524, p5lezO_, 0.9009, 0.93, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
525, d5lexO_, 0.9007, 0.93, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
526, d1iruP_, 0.9007, 1.11, 0.608, 233, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
527, p5leyO_, 0.9004, 0.93, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
528, p3unec_, 0.9004, 1.14, 0.608, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
529, d5lf3O_, 0.9003, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
530, d5lf1O_, 0.9003, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
531, p5lezA_, 0.9003, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
532, d5lf7O_, 0.9002, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
533, d5lexA_, 0.9002, 0.94, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
534, p5lf6O_, 0.9001, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
535, d5lf4O_, 0.9001, 0.94, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
536, d5le5O_, 0.9001, 0.94, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
537, p3uneq_, 0.9000, 1.13, 0.608, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
538, d3unbq_, 0.9000, 1.04, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
539, d3unbA_, 0.8998, 1.04, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
540, p5lf0O_, 0.8997, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
541, d3unbO_, 0.8997, 1.05, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
542, d3unbc_, 0.8996, 1.05, 0.606, 231, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
543, p5leyA_, 0.8995, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
544, p5lf6A_, 0.8994, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
545, p5gjqi_, 0.8994, 1.05, 0.602, 231, 231, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
546, d5lf3A_, 0.8993, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
547, d5lf4A_, 0.8992, 0.96, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
548, d5lf1A_, 0.8992, 0.97, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
549, p3uneA_, 0.8990, 1.17, 0.603, 233, 232, MOUSE CONSTITUTIVE 20S PROTEASOME
550, d5lf7A_, 0.8989, 0.97, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
551, p5lf0A_, 0.8988, 0.98, 0.613, 230, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
552, d5le5A_, 0.8988, 0.97, 0.613, 230, 230, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
553, d1iruB_, 0.8988, 1.18, 0.608, 233, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
554, p6avoP_, 0.8970, 1.00, 0.613, 230, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
555, p6avob_, 0.8970, 1.00, 0.613, 230, 230, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
556, p3unhO_, 0.8944, 1.08, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME
557, p3unhA_, 0.8944, 1.08, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME
558, d3unfO_, 0.8937, 1.10, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
559, d3unfA_, 0.8937, 1.10, 0.609, 230, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
560, p5m32O_, 0.8934, 1.06, 0.613, 230, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
561, p5m32A_, 0.8934, 1.06, 0.613, 230, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
562, p5vfsAA_, 0.8929, 1.17, 0.610, 232, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
563, p5vfsB_, 0.8926, 1.18, 0.610, 232, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
564, p5vfoh_, 0.8917, 1.19, 0.602, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
565, p5vfqAA_, 0.8914, 1.20, 0.602, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
566, p5vfpZ_, 0.8914, 1.20, 0.602, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
567, p5vfrh_, 0.8908, 1.20, 0.602, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
568, p5vfuS_, 0.8905, 1.21, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
569, p5vftH_, 0.8905, 1.21, 0.610, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
570, p5t0cZA_, 0.8904, 1.22, 0.610, 232, 231, 
571, p5t0cT_, 0.8904, 1.22, 0.610, 232, 231, 
572, p5vfuGA_, 0.8870, 1.27, 0.610, 232, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
573, p5vfth_, 0.8870, 1.27, 0.610, 232, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
574, p5t0gH_, 0.8857, 1.42, 0.608, 233, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
575, p5t0hH_, 0.8749, 1.50, 0.606, 232, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
576, p5ln3B_, 0.8738, 1.57, 0.616, 234, 232, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
577, d4r02P_, 0.8723, 2.14, 0.357, 244, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
578, d2gplP_, 0.8711, 2.20, 0.362, 244, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
579, d1rypQ_, 0.8711, 2.19, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
580, d4eu2Q_, 0.8710, 2.20, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
581, d2gplB_, 0.8710, 2.20, 0.362, 244, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
582, d4q1sP_, 0.8708, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
583, d3nzjP_, 0.8708, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
584, d3hyeP_, 0.8708, 2.20, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
585, d3wxrQ_, 0.8707, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
586, d3nzjB_, 0.8707, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
587, d3unfP_, 0.8706, 1.98, 0.356, 248, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
588, p3unfB_, 0.8706, 1.98, 0.356, 248, 233, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
589, d3hyeB_, 0.8706, 2.20, 0.357, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
590, d2fakP_, 0.8706, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
591, d5lajP_, 0.8705, 2.18, 0.353, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
592, d5fgaP_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
593, d5cgfP_, 0.8705, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
594, d5bouP_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
595, d5bouB_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
596, d4rurP_, 0.8705, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
597, d4r18P_, 0.8705, 2.17, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
598, d4r17P_, 0.8705, 2.16, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
599, d4r17B_, 0.8705, 2.16, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
600, d4qluP_, 0.8705, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
601, p4qluB_, 0.8705, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
602, d3nzwP_, 0.8705, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
603, d5lajB_, 0.8704, 2.18, 0.353, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
604, d5fgaB_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
605, d5cgfB_, 0.8704, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
606, d4z1lP_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
607, p4y6vP_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
608, d4rurB_, 0.8704, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
609, d4qlqP_, 0.8704, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
610, d4lqiP_, 0.8704, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
611, d3nzwB_, 0.8704, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
612, d2fnyP_, 0.8704, 2.23, 0.362, 244, 235,  
613, d2fakB_, 0.8704, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
614, d5bxlP_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
615, d4z1lB_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
616, d4y9yP_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
617, p4y8sP_, 0.8703, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
618, p4y6vB_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
619, p4y69P_, 0.8703, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
620, p4r18B_, 0.8703, 2.18, 0.357, 244, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
621, p4qlqB_, 0.8703, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
622, d4lqiB_, 0.8703, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
623, d3tddP_, 0.8703, 2.22, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
624, d2fnyB_, 0.8703, 2.23, 0.362, 244, 235,  
625, d5laiP_, 0.8702, 2.17, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
626, d5laiB_, 0.8702, 2.17, 0.357, 244, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
627, d5fg7P_, 0.8702, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
628, d5fg7B_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
629, d5cz4P_, 0.8702, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
630, d5bxlB_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
631, p4ya5P_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
632, d4ya4P_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
633, d4ya4B_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
634, d4ya1P_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
635, p4ya0P_, 0.8702, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
636, p4ya0B_, 0.8702, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
637, d4y9yB_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
638, p4y8sB_, 0.8702, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
639, d4y8rP_, 0.8702, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
640, p4y8nP_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
641, p4y69B_, 0.8702, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
642, d4qwfP_, 0.8702, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
643, d4qw6P_, 0.8702, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
644, d4qw1P_, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
645, d4qvyP_, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
646, d4qvwP_, 0.8702, 2.17, 0.357, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
647, d4qvlP_, 0.8702, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH BORTEZOMIB
648, d4qltP_, 0.8702, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
649, d3gpwP_, 0.8702, 2.21, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
650, d3e47P_, 0.8702, 2.23, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
651, d1g65P_, 0.8702, 2.21, 0.353, 244, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
652, d5l54P_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
653, d5fg9P_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
654, d5dkiP_, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
655, d5d0tP_, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
656, d5czaP_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
657, d5cz6P_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
658, d5cz6B_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
659, d5cz4B_, 0.8701, 2.17, 0.353, 244, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
660, p4ya5B_, 0.8701, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
661, d4ya1B_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
662, p4y8uP_, 0.8701, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
663, d4y8rB_, 0.8701, 2.16, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
664, p4y8nB_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
665, d4y8mP_, 0.8701, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
666, d4qz2P_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
667, d4qz2B_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
668, d4qwfB_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
669, d4qw6B_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
670, d4qw1B_, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
671, d4qvyB_, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
672, d4qvwB_, 0.8701, 2.17, 0.357, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
673, d4qvmP_, 0.8701, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
674, d4qvlB_, 0.8701, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH BORTEZOMIB
675, p4qltB_, 0.8701, 2.17, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
676, d4intP_, 0.8701, 2.23, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
677, d3tddB_, 0.8701, 2.22, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
678, d3gpwB_, 0.8701, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
679, d3e47B_, 0.8701, 2.23, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
680, d5lf4B_, 0.8700, 1.98, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
681, d5l54B_, 0.8700, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
682, d5fg9B_, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
683, d5dkjP_, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
684, d5dkjB_, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
685, d5dkiB_, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
686, d5d0xP_, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
687, d5d0wP_, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
688, d5d0wB_, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
689, d5d0tB_, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
690, d5czaB_, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
691, d5cz8P_, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
692, p4ya3P_, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
693, p4y8uB_, 0.8700, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
694, d4y8mB_, 0.8700, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
695, p4y8iP_, 0.8700, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
696, d4qz1P_, 0.8700, 2.19, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
697, d4qz1B_, 0.8700, 2.19, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
698, d4qwuP_, 0.8700, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
699, d4qw0P_, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
700, d4qw0B_, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
701, d4qvvP_, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
702, d4qvpP_, 0.8700, 2.17, 0.357, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
703, d4qvmB_, 0.8700, 2.18, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
704, d4qlsP_, 0.8700, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
705, p4qlsB_, 0.8700, 2.19, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
706, d4nnwP_, 0.8700, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
707, p3unhP_, 0.8700, 1.99, 0.356, 248, 233, MOUSE 20S IMMUNOPROTEASOME
708, p3unhB_, 0.8700, 1.99, 0.356, 248, 233, MOUSE 20S IMMUNOPROTEASOME
709, d5l65P_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
710, d5l65B_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
711, d5l5sP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
712, d5l5iP_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
713, d5l5iB_, 0.8699, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
714, p5gjqD_, 0.8699, 1.98, 0.356, 240, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
715, p5fghP_, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
716, d5d0xB_, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
717, d5cz8B_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
718, d5cz7P_, 0.8699, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
719, p4ya3B_, 0.8699, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
720, p4y8iB_, 0.8699, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
721, p4y84P_, 0.8699, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
722, d4qz4P_, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
723, d4qz0P_, 0.8699, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
724, d4qxjP_, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
725, d4qxjB_, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
726, d4qwuB_, 0.8699, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
727, d4qw7P_, 0.8699, 2.19, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
728, d4qw4P_, 0.8699, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH CARFILZOMIB
729, d4qvvB_, 0.8699, 2.18, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
730, d4qvqP_, 0.8699, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
731, d4qvpB_, 0.8699, 2.17, 0.357, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
732, d4qvnP_, 0.8699, 2.17, 0.357, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
733, d4quxP_, 0.8699, 2.18, 0.357, 244, 235, YCP BETA5-A49T-MUTANT
734, d4nnwB_, 0.8699, 2.18, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
735, d3nzxP_, 0.8699, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
736, d5le5B_, 0.8698, 1.98, 0.356, 248, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
737, d5l69P_, 0.8698, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
738, d5l60P_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
739, d5l5zP_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
740, d5l5sB_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
741, d5l5eP_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
742, d5l5eB_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
743, d5fgiP_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
744, p5fghB_, 0.8698, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
745, d5cz7B_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
746, d5bxnP_, 0.8698, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
747, p4ya9P_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
748, p4ya2P_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
749, p4y8lP_, 0.8698, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
750, p4y8gP_, 0.8698, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
751, p4y8gB_, 0.8698, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
752, p4y84B_, 0.8698, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
753, p4y6aP_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
754, p4y6aB_, 0.8698, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
755, d4qz7P_, 0.8698, 2.17, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
756, d4qz6P_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
757, d4qz5P_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
758, d4qz5B_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
759, d4qz4B_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
760, d4qz0B_, 0.8698, 2.18, 0.353, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
761, d4qwiP_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
762, d4qw7B_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
763, d4qw5P_, 0.8698, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
764, d4qw4B_, 0.8698, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH CARFILZOMIB
765, d4qvqB_, 0.8698, 2.18, 0.353, 244, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
766, d4qvnB_, 0.8698, 2.18, 0.357, 244, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
767, d4qv6P_, 0.8698, 2.18, 0.357, 244, 235, YCP BETA5-A49V MUTANT
768, d4quxB_, 0.8698, 2.18, 0.357, 244, 235, YCP BETA5-A49T-MUTANT
769, d4ltcP_, 0.8698, 2.20, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
770, d3d29B_, 0.8698, 2.24, 0.357, 244, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
771, p6gopP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
772, d5m2bP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
773, d5lttP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
774, d5lttB_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
775, d5lf3B_, 0.8697, 1.98, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
776, p5lezB_, 0.8697, 1.99, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
777, d5l6bP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
778, d5l69B_, 0.8697, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
779, d5l68P_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
780, d5l60B_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
781, d5l5zB_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
782, d5l5xP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
783, d5l5tP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
784, d5l5tB_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
785, d5l5jP_, 0.8697, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
786, d5l5hP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
787, d5l5fP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
788, d5l5fB_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
789, d5l5dP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
790, d5l5aP_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
791, d5jhsP_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
792, d5fgiB_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
793, d5d0vP_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
794, p5cgiP_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
795, d5bxnB_, 0.8697, 2.17, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
796, p4ya9B_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
797, p4ya2B_, 0.8697, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
798, p4y9zP_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
799, p4y8lB_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
800, p4y8hP_, 0.8697, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
801, p4y7xP_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
802, p4y7xB_, 0.8697, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
803, d4qzzP_, 0.8697, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH OMURALIDE
804, d4qz7B_, 0.8697, 2.17, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
805, d4qz6B_, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
806, d4qwlP_, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
807, d4qwiB_, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
808, d4qw5B_, 0.8697, 2.19, 0.353, 244, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
809, d4qw3P_, 0.8697, 2.18, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
810, d4qw3B_, 0.8697, 2.18, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
811, d4qv6B_, 0.8697, 2.18, 0.357, 244, 235, YCP BETA5-A49V MUTANT
812, d4quyP_, 0.8697, 2.18, 0.357, 244, 235, YCP BETA5-A49S-MUTANT
813, d4quyB_, 0.8697, 2.18, 0.357, 244, 235, YCP BETA5-A49S-MUTANT
814, d4hrdP_, 0.8697, 2.20, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
815, d3nzxB_, 0.8697, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
816, d3mg4P_, 0.8697, 2.27, 0.362, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
817, d3dy4P_, 0.8697, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
818, d3dy4B_, 0.8697, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
819, d3d29P_, 0.8697, 2.24, 0.357, 244, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
820, d2f16P_, 0.8697, 2.22, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
821, p6gopB_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
822, d5m2bB_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
823, d5lf7B_, 0.8696, 1.98, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
824, d5l6cP_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
825, d5l6bB_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
826, d5l68B_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
827, d5l67P_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
828, d5l66P_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
829, d5l66B_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
830, d5l64P_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
831, d5l63P_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
832, d5l63B_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
833, d5l5yP_, 0.8696, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
834, d5l5xB_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
835, d5l5uP_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
836, d5l5uB_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
837, d5l5pP_, 0.8696, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
838, d5l5jB_, 0.8696, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
839, d5l5hB_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
840, d5l5dB_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
841, d5l5aB_, 0.8696, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
842, d5jhsB_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
843, d5fgfP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
844, d5fgdP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
845, d5d0zP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
846, d5d0vB_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
847, p5cgiB_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
848, p5cghP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
849, p4y9zB_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
850, p4y8pP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
851, p4y8pB_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
852, p4y8oP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
853, p4y8jP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
854, p4y8jB_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
855, p4y8hB_, 0.8696, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
856, p4y7yP_, 0.8696, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
857, d4qzzB_, 0.8696, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH OMURALIDE
858, d4qzxP_, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
859, d4qzxB_, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
860, d4qzwP_, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
861, d4qz3P_, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
862, d4qwxP_, 0.8696, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
863, d4qwxB_, 0.8696, 2.19, 0.353, 244, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
864, d4qwrP_, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
865, d4qwlB_, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
866, d4qwkP_, 0.8696, 2.19, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
867, d4qwjP_, 0.8696, 2.20, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
868, p4gk7P_, 0.8696, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
869, d3mg0P_, 0.8696, 2.26, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
870, d3gptP_, 0.8696, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
871, d3dy3P_, 0.8696, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
872, d3dy3B_, 0.8696, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
873, p5t0iH_, 0.8695, 1.56, 0.613, 233, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
874, p5lf0B_, 0.8695, 1.99, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
875, d5l6cB_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
876, d5l67B_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
877, d5l64B_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
878, d5l5yB_, 0.8695, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
879, d5l5wP_, 0.8695, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
880, d5l5qP_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
881, d5l5qB_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
882, d5l5pB_, 0.8695, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
883, d5l5oP_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
884, d5l5oB_, 0.8695, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
885, d5l52P_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
886, d5jhrP_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
887, d5fgfB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
888, d5fgdB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
889, d5d0zB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
890, d5cz9P_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
891, p5cghB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
892, p4y8oB_, 0.8695, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
893, p4y80P_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
894, p4y7yB_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
895, p4y78P_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
896, p4y78B_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
897, p4y77P_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
898, p4y77B_, 0.8695, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
899, d4qzwB_, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
900, d4qz3B_, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
901, d4qwrB_, 0.8695, 2.19, 0.353, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
902, d4qwkB_, 0.8695, 2.20, 0.353, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
903, d4qwjB_, 0.8695, 2.20, 0.353, 244, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
904, d4qv9P_, 0.8695, 2.18, 0.357, 244, 235, YCP BETA5-C63F MUTANT
905, d4qv8P_, 0.8695, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT
906, d4qv7P_, 0.8695, 2.18, 0.357, 244, 235, YCP BETA5-A50V MUTANT
907, d4intB_, 0.8695, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
908, d4inrP_, 0.8695, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
909, d4hnpP_, 0.8695, 2.23, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
910, p4gk7B_, 0.8695, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
911, d3gptB_, 0.8695, 2.22, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
912, d2f16B_, 0.8695, 2.23, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
913, p6epfB_, 0.8694, 1.65, 0.608, 234, 232, GROUND STATE 26S PROTEASOME (GS1)
914, p5leyB_, 0.8694, 1.99, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
915, d5l62P_, 0.8694, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
916, d5l62B_, 0.8694, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
917, d5l5wB_, 0.8694, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
918, d5l5vP_, 0.8694, 2.19, 0.357, 244, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
919, d5l52B_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
920, d5jhrB_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
921, p5gjrIA_, 0.8694, 1.98, 0.356, 250, 233, 
922, d5fhsP_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
923, d5fgeP_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
924, d5d0sP_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
925, d5cz9B_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
926, d5cz5P_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
927, d5cz5B_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
928, p5cggP_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
929, p4ya7P_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
930, p4ya7B_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
931, p4y8tP_, 0.8694, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
932, p4y8tB_, 0.8694, 2.18, 0.353, 244, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
933, p4y8qP_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
934, p4y8qB_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
935, p4y8kP_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
936, p4y82P_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
937, p4y81P_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
938, p4y81B_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
939, p4y80B_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
940, p4y70P_, 0.8694, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
941, d4r00P_, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
942, d4r00B_, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
943, d4qv9B_, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-C63F MUTANT
944, d4qv8B_, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-C52F MUTANT
945, d4qv7B_, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-A50V MUTANT
946, d4qv1P_, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-M45A MUTANT
947, d4qv0P_, 0.8694, 2.18, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
948, d4qv0B_, 0.8694, 2.19, 0.357, 244, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
949, d4jsuP_, 0.8694, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
950, d4jsuB_, 0.8694, 2.22, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
951, d5lf1B_, 0.8693, 1.99, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
952, d5l6aP_, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
953, d5l61P_, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
954, d5l61B_, 0.8693, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
955, d5l5vB_, 0.8693, 2.19, 0.357, 244, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
956, d5l5rP_, 0.8693, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
957, d5l5bP_, 0.8693, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
958, d5l55P_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
959, d5l55B_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
960, d5fhsB_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
961, d5fggP_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
962, d5fggB_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
963, d5fgeB_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
964, d5d0sB_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
965, p5cggB_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
966, p4y8kB_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
967, p4y82B_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
968, p4y7wP_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
969, p4y75P_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
970, p4y74P_, 0.8693, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
971, p4y70B_, 0.8693, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
972, d4qwsP_, 0.8693, 2.19, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
973, d4qv1B_, 0.8693, 2.18, 0.357, 244, 235, YCP BETA5-M45A MUTANT
974, d3okjP_, 0.8693, 2.23, 0.362, 244, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
975, d3gpjP_, 0.8693, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
976, d3gpjB_, 0.8693, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
977, d5l6aB_, 0.8692, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
978, d5l5rB_, 0.8692, 2.19, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
979, d5l5bB_, 0.8692, 2.18, 0.357, 244, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
980, p4y7wB_, 0.8692, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
981, p4y75B_, 0.8692, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
982, p4y74B_, 0.8692, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
983, d4qwsB_, 0.8692, 2.20, 0.353, 244, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
984, d4qv4P_, 0.8692, 2.19, 0.357, 244, 235, YCP BETA5-M45T MUTANT
985, d4qlvP_, 0.8692, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
986, d4no9P_, 0.8692, 2.21, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
987, d4inrB_, 0.8692, 2.25, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
988, d4fzcP_, 0.8692, 2.25, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
989, d3okjB_, 0.8692, 2.23, 0.362, 244, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
990, p5lezP_, 0.8691, 2.01, 0.356, 247, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
991, d5lexB_, 0.8691, 2.00, 0.356, 248, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
992, p5gjrU_, 0.8691, 1.99, 0.356, 250, 233, 
993, p4y6zP_, 0.8691, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
994, p4y6zB_, 0.8691, 2.20, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
995, d4qv4B_, 0.8691, 2.19, 0.357, 244, 235, YCP BETA5-M45T MUTANT
996, d4qv3P_, 0.8691, 2.19, 0.357, 244, 235, YCP BETA5-M45V MUTANT
997, p4qlvB_, 0.8691, 2.18, 0.357, 244, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
998, p4qbyP_, 0.8691, 2.17, 0.353, 244, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
999, d4no9B_, 0.8691, 2.21, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1000, d4j70P_, 0.8691, 2.26, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1001, d4fzcB_, 0.8691, 2.25, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1002, d3bdmP_, 0.8691, 2.27, 0.357, 244, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1003, d4qv5P_, 0.8690, 2.19, 0.357, 244, 235, YCP BETA5-M45I MUTANT
1004, d4qv5B_, 0.8690, 2.19, 0.357, 244, 235, YCP BETA5-M45I MUTANT
1005, d4qv3B_, 0.8690, 2.19, 0.357, 244, 235, YCP BETA5-M45V MUTANT
1006, p4qbyB_, 0.8690, 2.17, 0.353, 244, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1007, d4nnnP_, 0.8690, 2.20, 0.353, 244, 235, YCP IN COMPLEX WITH MG132
1008, d4nnnB_, 0.8690, 2.20, 0.353, 244, 235, YCP IN COMPLEX WITH MG132
1009, d3bdmB_, 0.8690, 2.27, 0.357, 244, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1010, d1g65B_, 0.8690, 2.22, 0.362, 244, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1011, p5lf6B_, 0.8689, 2.00, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1012, d5ahjP_, 0.8689, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1013, d5ahjB_, 0.8689, 2.19, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1014, d4r02B_, 0.8689, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1015, d4inuP_, 0.8689, 2.25, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1016, d1rypC_, 0.8689, 2.22, 0.362, 244, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1017, d4jsqP_, 0.8688, 2.25, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1018, d3unfQ_, 0.8688, 1.52, 0.336, 238, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1019, d3unfC_, 0.8688, 1.52, 0.336, 238, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1020, d3shjP_, 0.8688, 2.25, 0.357, 244, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1021, d2zcyP_, 0.8688, 2.25, 0.357, 244, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1022, d2zcyB_, 0.8688, 2.25, 0.357, 244, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1023, d4qwgP_, 0.8687, 2.21, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1024, d4no6P_, 0.8687, 2.21, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1025, d4no6B_, 0.8687, 2.21, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1026, d4no1P_, 0.8687, 2.20, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1027, d4jsqB_, 0.8687, 2.25, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1028, p3un4P_, 0.8687, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1029, d3dy3R_, 0.8687, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1030, d3dy3D_, 0.8687, 1.60, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1031, d4qwgB_, 0.8686, 2.21, 0.353, 244, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1032, d4no1B_, 0.8686, 2.20, 0.353, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1033, d4hrcP_, 0.8686, 2.26, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1034, p3unhQ_, 0.8686, 1.52, 0.336, 238, 229, MOUSE 20S IMMUNOPROTEASOME
1035, p3unhC_, 0.8686, 1.52, 0.336, 238, 229, MOUSE 20S IMMUNOPROTEASOME
1036, p3unbB_, 0.8686, 2.03, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1037, p3un4B_, 0.8686, 2.24, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1038, d3shjB_, 0.8686, 2.25, 0.357, 244, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1039, d5lf4P_, 0.8685, 2.01, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1040, d4jt0P_, 0.8685, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1041, d4jt0B_, 0.8685, 2.23, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1042, d4j70D_, 0.8685, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1043, d3un8P_, 0.8685, 2.25, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1044, d5lf1P_, 0.8684, 2.01, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1045, d5le5P_, 0.8684, 2.01, 0.356, 247, 233, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1046, p4x6zQ_, 0.8684, 2.22, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1047, p4q1sB_, 0.8684, 2.20, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1048, d4no8P_, 0.8684, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1049, d4j70R_, 0.8684, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1050, d4j70B_, 0.8684, 2.26, 0.353, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1051, d4inuB_, 0.8684, 2.25, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1052, d4fzgP_, 0.8684, 2.26, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1053, p3unbP_, 0.8684, 2.03, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1054, d4no8B_, 0.8683, 2.20, 0.357, 244, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1055, d4fzgB_, 0.8683, 2.26, 0.357, 244, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1056, d4eu2S_, 0.8683, 1.63, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1057, d3mg0R_, 0.8683, 1.60, 0.329, 242, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1058, d4hnpB_, 0.8682, 2.24, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1059, d3mg0D_, 0.8682, 1.61, 0.329, 242, 228, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1060, p5nifS_, 0.8681, 1.46, 0.330, 236, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1061, p5lezC_, 0.8681, 1.45, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1062, p4zzgS_, 0.8681, 1.46, 0.330, 236, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1063, p3unbd_, 0.8681, 2.03, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1064, d3dy4D_, 0.8681, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1065, d2gplD_, 0.8681, 1.60, 0.329, 242, 228, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1066, d2fakR_, 0.8681, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1067, d2fakD_, 0.8681, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1068, d5lf7P_, 0.8680, 2.02, 0.356, 247, 233, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1069, d4ltcB_, 0.8680, 2.22, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1070, d3nzjR_, 0.8680, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1071, d3nzjD_, 0.8680, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1072, d3mg0B_, 0.8680, 2.28, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1073, d3dy4R_, 0.8680, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1074, d2zcyD_, 0.8680, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1075, d2gplR_, 0.8680, 1.60, 0.329, 242, 228, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1076, p5lf6P_, 0.8679, 2.02, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1077, d5lf3P_, 0.8679, 2.02, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1078, d4lqiR_, 0.8679, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1079, d4lqiD_, 0.8679, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1080, d3tddR_, 0.8679, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1081, d3tddD_, 0.8679, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1082, d2zcyR_, 0.8679, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1083, p5mp9c_, 0.8678, 2.16, 0.353, 244, 235, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1084, p5lf0P_, 0.8678, 2.03, 0.356, 248, 233, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1085, d4intD_, 0.8678, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1086, d4eu2E_, 0.8678, 1.67, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1087, p3unbr_, 0.8678, 2.04, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1088, d5lexP_, 0.8677, 2.03, 0.356, 247, 233, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1089, p4fzgD_, 0.8677, 1.61, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1090, d4q1sD_, 0.8676, 1.66, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1091, p4gk7D_, 0.8676, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1092, p4fzgR_, 0.8676, 1.61, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1093, d3gpwD_, 0.8676, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1094, d3d29R_, 0.8676, 1.62, 0.329, 242, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1095, d3d29D_, 0.8676, 1.62, 0.329, 242, 228, PROTEASOME INHIBITION BY FELLUTAMIDE B
1096, p5nifQ_, 0.8675, 2.01, 0.361, 242, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1097, p4zzgQ_, 0.8675, 2.02, 0.361, 242, 233, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1098, p4gk7R_, 0.8675, 1.61, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1099, p3un4D_, 0.8675, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1100, d3gpwR_, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1101, d3gptD_, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1102, d3gpjR_, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1103, d3gpjD_, 0.8675, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1104, d2f16R_, 0.8675, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1105, d2f16D_, 0.8675, 1.61, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1106, p5leyP_, 0.8674, 2.03, 0.356, 247, 233, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1107, d4q1sR_, 0.8674, 1.64, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1108, p4jt0D_, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1109, d4intR_, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1110, d4hrdB_, 0.8674, 2.24, 0.362, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1111, d3un8B_, 0.8674, 2.26, 0.362, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1112, p3un4R_, 0.8674, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1113, d3nzwD_, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1114, d3hyeR_, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1115, d3hyeD_, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1116, d3gptR_, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1117, p3e47D_, 0.8674, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1118, d1jd2W_, 0.8674, 2.25, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1119, d5lf7C_, 0.8673, 1.46, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1120, p4jt0R_, 0.8673, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1121, d4inrD_, 0.8673, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1122, d3okjR_, 0.8673, 1.62, 0.329, 242, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1123, d3okjD_, 0.8673, 1.62, 0.329, 242, 228, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1124, d3nzwR_, 0.8673, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1125, p3e47R_, 0.8673, 1.62, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1126, p5l4gQ_, 0.8672, 2.01, 0.356, 240, 233, 
1127, p5gjqj_, 0.8672, 2.01, 0.356, 240, 233, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1128, d4jsuR_, 0.8672, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1129, d4jsuD_, 0.8672, 1.62, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1130, p4inuD_, 0.8672, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1131, p3unbe_, 0.8672, 1.53, 0.332, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1132, d5le5C_, 0.8671, 1.47, 0.338, 236, 228, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1133, d4inrR_, 0.8671, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1134, d4hrdD_, 0.8671, 1.66, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1135, d4fzcD_, 0.8671, 1.62, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1136, d3nzxD_, 0.8671, 1.63, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1137, d4jsqD_, 0.8670, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1138, d4hrcB_, 0.8670, 2.29, 0.357, 244, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1139, d4fzcR_, 0.8670, 1.62, 0.329, 242, 228, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1140, d3wxrS_, 0.8670, 1.47, 0.330, 238, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1141, d3shjR_, 0.8670, 1.62, 0.329, 242, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1142, d3shjD_, 0.8670, 1.62, 0.329, 242, 228, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1143, d3nzxR_, 0.8670, 1.63, 0.329, 242, 228, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1144, d5lf4C_, 0.8669, 1.47, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1145, p5leyC_, 0.8669, 1.47, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1146, d5lexC_, 0.8669, 1.47, 0.338, 236, 228, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1147, d4ltcD_, 0.8669, 1.64, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1148, d4jsqR_, 0.8669, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1149, d4eu2C_, 0.8669, 2.26, 0.362, 244, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1150, d5lf3C_, 0.8668, 1.47, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1151, d5lf1C_, 0.8668, 1.47, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1152, d4ltcR_, 0.8668, 1.64, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1153, p4inuR_, 0.8668, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1154, d3un8D_, 0.8668, 1.63, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1155, d4q1sC_, 0.8667, 1.54, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1156, d4hrcD_, 0.8667, 1.65, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1157, d3mg8R_, 0.8667, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1158, d1g65D_, 0.8667, 1.64, 0.329, 242, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1159, p5lf6C_, 0.8666, 1.48, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1160, d3mg7R_, 0.8666, 1.46, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1161, p5lf0C_, 0.8665, 1.48, 0.338, 236, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1162, p3uneP_, 0.8665, 2.05, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1163, d3dy4C_, 0.8665, 1.53, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1164, d5l60R_, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1165, d5l60D_, 0.8664, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1166, d3un8R_, 0.8664, 1.64, 0.329, 242, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1167, d3mg8D_, 0.8664, 1.48, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1168, d3dy4Q_, 0.8664, 1.53, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1169, d3bdmD_, 0.8664, 1.45, 0.330, 242, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1170, d2zcyC_, 0.8664, 1.53, 0.367, 241, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1171, p5nifD_, 0.8663, 1.54, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1172, d5lttR_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1173, d5lttD_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1174, d5l62R_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1175, d5l62D_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1176, d5l5yD_, 0.8663, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1177, p4zzgD_, 0.8663, 1.54, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1178, d4hrcR_, 0.8663, 1.68, 0.329, 242, 228, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1179, d3oeuD_, 0.8663, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1180, d3mg6R_, 0.8663, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1181, d3bdmR_, 0.8663, 1.45, 0.330, 242, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1182, d2zcyQ_, 0.8663, 1.53, 0.367, 241, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1183, d5l5zR_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1184, d5l5zD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1185, d5l5yR_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1186, d5l5xR_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1187, d5l5xD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1188, d5l5wR_, 0.8662, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1189, d5l5wD_, 0.8662, 1.57, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1190, d5l5sD_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1191, p4ya0R_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1192, p4ya0D_, 0.8662, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1193, p3unbQ_, 0.8662, 1.54, 0.336, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1194, d3oevR_, 0.8662, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1195, d1rypE_, 0.8662, 1.46, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1196, d1jd2B_, 0.8662, 2.27, 0.353, 244, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1197, d5l63R_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1198, d5l63D_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1199, d5l61R_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1200, d5l61D_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1201, d5l5vR_, 0.8661, 1.58, 0.330, 235, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1202, d5l5vD_, 0.8661, 1.58, 0.330, 235, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1203, d5l5tR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1204, d5l5tD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1205, d5l5sR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1206, d5l5iR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1207, d5l5iD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1208, d5l5eR_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1209, d5l5eD_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1210, p5l4gC_, 0.8661, 2.04, 0.356, 240, 233, 
1211, d5cz4R_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1212, d5cz4D_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1213, p4ya5D_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1214, p4ya3R_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1215, p4ya3D_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1216, p4y8uR_, 0.8661, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1217, p4y8uD_, 0.8661, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1218, p4y69R_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1219, p4y69D_, 0.8661, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1220, p4r67s_, 0.8661, 2.04, 0.356, 240, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1221, d4r67Q_, 0.8661, 2.04, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1222, p4r67e_, 0.8661, 2.04, 0.356, 239, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1223, d4r67C_, 0.8661, 2.04, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1224, d4qw3R_, 0.8661, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1225, d4qw3D_, 0.8661, 1.58, 0.330, 235, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1226, d4qvvR_, 0.8661, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1227, d4qvvD_, 0.8661, 1.58, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1228, d4hnpR_, 0.8661, 1.46, 0.330, 242, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1229, d4hnpD_, 0.8661, 1.46, 0.330, 242, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1230, p3unbC_, 0.8661, 1.56, 0.332, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1231, d3dy3C_, 0.8661, 1.53, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1232, d5l6cR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1233, d5l6cD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1234, d5l68R_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1235, d5l68D_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1236, d5l65R_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1237, d5l65D_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1238, d5l64R_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1239, d5l64D_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1240, d5l5qR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1241, d5l5qD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1242, d5l5pR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1243, d5l5pD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1244, d5l5jR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1245, d5l5jD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1246, d5l5aR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1247, d5l5aD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1248, p5fghR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1249, p5fghD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1250, d5dkiR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1251, d5dkiD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1252, p4ya5R_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1253, p4y8nR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1254, p4y8nD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1255, p4y6vR_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1256, p4y6vD_, 0.8660, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1257, d4r3oQ_, 0.8660, 2.05, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
1258, d4r3oC_, 0.8660, 2.05, 0.356, 250, 233, HUMAN CONSTITUTIVE 20S PROTEASOME
1259, p3unbs_, 0.8660, 1.55, 0.336, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1260, d3mg4R_, 0.8660, 1.47, 0.330, 242, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1261, d3mg4B_, 0.8660, 2.33, 0.357, 244, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1262, d3dy3Q_, 0.8660, 1.54, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1263, d5l69R_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1264, d5l69D_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1265, d5l67R_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1266, d5l67D_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1267, d5l5oR_, 0.8659, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1268, d5l5oD_, 0.8659, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1269, d5l5hD_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1270, d5l5fR_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1271, d5l5fD_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1272, d5d0xR_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1273, d5d0xD_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1274, d5bouR_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1275, d5bouD_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1276, p4zzgR_, 0.8659, 1.55, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1277, p4y6aR_, 0.8659, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1278, p4y6aD_, 0.8659, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1279, d4rurR_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1280, d4rurD_, 0.8659, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1281, d4hrdR_, 0.8659, 1.49, 0.330, 242, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1282, d3oevD_, 0.8659, 1.48, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1283, d3mg6D_, 0.8659, 1.48, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1284, p5nifR_, 0.8658, 1.56, 0.362, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1285, d5m2bR_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1286, d5m2bD_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1287, d5lajR_, 0.8658, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1288, d5lajD_, 0.8658, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1289, d5l6bR_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1290, d5l6bD_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1291, d5l66R_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1292, d5l66D_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1293, d5l5hR_, 0.8658, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1294, d5dkjD_, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1295, d5cz7R_, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1296, d5cz7D_, 0.8658, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1297, d4qwjR_, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1298, d4qwjD_, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1299, d4qw0R_, 0.8658, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1300, d4qw0D_, 0.8658, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1301, d4qvmR_, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1302, d4qvmD_, 0.8658, 1.58, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1303, d4q1sQ_, 0.8658, 1.53, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1304, d3oeuR_, 0.8658, 1.53, 0.330, 236, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1305, d3mg4D_, 0.8658, 1.50, 0.330, 242, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1306, p3jcpLA_, 0.8658, 2.21, 0.362, 244, 235, 
1307, p3jcpL_, 0.8658, 2.21, 0.362, 244, 235, 
1308, d1g65R_, 0.8658, 1.65, 0.329, 242, 228, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1309, d5laiR_, 0.8657, 1.59, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1310, d5laiD_, 0.8657, 1.58, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1311, d5l5uR_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1312, d5l5uD_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1313, d5fg9R_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1314, d5fg9D_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1315, d5dkjR_, 0.8657, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1316, d5d0tR_, 0.8657, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1317, d5d0tD_, 0.8657, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1318, d4y9yD_, 0.8657, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1319, p4quxR_, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT
1320, p4quxD_, 0.8657, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT
1321, d3mg7D_, 0.8657, 1.48, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1322, d5l6aD_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1323, d5l5rR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1324, d5l5rD_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1325, d5l5dR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1326, d5l5dD_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1327, d5fgaR_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1328, d5fgaD_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1329, d5cz6R_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1330, d5cz6D_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1331, d4z1lD_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1332, d4y9yR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1333, p4y8oR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1334, p4y8oD_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1335, d4y8mR_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1336, d4y8mD_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1337, p4y8iR_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1338, p4y8iD_, 0.8656, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1339, p4y78D_, 0.8656, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1340, d4r18R_, 0.8656, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1341, d4r18D_, 0.8656, 1.59, 0.330, 235, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1342, d4qwiR_, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1343, d4qwiD_, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1344, d4qvyR_, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1345, d4qvyD_, 0.8656, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1346, p4qvwR_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1347, p4qvwD_, 0.8656, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1348, d1rypS_, 0.8656, 1.46, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1349, d5l6aR_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1350, d5l5bR_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1351, d5l5bD_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1352, d5cgfR_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1353, d5cgfD_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1354, d4z1lR_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1355, d4ya1D_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1356, p4y8tD_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1357, p4y78R_, 0.8655, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1358, p4x6zR_, 0.8655, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1359, p4x6zC_, 0.8655, 2.30, 0.357, 244, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1360, p4qz1D_, 0.8655, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1361, d4eu2D_, 0.8655, 1.56, 0.362, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1362, d3wxrE_, 0.8655, 1.68, 0.329, 239, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1363, d5fg7R_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1364, d5fg7D_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1365, d5bxlR_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1366, d5bxlD_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1367, d4ya1R_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1368, p4y8tR_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1369, p4y80R_, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1370, p4y80D_, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1371, p4y7yR_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1372, p4y7yD_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1373, p4y7xR_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1374, p4y7xD_, 0.8654, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1375, p4y7wR_, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1376, p4y7wD_, 0.8654, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1377, d4r00R_, 0.8654, 1.60, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1378, d4r00D_, 0.8654, 1.60, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1379, d4qz5R_, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1380, d4qz5D_, 0.8654, 1.58, 0.330, 235, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1381, p4qz1R_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1382, d4qw4R_, 0.8654, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH CARFILZOMIB
1383, d4qw4D_, 0.8654, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH CARFILZOMIB
1384, d4qvqR_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1385, d4qvqD_, 0.8654, 1.59, 0.330, 235, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1386, d4qvlR_, 0.8654, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH BORTEZOMIB
1387, d4qvlD_, 0.8654, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH BORTEZOMIB
1388, p3uner_, 0.8654, 2.08, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1389, p6avoZ_, 0.8653, 2.05, 0.356, 240, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1390, p6avoO_, 0.8653, 2.05, 0.356, 240, 233, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1391, d5czaR_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1392, d5czaD_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1393, p4y8lR_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1394, p4y8lD_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1395, p4y8jR_, 0.8653, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1396, p4y8jD_, 0.8653, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1397, p4y81R_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1398, p4y81D_, 0.8653, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1399, p4y70R_, 0.8653, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1400, p4y70D_, 0.8653, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1401, p4x6zD_, 0.8653, 1.55, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1402, d4r02C_, 0.8653, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1403, d4qzzR_, 0.8653, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH OMURALIDE
1404, d4qzzD_, 0.8653, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH OMURALIDE
1405, d4qz3D_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1406, d4qxjR_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1407, d4qwgR_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1408, d4qwgD_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1409, d4qw1R_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1410, d4qw1D_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1411, d4qvpR_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1412, d4qvpD_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1413, d4qv8R_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT
1414, d4qv8D_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-C52F MUTANT
1415, d4qv7R_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT
1416, d4qv7D_, 0.8653, 1.59, 0.330, 235, 227, YCP BETA5-A50V MUTANT
1417, d3d29C2, 0.8653, 1.55, 0.367, 234, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
1418, p6gopQ_, 0.8652, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1419, p6gopC_, 0.8652, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1420, d5lajC_, 0.8652, 1.55, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1421, d5fhsR_, 0.8652, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1422, d5fhsD_, 0.8652, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1423, p4y9zR_, 0.8652, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1424, p4y9zD_, 0.8652, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1425, p4y8sR_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1426, p4y8sD_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1427, d4y8rR_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1428, d4y8rD_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1429, p4y82D_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1430, p4y74R_, 0.8652, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1431, p4y74D_, 0.8652, 1.58, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1432, p4y6zR_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1433, p4y6zD_, 0.8652, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1434, d4r17R_, 0.8652, 1.59, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1435, d4r17D_, 0.8652, 1.59, 0.330, 235, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1436, d4qz3R_, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1437, d4qxjD_, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1438, d4qvvQ_, 0.8652, 1.55, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1439, d4qvvC_, 0.8652, 1.55, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1440, d4qv4R_, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT
1441, d4qv4D_, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT
1442, p4qv0R_, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1443, p4qv0D_, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1444, d4quyD_, 0.8652, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT
1445, d4hrcC_, 0.8652, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1446, d3wxrC_, 0.8652, 2.11, 0.361, 242, 233, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1447, d3mg6C_, 0.8652, 1.56, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1448, d3d29Q2, 0.8652, 1.55, 0.367, 234, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
1449, d5lajQ_, 0.8651, 1.55, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1450, d5jhsR_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1451, d5jhsD_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1452, d5d0wR_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1453, d5d0wD_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1454, d5cz9R_, 0.8651, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1455, d5cz9D_, 0.8651, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1456, p5cgiR_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1457, p5cgiD_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1458, d4ya4R_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1459, d4ya4D_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1460, p4y82R_, 0.8651, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1461, d4qz6R_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1462, d4qz6D_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1463, p4qwuR_, 0.8651, 1.60, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1464, p4qwuD_, 0.8651, 1.60, 0.330, 235, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1465, d4qw7R_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1466, d4qw7D_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1467, d4qv5R_, 0.8651, 1.60, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1468, d4qv5D_, 0.8651, 1.60, 0.330, 235, 227, YCP BETA5-M45I MUTANT
1469, p4qv3D_, 0.8651, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT
1470, d4qv1R_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT
1471, d4qv1D_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-M45A MUTANT
1472, d4quyR_, 0.8651, 1.59, 0.330, 235, 227, YCP BETA5-A49S-MUTANT
1473, d3sdkC_, 0.8651, 1.56, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1474, p6gopD_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1475, p5mp9C_, 0.8650, 2.24, 0.353, 244, 235, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1476, d5dkjC_, 0.8650, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1477, d5dkiC_, 0.8650, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1478, d5d0tQ_, 0.8650, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1479, d5d0tC_, 0.8650, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1480, d5bxnR_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1481, d5bxnD_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1482, p4ya9R_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1483, p4ya9D_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1484, p4y8pR_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1485, p4y8pD_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1486, p4y77R_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1487, p4y77D_, 0.8650, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1488, p4qz4R_, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1489, p4qz4D_, 0.8650, 1.59, 0.330, 235, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1490, d4qwxR_, 0.8650, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1491, d4qwxD_, 0.8650, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1492, d4qv6Q_, 0.8650, 1.55, 0.367, 240, 229, YCP BETA5-A49V MUTANT
1493, d4qv6C_, 0.8650, 1.55, 0.367, 240, 229, YCP BETA5-A49V MUTANT
1494, p4qv3R_, 0.8650, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT
1495, p3uned_, 0.8650, 2.08, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1496, d3gpjC_, 0.8650, 1.55, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1497, p6gopR_, 0.8649, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1498, d5dkjQ_, 0.8649, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1499, d5dkiQ_, 0.8649, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1500, p4ya7R_, 0.8649, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1501, p4ya7D_, 0.8649, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1502, p4y75R_, 0.8649, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1503, p4y75D_, 0.8649, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1504, p4x6zE_, 0.8649, 1.54, 0.330, 242, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1505, d4r00C_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1506, d4qwjQ_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1507, d4qwjC_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1508, d4qw1C_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1509, d4qw0C_, 0.8649, 1.55, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1510, d4qvpQ_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1511, d4qvpC_, 0.8649, 1.55, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1512, d4qv6R_, 0.8649, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT
1513, d4qv6D_, 0.8649, 1.59, 0.330, 235, 227, YCP BETA5-A49V MUTANT
1514, d4qv0Q_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1515, d4qv0C_, 0.8649, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1516, d4qlsR_, 0.8649, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1517, d4qlsD_, 0.8649, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1518, d4fzcQ_, 0.8649, 1.56, 0.367, 241, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1519, d4fzcC_, 0.8649, 1.56, 0.367, 241, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1520, d3mg0C_, 0.8649, 1.57, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1521, d3gpjQ_, 0.8649, 1.55, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1522, d1iruQ_, 0.8649, 2.04, 0.356, 250, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1523, d5fgdR_, 0.8648, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1524, d5fgdD_, 0.8648, 1.40, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1525, d5d0xQ_, 0.8648, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1526, d5d0xC_, 0.8648, 1.55, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1527, d5cz8Q_, 0.8648, 1.56, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1528, d5cz8C_, 0.8648, 1.56, 0.362, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1529, p4zzgC_, 0.8648, 2.04, 0.362, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1530, p4r67t_, 0.8648, 1.57, 0.336, 232, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1531, p4r67f_, 0.8648, 1.57, 0.336, 232, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1532, p4r67D_, 0.8648, 1.57, 0.336, 232, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1533, p4r3oR_, 0.8648, 1.57, 0.341, 231, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
1534, p4r3oD_, 0.8648, 1.57, 0.341, 231, 229, HUMAN CONSTITUTIVE 20S PROTEASOME
1535, d4r00Q_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1536, d4qzzQ_, 0.8648, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH OMURALIDE
1537, d4qzzC_, 0.8648, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH OMURALIDE
1538, d4qz6Q_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1539, d4qz6C_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1540, d4qz5Q_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1541, d4qz5C_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1542, d4qwuQ_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1543, d4qwuC_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1544, d4qw1Q_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1545, d4qw0Q_, 0.8648, 1.55, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1546, d4qv9R_, 0.8648, 1.60, 0.330, 235, 227, YCP BETA5-C63F MUTANT
1547, d4qv9D_, 0.8648, 1.60, 0.330, 235, 227, YCP BETA5-C63F MUTANT
1548, d4qv7C_, 0.8648, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT
1549, d3bdmC_, 0.8648, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1550, d1iruC_, 0.8648, 2.04, 0.356, 250, 233, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1551, d5l52R_, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1552, d5l52D_, 0.8647, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1553, d5jhrR_, 0.8647, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1554, d5jhrD_, 0.8647, 1.59, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1555, d5fgaQ_, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1556, d5fgaC_, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1557, d5cgfQ_, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1558, d5cgfC_, 0.8647, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1559, d4r18C_, 0.8647, 1.56, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1560, d4qzwQ_, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1561, d4qzwC_, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1562, d4qz3C_, 0.8647, 1.57, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1563, d4qwlD_, 0.8647, 1.60, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1564, d4qwkR_, 0.8647, 1.40, 0.332, 235, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1565, d4qwkD_, 0.8647, 1.40, 0.332, 235, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1566, d4qwkC_, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1567, d4qvnR_, 0.8647, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1568, d4qvnD_, 0.8647, 1.60, 0.330, 235, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1569, d4qvmC_, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1570, d4qvlC_, 0.8647, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BORTEZOMIB
1571, d4qv8Q_, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT
1572, d4qv8C_, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-C52F MUTANT
1573, d4qv7Q_, 0.8647, 1.56, 0.367, 240, 229, YCP BETA5-A50V MUTANT
1574, d4nnnR_, 0.8647, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH MG132
1575, d4nnnD_, 0.8647, 1.59, 0.330, 235, 227, YCP IN COMPLEX WITH MG132
1576, d4hnpC_, 0.8647, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1577, d3oeuC_, 0.8647, 1.57, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1578, d3bdmQ_, 0.8647, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1579, p5nifC_, 0.8646, 2.04, 0.362, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1580, p5fghQ_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1581, p5fghC_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1582, d5fggR_, 0.8646, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1583, d5fggD_, 0.8646, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1584, d5fgfR_, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1585, d5fgfD_, 0.8646, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1586, d5cz7Q_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1587, d5cz7C_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1588, d4z1lQ_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1589, d4z1lC_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1590, d4y9yC_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1591, p4y8uQ_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1592, p4y8uC_, 0.8646, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1593, p4r67R_, 0.8646, 1.57, 0.336, 232, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1594, d4r18Q_, 0.8646, 1.56, 0.367, 240, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1595, d4r02R_, 0.8646, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1596, d4qz7R_, 0.8646, 1.40, 0.332, 235, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1597, d4qz7D_, 0.8646, 1.40, 0.332, 235, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1598, d4qz3Q_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1599, d4qxjC_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1600, p4qwsR_, 0.8646, 1.41, 0.332, 235, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1601, p4qwsD_, 0.8646, 1.41, 0.332, 235, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1602, d4qwlR_, 0.8646, 1.60, 0.330, 235, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1603, d4qwlQ_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1604, d4qwlC_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1605, d4qwkQ_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1606, d4qw7Q_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1607, d4qw7C_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1608, d4qw6C_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1609, d4qw5C_, 0.8646, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1610, d4qvyQ_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1611, d4qvyC_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1612, d4qvwQ_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1613, d4qvwC_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1614, d4qvqQ_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1615, d4qvqC_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1616, d4qvmQ_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1617, d4qvlQ_, 0.8646, 1.56, 0.367, 240, 229, YCP IN COMPLEX WITH BORTEZOMIB
1618, d4qv9Q_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT
1619, d4qv9C_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT
1620, d4quyQ_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT
1621, d4quyC_, 0.8646, 1.56, 0.367, 240, 229, YCP BETA5-A49S-MUTANT
1622, d4qlvR_, 0.8646, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1623, d4qlvD_, 0.8646, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1624, d4no8D_, 0.8646, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1625, d4eu2R_, 0.8646, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1626, d1g65C_, 0.8646, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1627, d5jhsQ_, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1628, d5jhsC_, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1629, d5fgeR_, 0.8645, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1630, d5fgeD_, 0.8645, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1631, d5fg9Q_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1632, d5fg9C_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1633, d5fg7Q_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1634, d5fg7C_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1635, p5cgiC_, 0.8645, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1636, p4ya0C_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1637, d4y9yQ_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1638, d4y8rQ_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1639, d4y8rC_, 0.8645, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1640, p4y8qR_, 0.8645, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1641, p4y8qD_, 0.8645, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1642, d4r02D_, 0.8645, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1643, d4qzxC_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1644, d4qz4Q_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1645, d4qz4C_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1646, d4qz2C_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1647, d4qxjQ_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1648, d4qwiQ_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1649, d4qwiC_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1650, d4qw6Q_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1651, d4qw5Q_, 0.8645, 1.57, 0.367, 240, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1652, d4qv3Q_, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT
1653, d4qv3C_, 0.8645, 1.56, 0.367, 240, 229, YCP BETA5-M45V MUTANT
1654, d4no8R_, 0.8645, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1655, d4nnwR_, 0.8645, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1656, d4nnwD_, 0.8645, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1657, d4j70C_, 0.8645, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1658, d3shjQ_, 0.8645, 1.56, 0.362, 241, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1659, d3shjC_, 0.8645, 1.56, 0.362, 241, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1660, d3hyeC_, 0.8645, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1661, d5l5sC_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1662, d5l55R_, 0.8644, 1.60, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1663, d5l52Q_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1664, d5l52C_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1665, d5fhsQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1666, d5fhsC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1667, d5d0zC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1668, d5d0vQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1669, d5d0vC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1670, d5d0sC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1671, d5czaQ_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1672, d5czaC_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1673, d5cz5R_, 0.8644, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1674, d5cz5Q_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1675, d5cz5D_, 0.8644, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1676, d5cz5C_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1677, p5cgiQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1678, p5cghR_, 0.8644, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1679, p5cghD_, 0.8644, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1680, d5bxlQ_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1681, d5bxlC_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1682, p4ya2R_, 0.8644, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1683, p4ya2D_, 0.8644, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1684, p4ya0Q_, 0.8644, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1685, p4y8sQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1686, p4y8sC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1687, p4y8lC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1688, p4y8iQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1689, p4y8iC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1690, p4y84R_, 0.8644, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1691, p4y84D_, 0.8644, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1692, p4y7yQ_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1693, p4y7yC_, 0.8644, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1694, d4qzxR_, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1695, d4qzxQ_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1696, d4qzxD_, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1697, p4qzwR_, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1698, p4qzwD_, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1699, d4qz2Q_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1700, d4qwrR_, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1701, d4qwrD_, 0.8644, 1.41, 0.332, 235, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1702, d4qwrC_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1703, d4qwfC_, 0.8644, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1704, d4qw4Q_, 0.8644, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH CARFILZOMIB
1705, d4qw4C_, 0.8644, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH CARFILZOMIB
1706, d4qw3Q_, 0.8644, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1707, d4qw3C_, 0.8644, 1.56, 0.367, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1708, d4qv1Q_, 0.8644, 1.56, 0.367, 240, 229, YCP BETA5-M45A MUTANT
1709, d4qv1C_, 0.8644, 1.56, 0.367, 240, 229, YCP BETA5-M45A MUTANT
1710, d4qltR_, 0.8644, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1711, d4qltD_, 0.8644, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1712, d3hyeQ_, 0.8644, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1713, d2fnyC_, 0.8644, 1.56, 0.367, 241, 229,  
1714, d1rypD_, 0.8644, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1715, d5lttQ_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1716, d5lttC_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1717, d5l60C_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1718, d5l5sQ_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1719, d5fgiR_, 0.8643, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1720, d5fgiQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1721, d5fgiD_, 0.8643, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1722, d5fgiC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1723, d5fggQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1724, d5fggC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1725, d5fgfQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1726, d5fgfC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1727, d5d0zQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1728, d5d0wQ_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1729, d5d0wC_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1730, d5d0sQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1731, d5cz9Q_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1732, d5cz9C_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1733, d5cz8R_, 0.8643, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1734, d5cz8D_, 0.8643, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1735, d5cz6Q_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1736, d5cz6C_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1737, d5bxnQ_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1738, d5bxnC_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1739, d4ya4Q_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1740, d4ya4C_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1741, p4ya3C_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1742, p4y9zQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1743, p4y9zC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1744, p4y8lQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1745, p4y8jQ_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1746, p4y8jC_, 0.8643, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1747, p4y69Q_, 0.8643, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1748, d4qz7Q_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1749, d4qz7C_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1750, d4qz0C_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1751, d4qwrQ_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1752, p4qwfR_, 0.8643, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1753, d4qwfQ_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1754, p4qwfD_, 0.8643, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1755, d4qvnC_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1756, d4qv4Q_, 0.8643, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT
1757, d4qv4C_, 0.8643, 1.56, 0.367, 240, 229, YCP BETA5-M45T MUTANT
1758, d4quxQ_, 0.8643, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT
1759, d4quxC_, 0.8643, 1.56, 0.367, 240, 229, YCP BETA5-A49T-MUTANT
1760, p4no6D_, 0.8643, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1761, d4lqiQ_, 0.8643, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1762, d4lqiC_, 0.8643, 1.56, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1763, d4fzgC_, 0.8643, 1.57, 0.367, 241, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1764, p3uneB_, 0.8643, 2.09, 0.356, 248, 233, MOUSE CONSTITUTIVE 20S PROTEASOME
1765, d3nzwC_, 0.8643, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1766, d3gptQ_, 0.8643, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1767, d3gptC_, 0.8643, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1768, d3e47C_, 0.8643, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1769, d2fnyQ_, 0.8643, 1.56, 0.367, 241, 229,  
1770, d5l60Q_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1771, d5l5xQ_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1772, d5l5xC_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1773, d5l5vC_, 0.8642, 1.56, 0.367, 240, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1774, d5l5uQ_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1775, d5l5uC_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1776, d5l5eQ_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1777, d5l5eC_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1778, d5l55Q_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1779, d5l55C_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1780, d5fgdQ_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1781, d5fgdC_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1782, d5cz4Q_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1783, d5cz4C_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1784, p4ya3Q_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1785, p4y78C_, 0.8642, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1786, p4y69C_, 0.8642, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1787, d4qz0Q_, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1788, d4qw6R_, 0.8642, 1.41, 0.332, 235, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1789, d4qw6D_, 0.8642, 1.41, 0.332, 235, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1790, d4qvnQ_, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1791, d4qv5Q_, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT
1792, d4qv5C_, 0.8642, 1.57, 0.367, 240, 229, YCP BETA5-M45I MUTANT
1793, p4no6R_, 0.8642, 1.60, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1794, d4fzgQ_, 0.8642, 1.57, 0.367, 241, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1795, d3gpwQ_, 0.8642, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1796, d3gpwC_, 0.8642, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1797, d3e47Q_, 0.8642, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1798, d5l67Q_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1799, d5l67C_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1800, d5l65Q_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1801, d5l65C_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1802, d5l5zQ_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1803, d5l5zC_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1804, d5l5vQ_, 0.8641, 1.57, 0.367, 240, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1805, d5l5qQ_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1806, d5l5qC_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1807, d5jhrQ_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1808, d5jhrC_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1809, d5fgeQ_, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1810, d5fgeC_, 0.8641, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1811, d5d0vR_, 0.8641, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1812, d5d0vD_, 0.8641, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1813, p5cggQ_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1814, p5cggC_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1815, p4ya5Q_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1816, p4ya5C_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1817, p4ya2C_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1818, d4ya1Q_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1819, d4ya1C_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1820, p4y8qC_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1821, p4y8nC_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1822, d4y8mQ_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1823, d4y8mC_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1824, p4y8gR_, 0.8641, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1825, p4y8gD_, 0.8641, 1.61, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1826, p4y80C_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1827, p4y78Q_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1828, p4y6vQ_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1829, p4y6vC_, 0.8641, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1830, d4rurQ_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1831, d4rurC_, 0.8641, 1.56, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1832, d4qz2R_, 0.8641, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1833, d4qz2D_, 0.8641, 1.41, 0.332, 235, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1834, d4qz1Q_, 0.8641, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1835, d4qz1C_, 0.8641, 1.57, 0.367, 240, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1836, d4qwxQ_, 0.8641, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1837, d4qwxC_, 0.8641, 1.57, 0.367, 240, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1838, p4qw5R_, 0.8641, 1.41, 0.332, 235, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1839, p4qw5D_, 0.8641, 1.41, 0.332, 235, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1840, d4no1R_, 0.8641, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1841, d4no1D_, 0.8641, 1.61, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1842, p3uneQ_, 0.8641, 1.57, 0.341, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
1843, d3tddC_, 0.8641, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1844, d3nzwQ_, 0.8641, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1845, d3nzjQ_, 0.8641, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1846, d3nzjC_, 0.8641, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1847, d3mg0Q_, 0.8641, 1.57, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1848, p5nifE_, 0.8640, 1.42, 0.332, 236, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1849, p5mpaC_, 0.8640, 2.27, 0.353, 244, 235, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1850, d5l6cQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1851, d5l6cC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1852, d5l64Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1853, d5l64C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1854, d5l62Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1855, d5l62C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1856, d5l61Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1857, d5l61C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1858, d5l5yQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1859, d5l5yC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1860, d5l5wQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1861, d5l5wC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1862, d5l5iQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1863, d5l5iC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1864, d5l5hQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1865, d5l5hC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1866, d5l5fQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1867, d5l5fC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1868, p5gjrJA_, 0.8640, 1.58, 0.341, 231, 229, 
1869, d5d0zR_, 0.8640, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1870, d5d0zD_, 0.8640, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1871, d5bouQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1872, d5bouC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1873, p4ya9Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1874, p4ya9C_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1875, p4ya7Q_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1876, p4ya7C_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1877, p4ya2Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1878, p4y8qQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1879, p4y8pQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1880, p4y8pC_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1881, p4y8nQ_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1882, p4y8kR_, 0.8640, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1883, p4y8kD_, 0.8640, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1884, p4y8hR_, 0.8640, 1.62, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1885, p4y8hD_, 0.8640, 1.62, 0.330, 235, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1886, p4y80Q_, 0.8640, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1887, p4y7xC_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1888, p4y7wQ_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1889, p4y7wC_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1890, p4y70Q_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1891, p4y70C_, 0.8640, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1892, p4x6zS_, 0.8640, 1.56, 0.330, 242, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1893, d4qluR_, 0.8640, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1894, d4qluD_, 0.8640, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1895, d4j70Q_, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1896, d4inrQ_, 0.8640, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1897, d4inrC_, 0.8640, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1898, d4hrdC_, 0.8640, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1899, d3un8Q_, 0.8640, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1900, d3un8C_, 0.8640, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1901, d3tddQ_, 0.8640, 1.56, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1902, d3oevC_, 0.8640, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1903, d3mg8C_, 0.8640, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1904, d1z7qQ1, 0.8640, 1.87, 0.355, 243, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1905, d1z7qC1, 0.8640, 1.87, 0.355, 243, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1906, d1rypR_, 0.8640, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1907, d5l6bQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1908, d5l6bC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1909, d5l69C_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1910, d5l66Q_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1911, d5l66C_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1912, d5l63Q_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1913, d5l63C_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1914, d5l5tQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1915, d5l5tC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1916, d5l54R_, 0.8639, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1917, d5l54D_, 0.8639, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1918, p5gjrV_, 0.8639, 1.58, 0.341, 231, 229, 
1919, p5cggR_, 0.8639, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1920, p5cggD_, 0.8639, 1.41, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1921, p4y7xQ_, 0.8639, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1922, p4y6aQ_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1923, p4y6aC_, 0.8639, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1924, d4qwsQ_, 0.8639, 1.58, 0.362, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1925, d4qwsC_, 0.8639, 1.58, 0.362, 240, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1926, d4ltcQ_, 0.8639, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1927, d4ltcC_, 0.8639, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1928, p4gk7Q_, 0.8639, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1929, p4gk7C_, 0.8639, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1930, d3oeuP_, 0.8639, 1.81, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1931, d3nzxQ_, 0.8639, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1932, d3nzxC_, 0.8639, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1933, d2fakC_, 0.8639, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1934, d5l69Q_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1935, d5l68C_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1936, d5l5pQ_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1937, d5l5pC_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1938, d5l5jQ_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1939, d5l5jC_, 0.8638, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1940, d5l54C_, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1941, d5d0sR_, 0.8638, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1942, d5d0sD_, 0.8638, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1943, p5cghQ_, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1944, p5cghC_, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1945, p4zzgE_, 0.8638, 1.43, 0.332, 236, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1946, p4y8oQ_, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1947, p4y8oC_, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1948, p4y77Q_, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1949, p4y77C_, 0.8638, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1950, p4qz0R_, 0.8638, 1.42, 0.332, 235, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1951, p4qz0D_, 0.8638, 1.42, 0.332, 235, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1952, d4no9R_, 0.8638, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1953, d4no9D_, 0.8638, 1.62, 0.330, 235, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1954, d4nnnQ_, 0.8638, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1955, d3wxrD_, 0.8638, 1.59, 0.362, 241, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1956, p3un4Q_, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1957, p3un4C_, 0.8638, 1.57, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1958, d3mg8Q_, 0.8638, 1.57, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1959, d2fakQ_, 0.8638, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1960, d2f16C_, 0.8638, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1961, d5l6aQ_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1962, d5l6aC_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1963, d5l68Q_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1964, d5l5oQ_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1965, d5l5oC_, 0.8637, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1966, d5l54Q_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1967, p5gjqE_, 0.8637, 1.59, 0.341, 231, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1968, d5ahjQ_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1969, d5ahjC_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1970, p4y8tC_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1971, p4y82Q_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1972, p4y82C_, 0.8637, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1973, d4qlqR_, 0.8637, 1.42, 0.332, 235, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1974, d4qlqD_, 0.8637, 1.42, 0.332, 235, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1975, p4qbyR_, 0.8637, 1.63, 0.330, 235, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1976, p4qbyD_, 0.8637, 1.63, 0.330, 235, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1977, d4nnnC_, 0.8637, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH MG132
1978, d4jsuQ_, 0.8637, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1979, d4jsuC_, 0.8637, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1980, d4intC_, 0.8637, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1981, d2f16Q_, 0.8637, 1.57, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1982, d5laiQ_, 0.8636, 1.57, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1983, d5laiC_, 0.8636, 1.57, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1984, d5l5aQ_, 0.8636, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1985, d5l5aC_, 0.8636, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1986, d5l55D_, 0.8636, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1987, p4y8tQ_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1988, p4y81Q_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1989, p4y81C_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1990, p4y75C_, 0.8636, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1991, d4r17Q_, 0.8636, 1.57, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1992, d4r17C_, 0.8636, 1.57, 0.367, 240, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1993, d4qltC_, 0.8636, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1994, d4no6Q_, 0.8636, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1995, d4no6C_, 0.8636, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1996, d1g65Q_, 0.8636, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1997, d5m2bQ_, 0.8635, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1998, d5m2bC_, 0.8635, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1999, d5l5dQ_, 0.8635, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2000, d5l5dC_, 0.8635, 1.57, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2001, p4y75Q_, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2002, p4y74Q_, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2003, p4y74C_, 0.8635, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2004, d4qltQ_, 0.8635, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2005, d4jt0Q_, 0.8635, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2006, d4jt0C_, 0.8635, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2007, d4inuC_, 0.8635, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2008, d4intQ_, 0.8635, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2009, d4hrcQ_, 0.8635, 1.58, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2010, d3mg7C_, 0.8635, 1.59, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2011, p1fntC_, 0.8635, 2.00, 0.358, 241, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2012, d5l5rQ_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2013, d5l5rC_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2014, d5l5bQ_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2015, d5l5bC_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2016, p4y8kQ_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2017, p4y8kC_, 0.8634, 1.58, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2018, d4qlsC_, 0.8634, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2019, d4no9C_, 0.8634, 1.59, 0.362, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2020, d4inuQ_, 0.8634, 1.58, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2021, d4hnpQ_, 0.8634, 1.59, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2022, p3uneC_, 0.8634, 1.58, 0.336, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2023, d3okjQ_, 0.8634, 1.58, 0.367, 241, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2024, d3okjC_, 0.8634, 1.58, 0.367, 241, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2025, p1fntQ_, 0.8634, 2.00, 0.358, 241, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2026, d4qlsQ_, 0.8633, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2027, p4qbyQ_, 0.8633, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2028, p4qbyC_, 0.8633, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2029, d4no9Q_, 0.8633, 1.59, 0.362, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2030, d4jsqQ_, 0.8633, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2031, d4jsqC_, 0.8633, 1.59, 0.367, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2032, d4hrdQ_, 0.8633, 1.59, 0.367, 241, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2033, d3oevQ_, 0.8633, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2034, d3oevP_, 0.8633, 1.83, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2035, d3mg6Q_, 0.8633, 1.57, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2036, d2gplC_, 0.8633, 1.58, 0.367, 241, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2037, d5ahjR_, 0.8632, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2038, d5ahjD_, 0.8632, 1.42, 0.332, 235, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2039, p4y8hQ_, 0.8632, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2040, p4y8hC_, 0.8632, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2041, p4y84Q_, 0.8632, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2042, p4y6zQ_, 0.8632, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2043, p4y6zC_, 0.8632, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2044, d4qlqQ_, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2045, d4qlqC_, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2046, d4no1Q_, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2047, d4no1C_, 0.8632, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2048, d3oeuB_, 0.8632, 1.76, 0.365, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2049, d2gplQ_, 0.8632, 1.58, 0.367, 241, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2050, p4y8gC_, 0.8631, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2051, p4y84C_, 0.8631, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2052, d4qwgC_, 0.8631, 1.59, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2053, d3sdkQ_, 0.8631, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2054, d3mg7P_, 0.8631, 1.84, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2055, d3mg4Q_, 0.8631, 1.58, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2056, p5mpad_, 0.8630, 1.58, 0.362, 240, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2057, p4y8gQ_, 0.8630, 1.59, 0.367, 240, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2058, d4r02Q_, 0.8630, 1.58, 0.367, 240, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2059, d4qwgQ_, 0.8630, 1.59, 0.367, 240, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2060, d3mg6P_, 0.8630, 1.85, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2061, d1jd2D_, 0.8630, 1.52, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2062, p5vfqB_, 0.8629, 1.35, 0.609, 230, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2063, d4qluQ_, 0.8629, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2064, d4qluC_, 0.8629, 1.59, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2065, p3unee_, 0.8629, 1.58, 0.341, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2066, d3oeuQ_, 0.8628, 1.59, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2067, d3mg4C_, 0.8628, 1.60, 0.367, 241, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2068, d4qlvC_, 0.8627, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2069, d3sdiP_, 0.8627, 1.85, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2070, d4qlvQ_, 0.8626, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2071, d4no8Q_, 0.8626, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2072, d4no8C_, 0.8626, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2073, d4r3oS_, 0.8624, 1.74, 0.322, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
2074, d4r3oE_, 0.8624, 1.74, 0.322, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
2075, d4nnwQ_, 0.8624, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2076, d4nnwC_, 0.8624, 1.60, 0.367, 240, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2077, d1jd2Y_, 0.8624, 1.52, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2078, p1fntS_, 0.8624, 1.58, 0.330, 244, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2079, d1z7qS1, 0.8623, 1.55, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2080, d1z7qE1, 0.8623, 1.55, 0.330, 242, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2081, d3mg8P_, 0.8622, 1.87, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2082, d3mg8B_, 0.8622, 1.80, 0.361, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2083, p1fntE_, 0.8622, 1.59, 0.330, 244, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2084, d4g4sC_, 0.8621, 1.88, 0.357, 237, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2085, d3mg7Q_, 0.8621, 1.60, 0.367, 241, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2086, d1jd2X_, 0.8621, 1.59, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2087, d1jd2C_, 0.8621, 1.59, 0.367, 241, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2088, d1g0uP_, 0.8621, 1.85, 0.357, 235, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2089, d3sdkP_, 0.8620, 1.88, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2090, p5l4gD_, 0.8619, 1.61, 0.332, 231, 229, 
2091, d3mg7B_, 0.8619, 1.80, 0.361, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2092, p5m32P_, 0.8617, 2.07, 0.356, 244, 233, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2093, p5l4gR_, 0.8617, 1.62, 0.341, 232, 229, 
2094, p5vfoH_, 0.8616, 1.38, 0.609, 230, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2095, p3unes_, 0.8616, 1.60, 0.341, 239, 229, MOUSE CONSTITUTIVE 20S PROTEASOME
2096, d3oevB_, 0.8616, 1.80, 0.361, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2097, p5mp9d_, 0.8615, 1.61, 0.362, 240, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2098, d3sdkB_, 0.8615, 1.81, 0.361, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2099, d3mg6B_, 0.8615, 1.83, 0.361, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2100, p5mp9D_, 0.8613, 1.62, 0.367, 240, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2101, p4r67u_, 0.8613, 1.77, 0.326, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2102, p4r67g_, 0.8613, 1.77, 0.326, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2103, d4r67S_, 0.8612, 1.77, 0.326, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2104, d4r67E_, 0.8612, 1.77, 0.326, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2105, p5gjrW_, 0.8611, 1.76, 0.322, 234, 227, 
2106, p5gjrKA_, 0.8610, 1.78, 0.322, 234, 227, 
2107, p5mpac_, 0.8609, 2.21, 0.355, 244, 234, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2108, d1iruR_, 0.8609, 1.61, 0.336, 243, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2109, d1iruD_, 0.8609, 1.61, 0.336, 243, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2110, p5vfpB_, 0.8608, 1.40, 0.609, 230, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2111, p3jcpMA_, 0.8608, 1.61, 0.367, 241, 229, 
2112, p3jcpM_, 0.8608, 1.61, 0.367, 241, 229, 
2113, d1iruS_, 0.8608, 1.77, 0.322, 234, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2114, d1iruE_, 0.8608, 1.77, 0.322, 234, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2115, d1g0uB_, 0.8608, 1.87, 0.357, 235, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2116, p5vfrH_, 0.8607, 1.39, 0.609, 230, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2117, d3wxrR_, 0.8606, 1.66, 0.367, 241, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2118, p6avoN_, 0.8605, 1.62, 0.336, 232, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2119, d5lexR_, 0.8604, 1.75, 0.326, 233, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2120, p5wvkY_, 0.8603, 1.59, 0.362, 241, 229, 
2121, p3jcoLA_, 0.8603, 2.28, 0.362, 244, 235, 
2122, p3jcoL_, 0.8603, 2.28, 0.362, 244, 235, 
2123, p5mp9E_, 0.8599, 1.64, 0.330, 242, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2124, d5le5R_, 0.8599, 1.59, 0.327, 233, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2125, p5gjql_, 0.8599, 1.60, 0.323, 234, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2126, p5gjqk_, 0.8599, 1.64, 0.336, 231, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2127, p3uneD_, 0.8599, 1.62, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2128, d5lexD_, 0.8598, 1.77, 0.326, 233, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2129, p5gjqF_, 0.8598, 1.60, 0.323, 234, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2130, p5lf6Q_, 0.8597, 1.60, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2131, d4g4sE_, 0.8596, 1.57, 0.330, 249, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2132, d3unbD_, 0.8596, 1.61, 0.323, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2133, p6avoI_, 0.8595, 1.64, 0.336, 232, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2134, d5lf1Q_, 0.8594, 1.60, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2135, d3sdiB_, 0.8593, 1.96, 0.357, 235, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2136, p5mp9e_, 0.8592, 1.61, 0.330, 242, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2137, d5lf4Q_, 0.8592, 1.61, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2138, p3uneR_, 0.8592, 1.61, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2139, p5lf6R_, 0.8591, 1.60, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2140, p5lf0Q_, 0.8591, 1.61, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2141, d3sdkD_, 0.8591, 1.36, 0.335, 233, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2142, p5mpaE_, 0.8590, 1.59, 0.330, 242, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2143, p3unbf_, 0.8590, 1.62, 0.323, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2144, d5lf1R_, 0.8589, 1.60, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2145, p5lezR_, 0.8589, 1.77, 0.326, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2146, p5lezD_, 0.8589, 1.77, 0.326, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2147, p5l4gS_, 0.8588, 1.62, 0.327, 234, 226, 
2148, d5lf7Q_, 0.8587, 1.61, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2149, p5leyQ_, 0.8587, 1.61, 0.338, 239, 228, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2150, d5le5D_, 0.8587, 1.62, 0.327, 233, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2151, p3unef_, 0.8587, 1.62, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2152, d5lf3R_, 0.8586, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2153, p5l4gE_, 0.8586, 1.81, 0.326, 234, 227, 
2154, p3unhR_, 0.8586, 1.60, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME
2155, p3unhD_, 0.8586, 1.60, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME
2156, p3jcpNA_, 0.8586, 1.57, 0.330, 242, 227, 
2157, p3jcpN_, 0.8586, 1.57, 0.330, 242, 227, 
2158, d5lf3Q_, 0.8585, 1.62, 0.338, 238, 228, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2159, d3unfR_, 0.8585, 1.60, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2160, d3unfD_, 0.8585, 1.60, 0.327, 233, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2161, p5lf6D_, 0.8584, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2162, d5lf7R_, 0.8583, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2163, p3unet_, 0.8583, 1.63, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2164, d5lf3D_, 0.8582, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2165, d5lf1D_, 0.8582, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2166, p5lf0R_, 0.8582, 1.61, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2167, d5lf7D_, 0.8581, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2168, d5lf4R_, 0.8581, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2169, p5leyR_, 0.8579, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2170, p6avoM_, 0.8578, 1.60, 0.327, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2171, d3unbR_, 0.8578, 1.63, 0.327, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2172, p5lf0D_, 0.8577, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2173, p5leyD_, 0.8577, 1.62, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2174, p6avoH_, 0.8576, 1.60, 0.327, 233, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2175, d3sdkR_, 0.8575, 1.29, 0.336, 232, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2176, d5lf4D_, 0.8574, 1.63, 0.327, 233, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2177, d1g0uD_, 0.8574, 1.24, 0.341, 230, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2178, p3unbt_, 0.8570, 1.65, 0.323, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2179, d1j2qB_, 0.8567, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2180, p5mpcC_, 0.8566, 2.13, 0.352, 244, 233, 
2181, p3jcoMA_, 0.8566, 1.67, 0.367, 241, 229, 
2182, p3jcoM_, 0.8566, 1.67, 0.367, 241, 229, 
2183, d1g0uR_, 0.8566, 1.26, 0.341, 230, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2184, p5mpae_, 0.8563, 1.74, 0.330, 242, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2185, d1j2qD_, 0.8563, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2186, d1j2qF_, 0.8562, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2187, d1j2qC_, 0.8562, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2188, d1j2qG_, 0.8561, 1.72, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2189, d1j2qE_, 0.8561, 1.72, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2190, d1j2qA_, 0.8561, 1.71, 0.388, 237, 227, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
2191, p5mpaD_, 0.8558, 1.72, 0.362, 240, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2192, d4cr2C_, 0.8558, 2.24, 0.362, 245, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2193, d3sdiR_, 0.8556, 1.20, 0.338, 229, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2194, p5m32C_, 0.8555, 1.77, 0.341, 234, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2195, d3sdiC_, 0.8554, 1.53, 0.367, 238, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2196, p5mpbQ_, 0.8552, 2.09, 0.352, 244, 233, 
2197, p5wvkZ_, 0.8547, 1.69, 0.330, 242, 227, 
2198, p5wvkR_, 0.8547, 1.74, 0.358, 241, 229, 
2199, d1g0uC_, 0.8545, 1.54, 0.367, 238, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2200, d1g0uQ_, 0.8537, 1.55, 0.367, 238, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2201, d3sdiQ_, 0.8531, 1.56, 0.367, 238, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2202, p3jcoN_, 0.8530, 1.65, 0.330, 242, 227, 
2203, p3jcoNA_, 0.8529, 1.65, 0.330, 242, 227, 
2204, d3sdiD_, 0.8525, 1.18, 0.339, 228, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2205, p5mpbS_, 0.8522, 1.93, 0.325, 242, 228, 
2206, p5m32Q_, 0.8521, 1.80, 0.341, 235, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2207, d4cr2E_, 0.8520, 1.91, 0.329, 243, 228, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2208, d3unbG_, 0.8520, 1.82, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2209, p6epcB_, 0.8515, 1.93, 0.608, 234, 232, GROUND STATE 26S PROTEASOME (GS2)
2210, p5a0qQ_, 0.8514, 1.96, 0.368, 237, 228, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2211, p5a0qC_, 0.8514, 1.96, 0.368, 237, 228, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2212, p4cr4C_, 0.8514, 2.39, 0.357, 245, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2213, p4v7oQ_, 0.8513, 1.87, 0.357, 232, 227, 
2214, d3l5qT_, 0.8513, 1.87, 0.357, 232, 227,  
2215, p4v7oKA_, 0.8512, 1.87, 0.357, 232, 227, 
2216, p4v7oC_, 0.8512, 1.87, 0.357, 232, 227, 
2217, d3l5qH_, 0.8512, 1.87, 0.357, 232, 227,  
2218, d1vsyQ_, 0.8512, 1.87, 0.357, 232, 227,  
2219, d1vsyC_, 0.8512, 1.87, 0.357, 232, 227,  
2220, p3unbw_, 0.8511, 1.83, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2221, d3unbU_, 0.8511, 1.83, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2222, p3unbi_, 0.8509, 1.84, 0.360, 243, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2223, p5wvkS_, 0.8506, 1.72, 0.330, 242, 227, 
2224, d3unfU_, 0.8505, 1.83, 0.360, 243, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2225, d3unfG_, 0.8505, 1.83, 0.360, 243, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2226, p5vfsC_, 0.8503, 2.22, 0.352, 250, 233, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2227, p5vfoI_, 0.8502, 1.86, 0.352, 248, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2228, p5vfsD_, 0.8501, 1.78, 0.341, 239, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2229, p5vfqC_, 0.8501, 1.86, 0.352, 248, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2230, p5a5bD_, 0.8501, 1.79, 0.358, 242, 229, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2231, p4cr3D_, 0.8501, 1.79, 0.358, 242, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2232, p3uneG_, 0.8501, 1.83, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2233, p5ln3E_, 0.8499, 1.66, 0.327, 232, 226, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2234, d4r3oO_, 0.8496, 1.86, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
2235, d1iruO_, 0.8495, 1.87, 0.360, 244, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2236, d4r3oA_, 0.8494, 1.87, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
2237, d4cr2D_, 0.8494, 1.77, 0.362, 242, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2238, d1iruA_, 0.8494, 1.87, 0.360, 244, 228, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2239, p5vfrI_, 0.8493, 1.86, 0.352, 248, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2240, p5vfsBA_, 0.8492, 2.23, 0.352, 240, 233, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2241, p5gjqn_, 0.8492, 1.85, 0.295, 243, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2242, p4r67q_, 0.8491, 1.86, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2243, d4r67O_, 0.8491, 1.86, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2244, p4r67c_, 0.8491, 1.86, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2245, d4r67A_, 0.8491, 1.86, 0.360, 244, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2246, p5vfpC_, 0.8488, 1.87, 0.352, 248, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2247, p3uneU_, 0.8488, 1.85, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2248, p3unew_, 0.8484, 1.86, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2249, p3unei_, 0.8483, 1.87, 0.360, 244, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2250, p5vfuU_, 0.8479, 1.81, 0.336, 239, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2251, p5vftJ_, 0.8479, 1.81, 0.336, 239, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2252, p5vfrK_, 0.8478, 1.54, 0.321, 228, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2253, p6avoQ_, 0.8477, 1.71, 0.296, 239, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2254, p6avoJ_, 0.8477, 1.71, 0.296, 239, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2255, p5vfok_, 0.8477, 1.57, 0.321, 228, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2256, p5vfuT_, 0.8475, 2.26, 0.352, 250, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2257, p5vftI_, 0.8475, 2.26, 0.352, 250, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2258, p5mpbC_, 0.8475, 2.28, 0.361, 244, 233, 
2259, p5gjqX_, 0.8474, 2.12, 0.285, 243, 228, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2260, p5mpcQ_, 0.8473, 2.26, 0.356, 244, 233, 
2261, p5vfqDA_, 0.8472, 1.57, 0.321, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2262, p5vfrk_, 0.8471, 1.57, 0.321, 228, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2263, p5vfsDA_, 0.8469, 1.56, 0.326, 228, 224, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2264, p5vfsCA_, 0.8469, 1.82, 0.336, 239, 229, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2265, p5l4gU_, 0.8469, 1.97, 0.285, 241, 228, 
2266, p5l4gG_, 0.8469, 2.14, 0.284, 242, 229, 
2267, p3uneF_, 0.8469, 1.74, 0.296, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2268, p5vfsE_, 0.8468, 1.69, 0.324, 228, 225, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2269, p5vfqE_, 0.8467, 1.69, 0.320, 228, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2270, d3unbT_, 0.8467, 1.74, 0.296, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2271, p5vfpE_, 0.8466, 1.56, 0.321, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2272, p3unbv_, 0.8466, 1.74, 0.296, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2273, p5vfpCA_, 0.8465, 1.58, 0.321, 228, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2274, p5vfoK_, 0.8465, 1.69, 0.320, 228, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2275, d1j2pF_, 0.8463, 1.73, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2276, p5t0cU_, 0.8461, 2.26, 0.352, 250, 233, 
2277, p5t0cAB_, 0.8461, 2.26, 0.352, 250, 233, 
2278, p5gjrMA_, 0.8461, 2.00, 0.286, 243, 227, 
2279, d1j2pG_, 0.8461, 1.73, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2280, d1j2pE_, 0.8461, 1.73, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2281, d1j2pD_, 0.8461, 1.73, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2282, d1j2pC_, 0.8461, 1.73, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2283, d1j2pA_, 0.8461, 1.73, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2284, d1j2pB_, 0.8460, 1.73, 0.381, 243, 226, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
2285, p5gjrY_, 0.8459, 2.00, 0.286, 243, 227, 
2286, d2ku2A1, 0.8459, 1.84, 0.390, 233, 228, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2287, d5lf3F_, 0.8457, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2288, d5lexT_, 0.8456, 1.74, 0.296, 240, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2289, d5lexF_, 0.8456, 1.74, 0.296, 239, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2290, p5t0cV_, 0.8454, 1.84, 0.336, 239, 229, 
2291, p5t0cBB_, 0.8454, 1.84, 0.336, 239, 229, 
2292, d5lf7F_, 0.8454, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2293, d5lf1F_, 0.8454, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2294, p5lezF_, 0.8454, 1.74, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2295, d5lf4F_, 0.8453, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2296, p5lf0F_, 0.8453, 1.75, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2297, p5lezT_, 0.8453, 1.74, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2298, p5leyF_, 0.8452, 1.76, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2299, p5vfuHA_, 0.8451, 2.29, 0.352, 240, 233, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2300, p5vfti_, 0.8451, 2.29, 0.352, 240, 233, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2301, d5lf1T_, 0.8451, 1.75, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2302, d5le5T_, 0.8450, 1.75, 0.296, 240, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2303, p5lf6T_, 0.8449, 1.76, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2304, d4r3oG_, 0.8449, 1.87, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
2305, d2ku1A1, 0.8449, 1.94, 0.395, 233, 228, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2306, p5mpcS_, 0.8448, 1.89, 0.335, 242, 227, 
2307, d5lf3T_, 0.8448, 1.75, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2308, d4r3oU_, 0.8448, 1.88, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
2309, d5lf7T_, 0.8447, 1.76, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2310, d5le5F_, 0.8447, 1.77, 0.296, 239, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2311, d5lf4T_, 0.8446, 1.76, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2312, p5lf0T_, 0.8446, 1.76, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2313, p5leyT_, 0.8445, 1.76, 0.296, 240, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2314, p5lf6F_, 0.8443, 1.78, 0.296, 239, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2315, p4cr4E_, 0.8441, 1.86, 0.313, 243, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2316, p5vftK_, 0.8438, 1.76, 0.329, 228, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2317, p4r67w_, 0.8438, 1.89, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2318, d4r67U_, 0.8438, 1.89, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2319, p4r67i_, 0.8438, 1.89, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2320, d1iruU_, 0.8437, 1.78, 0.296, 245, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2321, d1iruG_, 0.8437, 1.78, 0.296, 245, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2322, d4r67G_, 0.8436, 1.89, 0.288, 245, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2323, p3unev_, 0.8436, 1.90, 0.288, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2324, p3uneh_, 0.8436, 1.92, 0.288, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2325, p5lezQ_, 0.8435, 1.55, 0.345, 234, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2326, d3unbF_, 0.8435, 2.06, 0.286, 244, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2327, p5m32R_, 0.8434, 1.77, 0.311, 233, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2328, p5m32D_, 0.8434, 1.77, 0.311, 233, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2329, p5vfuV_, 0.8433, 1.76, 0.329, 228, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2330, d5lexQ_, 0.8433, 1.55, 0.345, 233, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2331, p3uneT_, 0.8433, 1.92, 0.292, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
2332, p3h4pH_, 0.8433, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2333, d3h4pD_, 0.8433, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2334, p3unbh_, 0.8431, 1.91, 0.288, 244, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2335, p5vftk_, 0.8430, 1.77, 0.324, 228, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2336, d5le5Q_, 0.8430, 1.56, 0.345, 233, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2337, p3unhT_, 0.8430, 1.91, 0.288, 244, 226, MOUSE 20S IMMUNOPROTEASOME
2338, p3unhF_, 0.8430, 1.91, 0.288, 244, 226, MOUSE 20S IMMUNOPROTEASOME
2339, p3h4pJ_, 0.8429, 1.68, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2340, d3h4pF_, 0.8428, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2341, d3h4pA_, 0.8428, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2342, p3h4pI_, 0.8426, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2343, d3unfT_, 0.8424, 1.92, 0.288, 244, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2344, d3unfF_, 0.8424, 1.92, 0.288, 244, 226, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2345, d3h4pE_, 0.8424, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2346, p5mpcE_, 0.8423, 2.00, 0.329, 242, 228, 
2347, p3h4pN_, 0.8423, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2348, d3h4pC_, 0.8423, 1.69, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2349, d3sdiF_, 0.8422, 2.02, 0.330, 242, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2350, p3h4pL_, 0.8422, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2351, d1z7qD1, 0.8422, 1.80, 0.360, 241, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2352, d5m2bF_, 0.8421, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2353, d5l63T_, 0.8421, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2354, d5l63F_, 0.8421, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2355, d1z7qR1, 0.8421, 1.81, 0.360, 241, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2356, p5t0cW_, 0.8420, 1.76, 0.329, 228, 225, 
2357, p5t0cCB_, 0.8420, 1.76, 0.329, 228, 225, 
2358, d5m2bT_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2359, d5l6aT_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2360, d5l6aF_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2361, d5l64T_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2362, d5l64F_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2363, d5l61T_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2364, d5l61F_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2365, d5l5rT_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2366, d5l5dT_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2367, d5l5dF_, 0.8420, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2368, p3h4pK_, 0.8420, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2369, d3h4pB_, 0.8420, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2370, d5l69T_, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2371, d5l69F_, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2372, d5l66T_, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2373, d5l66F_, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2374, d5l65F_, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2375, d5l5wT_, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2376, d5l5wF_, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2377, d5l5rF_, 0.8419, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2378, p3h4pM_, 0.8419, 1.71, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2379, d5l65T_, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2380, d5l62T_, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2381, d5l62F_, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2382, d5l5hT_, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2383, d5l5hF_, 0.8418, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2384, d4r18T_, 0.8418, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2385, d4r18F_, 0.8418, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2386, d4qv6F_, 0.8418, 1.87, 0.336, 243, 226, YCP BETA5-A49V MUTANT
2387, d5l6cT_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2388, d5l6cF_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2389, d5l5zT_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2390, d5l5zF_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2391, d5l5yT_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2392, d5l5yF_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2393, d5l5uT_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2394, d5l5uF_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2395, d5l5sT_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2396, d5l5sF_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2397, d5l5pT_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2398, d5l5pF_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2399, d5bxnT_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2400, d5bxnF_, 0.8417, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2401, d4r02T_, 0.8417, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2402, d4qvnT_, 0.8417, 1.87, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2403, d4qvnF_, 0.8417, 1.87, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2404, d4qv6T_, 0.8417, 1.87, 0.336, 243, 226, YCP BETA5-A49V MUTANT
2405, d3h4pG_, 0.8417, 1.70, 0.364, 232, 225, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2406, d5l6bT_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2407, d5l6bF_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2408, d5l60T_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2409, d5l60F_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2410, d5l5xT_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2411, d5l5xF_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2412, d5l5tT_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2413, d5l5tF_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2414, d5l5qT_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2415, d5l5qF_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2416, d5l5oT_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2417, d5l5oF_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2418, d5l5jT_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2419, d5l5jF_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2420, d5l5iT_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2421, d5l5iF_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2422, d5l5bT_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2423, d5l5bF_, 0.8416, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2424, d4r02F_, 0.8416, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2425, d5l68T_, 0.8415, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2426, d5l68F_, 0.8415, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2427, d5l67T_, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2428, d5l67F_, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2429, d5l5fT_, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2430, d5l5fF_, 0.8415, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2431, d5cz6F_, 0.8415, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2432, p4y8tT_, 0.8415, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2433, p4y8tF_, 0.8415, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2434, d4qvyT_, 0.8415, 1.87, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2435, d4qvyF_, 0.8415, 1.87, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2436, d4qvlT_, 0.8415, 1.87, 0.336, 243, 226, YCP IN COMPLEX WITH BORTEZOMIB
2437, p5vfuJA_, 0.8414, 1.80, 0.324, 228, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2438, d5l5vT_, 0.8414, 1.88, 0.336, 243, 226,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2439, d5l5vF_, 0.8414, 1.88, 0.336, 243, 226,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2440, d5l5aT_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2441, d5l5aF_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2442, d5cz6T_, 0.8414, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2443, d5bxlT_, 0.8414, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2444, d5bxlF_, 0.8414, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2445, d4ya4T_, 0.8414, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2446, d4ya4F_, 0.8414, 1.87, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2447, d4qvwT_, 0.8414, 1.88, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2448, d4qvwF_, 0.8414, 1.88, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2449, d4qvlF_, 0.8414, 1.87, 0.336, 243, 226, YCP IN COMPLEX WITH BORTEZOMIB
2450, d4nnwT_, 0.8414, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2451, d4nnwF_, 0.8414, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2452, d5lajT_, 0.8413, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2453, d5lajF_, 0.8413, 1.88, 0.336, 243, 226, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2454, d5l5eT_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2455, d5l5eF_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2456, p5dsvL_, 0.8413, 1.81, 0.296, 245, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2457, p5dsvF_, 0.8413, 1.81, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2458, d5bouT_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2459, d5bouF_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2460, p4ya9F_, 0.8413, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2461, d4hnpF_, 0.8413, 1.88, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2462, p5vfoj_, 0.8412, 1.90, 0.336, 239, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2463, p5t0gI_, 0.8412, 2.31, 0.352, 250, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2464, d5d0wF_, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2465, d5cz7F_, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2466, p4ya9T_, 0.8412, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2467, d4r17T_, 0.8412, 1.88, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2468, d4r17F_, 0.8412, 1.88, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2469, d4qzzT_, 0.8412, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH OMURALIDE
2470, d4qzzF_, 0.8412, 1.88, 0.336, 243, 226, YCP IN COMPLEX WITH OMURALIDE
2471, d4qw1T_, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2472, d4qw1F_, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2473, d4qvpT_, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2474, d4qvpF_, 0.8412, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2475, p6gopT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2476, p6gopF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2477, p5mp9g_, 0.8411, 1.87, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2478, d5lttT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2479, d5lttF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2480, d5fggT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2481, d5fggF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2482, d5d0wT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2483, d5czaT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2484, d5czaF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2485, d5cz7T_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2486, p5cghT_, 0.8411, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2487, p5cghF_, 0.8411, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2488, p4ya2T_, 0.8411, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2489, p4ya2F_, 0.8411, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2490, d4y8rF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2491, p4y8gT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2492, p4y8gF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2493, p4y6vF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2494, d4rurT_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2495, d4rurF_, 0.8411, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2496, d4qz7T_, 0.8411, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2497, d4qz7F_, 0.8411, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2498, d4qvqT_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2499, d4qvqF_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2500, d4qvmT_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2501, d4qvmF_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2502, d4qv1T_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45A MUTANT
2503, d4qv1F_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-M45A MUTANT
2504, d4quxT_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-A49T-MUTANT
2505, d4quxF_, 0.8411, 1.88, 0.336, 243, 226, YCP BETA5-A49T-MUTANT
2506, p1fntD_, 0.8411, 1.78, 0.364, 239, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2507, p5dsvB_, 0.8410, 1.81, 0.296, 245, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2508, p5dsvA_, 0.8410, 1.81, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2509, d4y9yT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2510, d4y9yF_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2511, d4y8rT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2512, d4y8mT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2513, d4y8mF_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2514, p4y75T_, 0.8410, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2515, p4y75F_, 0.8410, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2516, p4y6vT_, 0.8410, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2517, d4qwuT_, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2518, d4qwuF_, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2519, d4qv0T_, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2520, d4qv0F_, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2521, d4quyT_, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-A49S-MUTANT
2522, d4quyF_, 0.8410, 1.88, 0.336, 243, 226, YCP BETA5-A49S-MUTANT
2523, d4q1sF_, 0.8410, 1.88, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2524, p1fntR_, 0.8410, 1.78, 0.364, 239, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2525, d5fgaT_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2526, d5fgaF_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2527, d5fg9T_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2528, d5fg9F_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2529, d5ahjT_, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2530, d5ahjF_, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2531, d4ya1T_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2532, d4ya1F_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2533, p4y8sT_, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2534, p4y8sF_, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2535, p4y8pT_, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2536, p4y8pF_, 0.8409, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2537, p4y8nF_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2538, p4y6aT_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2539, p4y6aF_, 0.8409, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2540, d4qz4T_, 0.8409, 1.89, 0.336, 243, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2541, d4qz4F_, 0.8409, 1.89, 0.336, 243, 226, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2542, d4qw0T_, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2543, d4qw0F_, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2544, d4qv5F_, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-M45I MUTANT
2545, d4qv4T_, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT
2546, d4qv4F_, 0.8409, 1.88, 0.336, 243, 226, YCP BETA5-M45T MUTANT
2547, d4qlsT_, 0.8409, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2548, d4qlsF_, 0.8409, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2549, d4no1T_, 0.8409, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2550, d4no1F_, 0.8409, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2551, d5laiT_, 0.8408, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2552, d5laiF_, 0.8408, 1.89, 0.336, 243, 226, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2553, d5fg7T_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2554, d5fg7F_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2555, p5dsvN_, 0.8408, 1.82, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2556, p5dsvI_, 0.8408, 1.82, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2557, p4y8uT_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2558, p4y8uF_, 0.8408, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2559, p4y8nT_, 0.8408, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2560, p4y77T_, 0.8408, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2561, p4y77F_, 0.8408, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2562, p4y69F_, 0.8408, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2563, d4qz6T_, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2564, d4qz6F_, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2565, d4qwfT_, 0.8408, 1.90, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2566, d4qwfF_, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2567, d4qw6T_, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2568, d4qw6F_, 0.8408, 1.89, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2569, d4qv8T_, 0.8408, 1.88, 0.336, 243, 226, YCP BETA5-C52F MUTANT
2570, d4qv8F_, 0.8408, 1.88, 0.336, 243, 226, YCP BETA5-C52F MUTANT
2571, d4qv5T_, 0.8408, 1.88, 0.336, 243, 226, YCP BETA5-M45I MUTANT
2572, d4qltT_, 0.8408, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2573, d4qltF_, 0.8408, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2574, p4qbyT_, 0.8408, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2575, p4qbyF_, 0.8408, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2576, d5jhrT_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2577, d5jhrF_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2578, p5fghT_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2579, p5fghF_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2580, d5dkjT_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2581, d5dkjF_, 0.8407, 1.88, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2582, d5d0vT_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2583, d5d0vF_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2584, d5cz9F_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2585, p5cggT_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2586, p5cggF_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2587, p4ya7T_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2588, p4ya7F_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2589, p4ya5T_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2590, p4ya5F_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2591, p4y69T_, 0.8407, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2592, d4qwxT_, 0.8407, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2593, d4qwxF_, 0.8407, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2594, d4qv7T_, 0.8407, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT
2595, d4qv7F_, 0.8407, 1.88, 0.336, 243, 226, YCP BETA5-A50V MUTANT
2596, d4hrdF_, 0.8407, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2597, d3sdiT_, 0.8407, 1.89, 0.332, 242, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2598, d1rypU_, 0.8407, 1.88, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2599, d1rypG_, 0.8407, 1.88, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2600, d5l54T_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2601, d5l54F_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2602, d5d0xT_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2603, d5d0xF_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2604, d5d0tT_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2605, d5d0tF_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2606, d5cz9T_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2607, p4y84T_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2608, p4y84F_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2609, p4y74T_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2610, p4y74F_, 0.8406, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2611, p4x6zU_, 0.8406, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2612, d4qz0T_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2613, d4qz0F_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2614, d4qwlT_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2615, d4qwlF_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2616, d4qw7T_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2617, d4qw7F_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2618, d4qw5T_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2619, d4qw5F_, 0.8406, 1.89, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2620, d4qw4T_, 0.8406, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH CARFILZOMIB
2621, d4qw4F_, 0.8406, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH CARFILZOMIB
2622, d4qv9T_, 0.8406, 1.88, 0.336, 243, 226, YCP BETA5-C63F MUTANT
2623, d4qv9F_, 0.8406, 1.88, 0.336, 243, 226, YCP BETA5-C63F MUTANT
2624, d4qlqT_, 0.8406, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2625, d4qlqF_, 0.8406, 1.89, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2626, d4nnnT_, 0.8406, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH MG132
2627, d3nzjT_, 0.8406, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2628, d3nzjF_, 0.8406, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2629, d5l55T_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2630, d5l55F_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2631, d5fgeT_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2632, d5fgeF_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2633, p5dsvK_, 0.8405, 1.82, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2634, d5d0sT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2635, d5d0sF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2636, d5cgfT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2637, d5cgfF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2638, p4y9zT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2639, p4y9zF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2640, p4y8hT_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2641, p4y8hF_, 0.8405, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2642, p4y81T_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2643, p4y81F_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2644, p4y7xT_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2645, p4y7xF_, 0.8405, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2646, d4qz3F_, 0.8405, 1.89, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2647, d4qz1F_, 0.8405, 1.90, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2648, d4qw3T_, 0.8405, 1.89, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2649, d4qw3F_, 0.8405, 1.89, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2650, d4qluT_, 0.8405, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2651, d4qluF_, 0.8405, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2652, d4no9T_, 0.8405, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2653, d4no9F_, 0.8405, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2654, d4nnnF_, 0.8405, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH MG132
2655, d5jhsT_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2656, d5jhsF_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2657, d5fgiT_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2658, d5fgiF_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2659, p5dsvE_, 0.8404, 1.82, 0.296, 245, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2660, d5d0zT_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2661, d5d0zF_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2662, p4y8oT_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2663, p4y8oF_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2664, p4y8kT_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2665, p4y8kF_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2666, p4y6zT_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2667, p4y6zF_, 0.8404, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2668, p4x6zG_, 0.8404, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2669, d4qz5T_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2670, d4qz5F_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2671, d4qz3T_, 0.8404, 1.89, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2672, d4qz1T_, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2673, d4qwkT_, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2674, d4qwkF_, 0.8404, 1.90, 0.336, 243, 226, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2675, d4fzgF_, 0.8404, 1.89, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2676, p5t0gK_, 0.8403, 1.93, 0.327, 228, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2677, d5fgfT_, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2678, d5fgfF_, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2679, p4y82T_, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2680, p4y82F_, 0.8403, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2681, d4r00T_, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2682, d4r00F_, 0.8403, 1.89, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2683, d4qzwT_, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2684, d4qzwF_, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2685, d4qz2T_, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2686, d4qz2F_, 0.8403, 1.90, 0.336, 243, 226, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2687, d4ltcF_, 0.8403, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2688, d4j70F_, 0.8403, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2689, d4fzgT_, 0.8403, 1.89, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2690, d3un8F_, 0.8403, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2691, d5fgdT_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2692, d5fgdF_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2693, d5dkiT_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2694, d5dkiF_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2695, d5cz4T_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2696, d5cz4F_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2697, p4zzgG_, 0.8402, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2698, d4z1lT_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2699, d4z1lF_, 0.8402, 1.89, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2700, p4y8iT_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2701, p4y8iF_, 0.8402, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2702, d4qwrT_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2703, d4qwrF_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2704, d4qwiT_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2705, d4qwiF_, 0.8402, 1.90, 0.336, 243, 226, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2706, d4qv3T_, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-M45V MUTANT
2707, d4qv3F_, 0.8402, 1.89, 0.336, 243, 226, YCP BETA5-M45V MUTANT
2708, d4no8F_, 0.8402, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2709, d4no6T_, 0.8402, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2710, d4no6F_, 0.8402, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2711, d4intF_, 0.8402, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2712, d4hrcF_, 0.8402, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2713, d3mg0F_, 0.8402, 1.89, 0.336, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2714, d3hyeT_, 0.8402, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2715, d3hyeF_, 0.8402, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2716, d5l52T_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2717, d5l52F_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2718, p5dsvD_, 0.8401, 1.82, 0.296, 244, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2719, p4y8lT_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2720, p4y8lF_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2721, p4y70T_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2722, p4y70F_, 0.8401, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2723, d4qvvT_, 0.8401, 1.89, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2724, d4qvvF_, 0.8401, 1.89, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2725, d4no8T_, 0.8401, 1.90, 0.336, 243, 226, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2726, d4j70T_, 0.8401, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2727, d4hrdT_, 0.8401, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2728, d4hnpT_, 0.8401, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2729, d4eu2G_, 0.8401, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2730, p4cr4D_, 0.8401, 1.90, 0.358, 242, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2731, d3mg0T_, 0.8401, 1.89, 0.332, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2732, d3gptT_, 0.8401, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2733, d3gptF_, 0.8401, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2734, p5nifG_, 0.8400, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2735, p5cgiT_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2736, p5cgiF_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2737, p4ya3T_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2738, p4ya3F_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2739, p4ya0T_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2740, p4ya0F_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2741, p4y8qT_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2742, p4y8qF_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2743, p4y8jT_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2744, p4y8jF_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2745, p4y80T_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2746, p4y80F_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2747, p4y7wT_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2748, p4y7wF_, 0.8400, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2749, d4inrF_, 0.8400, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2750, d3un8T_, 0.8400, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2751, p5gjqm_, 0.8399, 1.63, 0.317, 238, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2752, p5dsvG_, 0.8399, 1.83, 0.296, 242, 226, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2753, d4qwgF_, 0.8399, 1.91, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2754, d4q1sT_, 0.8399, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2755, d4ltcT_, 0.8399, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2756, d3nzwT_, 0.8399, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2757, d3nzwF_, 0.8399, 1.89, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2758, d3mg4F_, 0.8399, 1.89, 0.332, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2759, d5fhsT_, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2760, d5fhsF_, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2761, d5cz8T_, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2762, d5cz8F_, 0.8398, 1.90, 0.336, 243, 226, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2763, d5cz5T_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2764, d5cz5F_, 0.8398, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2765, d4qxjT_, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2766, d4qxjF_, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2767, d4qwsT_, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2768, d4qwsF_, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2769, d4qwgT_, 0.8398, 1.91, 0.336, 243, 226, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2770, d4intT_, 0.8398, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2771, d4inrT_, 0.8398, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2772, d3tddT_, 0.8398, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2773, d3tddF_, 0.8398, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2774, d3d29T_, 0.8398, 1.90, 0.336, 244, 226, PROTEASOME INHIBITION BY FELLUTAMIDE B
2775, d3d29F_, 0.8398, 1.90, 0.336, 244, 226, PROTEASOME INHIBITION BY FELLUTAMIDE B
2776, d2ku2B1, 0.8398, 1.81, 0.394, 233, 226, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2777, p5vfuIA_, 0.8397, 1.93, 0.332, 239, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2778, p5vftj_, 0.8397, 1.93, 0.332, 239, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2779, p5mpbR_, 0.8397, 1.94, 0.362, 240, 229, 
2780, p4zzgU_, 0.8397, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2781, d4qwjT_, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2782, d4qwjF_, 0.8397, 1.91, 0.336, 243, 226, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2783, d4lqiF_, 0.8397, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2784, p5t0hI_, 0.8396, 2.32, 0.352, 250, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2785, p5nifU_, 0.8396, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2786, p5mp9G_, 0.8396, 1.89, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2787, p4y7yT_, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2788, p4y7yF_, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2789, p4y78T_, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2790, p4y78F_, 0.8396, 1.91, 0.336, 243, 226, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2791, d4qzxT_, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2792, d4qzxF_, 0.8396, 1.91, 0.336, 243, 226, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2793, d4qlvT_, 0.8396, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2794, d4qlvF_, 0.8396, 1.91, 0.336, 243, 226, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2795, d4lqiT_, 0.8396, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2796, d4jsqT_, 0.8396, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2797, d4jsqF_, 0.8396, 1.89, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2798, d4inuF_, 0.8396, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2799, d2fnyF_, 0.8396, 1.90, 0.332, 244, 226,  
2800, d1g0uF_, 0.8396, 1.89, 0.336, 242, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2801, d3nzxT_, 0.8395, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2802, d3nzxF_, 0.8395, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2803, d3gpwT_, 0.8395, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2804, d3gpwF_, 0.8395, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2805, d3dy3T_, 0.8395, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2806, d3dy3F_, 0.8395, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2807, d2fnyT_, 0.8395, 1.90, 0.332, 244, 226,  
2808, d4jt0T_, 0.8394, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2809, d4jt0F_, 0.8394, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2810, d4jsuF_, 0.8394, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2811, d4inuT_, 0.8394, 1.90, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2812, d4g4sG_, 0.8394, 1.90, 0.336, 246, 226, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2813, d3e47T_, 0.8394, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2814, d3e47F_, 0.8394, 1.91, 0.332, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2815, d4jsuT_, 0.8393, 1.90, 0.336, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2816, d4hrcT_, 0.8393, 1.90, 0.332, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2817, p4gk7F_, 0.8393, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2818, d3gpjT_, 0.8393, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2819, d2fakT_, 0.8393, 1.90, 0.341, 244, 226, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2820, d2fakF_, 0.8393, 1.90, 0.341, 244, 226, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2821, d1g65F_, 0.8393, 1.89, 0.336, 244, 226, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2822, d1g0uT_, 0.8393, 1.90, 0.336, 242, 226, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2823, p4v7oG_, 0.8392, 1.92, 0.341, 244, 226, 
2824, p4gk7T_, 0.8392, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2825, d4fzcF_, 0.8392, 1.91, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2826, d3l5qL_, 0.8392, 1.92, 0.341, 244, 226,  
2827, d3gpjF_, 0.8392, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2828, d2zcyT_, 0.8392, 1.91, 0.336, 244, 226, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2829, d2gplF_, 0.8392, 1.91, 0.332, 244, 226, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2830, d1jd2F_, 0.8392, 1.90, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2831, d1g65T_, 0.8392, 1.89, 0.336, 244, 226, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2832, p5vfqCA_, 0.8391, 1.93, 0.336, 239, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2833, p4v7oU_, 0.8391, 1.92, 0.341, 244, 226, 
2834, d4fzcT_, 0.8391, 1.91, 0.332, 244, 226, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2835, d3okjF_, 0.8391, 1.90, 0.332, 244, 226, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2836, d3l5qX_, 0.8391, 1.92, 0.341, 244, 226,  
2837, d3dy4T_, 0.8391, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2838, d3dy4F_, 0.8391, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2839, d3bdmT_, 0.8391, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2840, d3bdmF_, 0.8391, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2841, d2zcyF_, 0.8391, 1.91, 0.336, 244, 226, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2842, d2gplT_, 0.8391, 1.91, 0.332, 244, 226, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2843, p4v7oCB_, 0.8390, 1.92, 0.341, 244, 226, 
2844, p3un4T_, 0.8390, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2845, p3un4F_, 0.8390, 1.91, 0.332, 244, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2846, d3shjT_, 0.8390, 1.91, 0.332, 244, 226, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2847, d3shjF_, 0.8390, 1.91, 0.332, 244, 226, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2848, d3okjT_, 0.8390, 1.91, 0.332, 244, 226, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2849, d3mg4T_, 0.8390, 1.91, 0.332, 244, 226, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2850, d1vsyU_, 0.8390, 1.92, 0.341, 244, 226,  
2851, p4v7oOA_, 0.8389, 1.92, 0.341, 244, 226, 
2852, d4eu2U_, 0.8389, 1.92, 0.341, 244, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2853, d1vsyG_, 0.8389, 1.92, 0.341, 244, 226,  
2854, p5m32T_, 0.8388, 2.31, 0.288, 240, 229, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2855, d1jd21_, 0.8388, 1.91, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2856, p5vfoM_, 0.8387, 1.96, 0.286, 240, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2857, p5vfpBA_, 0.8386, 1.93, 0.336, 239, 229, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2858, d3mg8F_, 0.8385, 1.85, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2859, d1z7qU1, 0.8385, 1.92, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2860, d1z7qG1, 0.8385, 1.92, 0.336, 243, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2861, d2f16T_, 0.8383, 1.92, 0.336, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2862, d2f16F_, 0.8383, 1.92, 0.341, 244, 226, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2863, d3oeuF_, 0.8382, 1.86, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2864, p5vfrj_, 0.8381, 1.94, 0.336, 239, 229, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2865, d3oevF_, 0.8381, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2866, d3mg8T_, 0.8381, 1.86, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2867, d3mg7F_, 0.8381, 1.86, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2868, d2ku2C1, 0.8381, 1.81, 0.396, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2869, d3oevT_, 0.8379, 1.86, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2870, d3mg6T_, 0.8379, 1.86, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2871, p5vfqG_, 0.8378, 1.97, 0.286, 240, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2872, d3mg7T_, 0.8378, 1.86, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2873, d3oeuT_, 0.8377, 1.86, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2874, d3mg6F_, 0.8377, 1.87, 0.329, 237, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2875, p5m32F_, 0.8376, 1.87, 0.292, 232, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2876, p5m32B_, 0.8376, 2.07, 0.354, 234, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2877, p6epfC_, 0.8373, 2.47, 0.361, 249, 233, GROUND STATE 26S PROTEASOME (GS1)
2878, p5wviCA_, 0.8372, 2.30, 0.356, 245, 233, 
2879, d4eu2O_, 0.8372, 1.83, 0.311, 241, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2880, p5vfpG_, 0.8371, 1.98, 0.286, 240, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2881, p5t0jI_, 0.8368, 2.04, 0.352, 250, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2882, p5t0hK_, 0.8368, 1.79, 0.329, 228, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2883, p5a5bE_, 0.8367, 2.22, 0.328, 243, 229, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2884, p4cr3E_, 0.8367, 2.22, 0.328, 243, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2885, p5wviBA_, 0.8366, 1.90, 0.326, 243, 227, 
2886, p5nifA_, 0.8365, 1.85, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2887, p5mpag_, 0.8365, 1.94, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2888, p4zzgA_, 0.8365, 1.85, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2889, d3sdkU_, 0.8365, 1.84, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2890, d3mg4U_, 0.8364, 1.84, 0.311, 243, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2891, p3jcpPA_, 0.8364, 1.93, 0.341, 244, 226, 
2892, d3mg7U_, 0.8362, 1.85, 0.311, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2893, p5vfuX_, 0.8360, 1.90, 0.296, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2894, p5vftM_, 0.8360, 1.90, 0.296, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2895, p5vfom_, 0.8360, 1.88, 0.296, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2896, d5d0wU_, 0.8360, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2897, d5d0wG_, 0.8360, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2898, p3jcpP_, 0.8360, 1.94, 0.341, 244, 226, 
2899, p5vfsG_, 0.8359, 1.90, 0.296, 240, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2900, p5vfrM_, 0.8359, 1.99, 0.286, 240, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2901, d4ya4U_, 0.8359, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2902, d4qv9U_, 0.8359, 1.86, 0.307, 241, 225, YCP BETA5-C63F MUTANT
2903, d4qv9G_, 0.8359, 1.86, 0.307, 241, 225, YCP BETA5-C63F MUTANT
2904, d3sdkF_, 0.8359, 1.83, 0.335, 236, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2905, d5l5bU_, 0.8358, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2906, d5l5bG_, 0.8358, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2907, d5czaU_, 0.8358, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2908, d4ya4G_, 0.8358, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2909, d3sdiU_, 0.8358, 1.85, 0.311, 240, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2910, d5fggU_, 0.8357, 1.85, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2911, d5fggG_, 0.8357, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2912, p5dsvH_, 0.8357, 1.94, 0.289, 239, 225, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2913, d5czaG_, 0.8357, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2914, d4y8rU_, 0.8357, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2915, d4y8rG_, 0.8357, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2916, d4qv3U_, 0.8357, 1.86, 0.307, 241, 225, YCP BETA5-M45V MUTANT
2917, d4qv3G_, 0.8357, 1.86, 0.307, 241, 225, YCP BETA5-M45V MUTANT
2918, d4no9U_, 0.8357, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2919, d4no9G_, 0.8357, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2920, d3mg6U_, 0.8357, 1.96, 0.310, 243, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2921, d5l55U_, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2922, d5l55G_, 0.8356, 1.86, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2923, p5gjrX_, 0.8356, 1.69, 0.317, 238, 224, 
2924, d5fg7U_, 0.8356, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2925, d5fg7G_, 0.8356, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2926, d5ahjU_, 0.8356, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2927, d4ya1U_, 0.8356, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2928, d4nnnU_, 0.8356, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH MG132
2929, d4eu2A_, 0.8356, 1.86, 0.307, 241, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2930, d3wxrO_, 0.8356, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2931, p6epdC_, 0.8355, 2.07, 0.361, 249, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
2932, p5gjqG_, 0.8355, 1.69, 0.317, 238, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2933, p5cggU_, 0.8355, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2934, d5cgfU_, 0.8355, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2935, d5cgfG_, 0.8355, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2936, d5ahjG_, 0.8355, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2937, d4ya1G_, 0.8355, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2938, d4quyU_, 0.8355, 1.86, 0.307, 241, 225, YCP BETA5-A49S-MUTANT
2939, d4quyG_, 0.8355, 1.87, 0.307, 241, 225, YCP BETA5-A49S-MUTANT
2940, d4nnnG_, 0.8355, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH MG132
2941, d4hnpU_, 0.8355, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2942, d3un8U_, 0.8355, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2943, d3mg8U_, 0.8355, 1.97, 0.310, 243, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2944, p1fntU_, 0.8355, 1.97, 0.336, 240, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2945, p1fntG_, 0.8355, 1.97, 0.336, 240, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2946, p5vfoL_, 0.8354, 1.70, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2947, p5gjrLA_, 0.8354, 1.70, 0.317, 238, 224, 
2948, d5fgaU_, 0.8354, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2949, p5cggG_, 0.8354, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2950, d5bxlU_, 0.8354, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2951, d4no8U_, 0.8354, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2952, d4no8G_, 0.8354, 1.86, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2953, d4g4sA_, 0.8354, 2.12, 0.308, 241, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2954, d3sdkT_, 0.8354, 1.84, 0.330, 236, 224, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2955, d1g0uU_, 0.8354, 1.86, 0.307, 240, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2956, d5l5rU_, 0.8353, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2957, d5l5rG_, 0.8353, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2958, d5jhrU_, 0.8353, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2959, d5jhrG_, 0.8353, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2960, d5fgaG_, 0.8353, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2961, d5d0sU_, 0.8353, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2962, d5bxlG_, 0.8353, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2963, d4qwlU_, 0.8353, 1.86, 0.311, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2964, d4qwlG_, 0.8353, 1.86, 0.311, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2965, d4qv7U_, 0.8353, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT
2966, d4qv7G_, 0.8353, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT
2967, d4ltcU_, 0.8353, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2968, d4j70U_, 0.8353, 1.87, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2969, d3oevG_, 0.8353, 1.86, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2970, p5vfqFA_, 0.8352, 2.00, 0.286, 240, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2971, p5t0cY_, 0.8352, 2.04, 0.295, 240, 227, 
2972, p5t0cEB_, 0.8352, 2.04, 0.295, 240, 227, 
2973, d5l5uU_, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2974, d5l52U_, 0.8352, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2975, d5l52G_, 0.8352, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2976, d5d0sG_, 0.8352, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2977, d5bxnU_, 0.8352, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2978, p4y8hU_, 0.8352, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2979, p4y8hG_, 0.8352, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2980, d4qz6U_, 0.8352, 1.86, 0.311, 241, 225, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2981, d4no1U_, 0.8352, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2982, d4no1G_, 0.8352, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2983, d4hrcU_, 0.8352, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2984, d3oeuU_, 0.8352, 1.97, 0.310, 243, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2985, p6gopU_, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2986, p5t0gJ_, 0.8351, 1.99, 0.332, 239, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2987, p5nifO_, 0.8351, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2988, d5l5uG_, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2989, d5bxnG_, 0.8351, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2990, p4ya7U_, 0.8351, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2991, d4qz6G_, 0.8351, 1.86, 0.311, 241, 225, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2992, d4qwuU_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2993, d4qwuG_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2994, d4qv6U_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-A49V MUTANT
2995, d4qv5U_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-M45I MUTANT
2996, d4qv1U_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-M45A MUTANT
2997, d4qv1G_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-M45A MUTANT
2998, d4qv0U_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2999, d4qv0G_, 0.8351, 1.87, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3000, d4q1sU_, 0.8351, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3001, d4hrdU_, 0.8351, 1.86, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3002, d1rypO_, 0.8351, 1.87, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3003, p5vfpEA_, 0.8350, 2.00, 0.286, 240, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3004, p4zzgO_, 0.8350, 1.88, 0.307, 242, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3005, d4z1lU_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3006, p4ya7G_, 0.8350, 1.86, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3007, d4y9yU_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3008, d4y9yG_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3009, p4y8pU_, 0.8350, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3010, p4y8pG_, 0.8350, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3011, d4y8mU_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3012, d4y8mG_, 0.8350, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3013, d4r17U_, 0.8350, 1.87, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3014, d4r17G_, 0.8350, 1.88, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3015, d4qzzU_, 0.8350, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH OMURALIDE
3016, d4qzzG_, 0.8350, 1.87, 0.307, 241, 225, YCP IN COMPLEX WITH OMURALIDE
3017, d4qz0U_, 0.8350, 1.86, 0.311, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3018, d4qvnU_, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3019, d4qv6G_, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-A49V MUTANT
3020, d4qv5G_, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45I MUTANT
3021, d4qv4U_, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT
3022, d4qv4G_, 0.8350, 1.87, 0.307, 241, 225, YCP BETA5-M45T MUTANT
3023, d3gpjU_, 0.8350, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3024, d3gpjG_, 0.8350, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3025, p6gopG_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3026, d5l6aU_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3027, d5l6aG_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3028, d5fg9U_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3029, d5d0zU_, 0.8349, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3030, d5d0zG_, 0.8349, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3031, d4z1lG_, 0.8349, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3032, d4qz0G_, 0.8349, 1.86, 0.311, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3033, d4qvnG_, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3034, d4qv8U_, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT
3035, d4qv8G_, 0.8349, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT
3036, d4j70G_, 0.8349, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3037, p3un4U_, 0.8349, 1.86, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3038, d3oevU_, 0.8349, 1.98, 0.310, 243, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3039, p3jcpJA_, 0.8349, 1.87, 0.307, 243, 225, 
3040, p3jcpJ_, 0.8349, 1.87, 0.307, 243, 225, 
3041, d2ku1B1, 0.8349, 1.89, 0.400, 233, 225, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3042, d1g65U_, 0.8349, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3043, p5vfsFA_, 0.8348, 1.92, 0.296, 240, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3044, d5fgfU_, 0.8348, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3045, d5fgfG_, 0.8348, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3046, d5fg9G_, 0.8348, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3047, d5cz9U_, 0.8348, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3048, d5cz9G_, 0.8348, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3049, p4y9zU_, 0.8348, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3050, p4y9zG_, 0.8348, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3051, p4x6zO_, 0.8348, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3052, d4r00U_, 0.8348, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3053, d4r00G_, 0.8348, 1.87, 0.307, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3054, d4fzgU_, 0.8348, 1.87, 0.311, 243, 225, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3055, p3un4G_, 0.8348, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3056, d3tddU_, 0.8348, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3057, d3tddG_, 0.8348, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3058, d3nzjU_, 0.8348, 1.87, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3059, p5mpaG_, 0.8347, 1.96, 0.336, 243, 226, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3060, d5fhsU_, 0.8347, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3061, p4y8sU_, 0.8347, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3062, p4y8sG_, 0.8347, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3063, p4y8gU_, 0.8347, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3064, p4y75U_, 0.8347, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3065, d4qz5U_, 0.8347, 1.87, 0.311, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3066, d4qz5G_, 0.8347, 1.87, 0.311, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3067, d4qz3U_, 0.8347, 1.87, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3068, d4qw1U_, 0.8347, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3069, d4qvlU_, 0.8347, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH BORTEZOMIB
3070, d4no6U_, 0.8347, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3071, d4jsuU_, 0.8347, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3072, d4jsuG_, 0.8347, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3073, d3nzjG_, 0.8347, 1.87, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3074, d3mg0U_, 0.8347, 1.87, 0.311, 243, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3075, d3gpwU_, 0.8347, 1.88, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3076, d3gptU_, 0.8347, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3077, d1jd22_, 0.8347, 1.88, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3078, d1g0uG_, 0.8347, 1.87, 0.307, 240, 225, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3079, d5l6bU_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3080, d5l6bG_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3081, d5jhsU_, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3082, d5jhsG_, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3083, d5fhsG_, 0.8346, 1.87, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3084, d5d0vU_, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3085, d5cz8U_, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3086, p4ya2U_, 0.8346, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3087, p4ya2G_, 0.8346, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3088, p4y8tU_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3089, p4y8tG_, 0.8346, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3090, p4y8kU_, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3091, p4y8gG_, 0.8346, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3092, p4y75G_, 0.8346, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3093, d4qz3G_, 0.8346, 1.87, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3094, d4qw7U_, 0.8346, 1.87, 0.311, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3095, d4qw5U_, 0.8346, 1.87, 0.311, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3096, d4qw5G_, 0.8346, 1.87, 0.311, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3097, d4qw1G_, 0.8346, 1.87, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3098, d4qvlG_, 0.8346, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH BORTEZOMIB
3099, d4qltU_, 0.8346, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3100, d4no6G_, 0.8346, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3101, d4lqiU_, 0.8346, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3102, d4jt0U_, 0.8346, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3103, d4jt0G_, 0.8346, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3104, d4jsqU_, 0.8346, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3105, d4intU_, 0.8346, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3106, d4fzgG_, 0.8346, 1.87, 0.311, 243, 225, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3107, d3shjU_, 0.8346, 1.88, 0.311, 243, 225, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3108, d3nzxU_, 0.8346, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3109, d3mg4G_, 0.8346, 1.87, 0.307, 243, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3110, d3gptG_, 0.8346, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3111, d1rypA_, 0.8346, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3112, p5vfrl_, 0.8345, 1.72, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3113, d5lttU_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3114, d5lttG_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3115, d5l63U_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3116, d5l61U_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3117, d5l5aU_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3118, d5l5aG_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3119, d5d0vG_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3120, d5cz8G_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3121, d5cz7U_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3122, d5cz6U_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3123, d5cz6G_, 0.8345, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3124, p4ya9U_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3125, p4y8lU_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3126, p4y8lG_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3127, p4y8kG_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3128, p4y77U_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3129, p4y77G_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3130, p4y70U_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3131, p4y70G_, 0.8345, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3132, p4v7oO_, 0.8345, 1.88, 0.307, 243, 225, 
3133, p4v7oIA_, 0.8345, 1.88, 0.307, 243, 225, 
3134, p4v7oA_, 0.8345, 1.88, 0.307, 243, 225, 
3135, d4qz4U_, 0.8345, 1.87, 0.311, 241, 225, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3136, d4qw7G_, 0.8345, 1.87, 0.311, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3137, d4qw6U_, 0.8345, 1.87, 0.311, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3138, d4qvyU_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3139, d4qvyG_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3140, d4qvpU_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3141, d4quxU_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT
3142, d4quxG_, 0.8345, 1.88, 0.307, 241, 225, YCP BETA5-A49T-MUTANT
3143, d4qltG_, 0.8345, 1.87, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3144, d4nnwU_, 0.8345, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3145, d4nnwG_, 0.8345, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3146, d4jsqG_, 0.8345, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3147, d4inrU_, 0.8345, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3148, d3un8G_, 0.8345, 1.87, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3149, d3shjG_, 0.8345, 1.88, 0.311, 243, 225, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3150, d3sdkG_, 0.8345, 1.88, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3151, d3nzxG_, 0.8345, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3152, d3mg7G_, 0.8345, 1.99, 0.305, 243, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3153, d3l5qC_, 0.8345, 1.88, 0.307, 243, 225,  
3154, d3l5qA_, 0.8345, 1.88, 0.307, 243, 225,  
3155, d3gpwG_, 0.8345, 1.88, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3156, d3bdmU_, 0.8345, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3157, d3bdmG_, 0.8345, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3158, d1vsyA_, 0.8345, 1.88, 0.307, 243, 225,  
3159, d5l63G_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3160, d5l61G_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3161, d5l5oU_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3162, d5l5oG_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3163, d5l5hU_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3164, d5l5hG_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3165, d5l5dU_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3166, d5l5dG_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3167, d5cz7G_, 0.8344, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3168, p5cgiU_, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3169, p4ya9G_, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3170, p4y7wU_, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3171, p4y7wG_, 0.8344, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3172, p4v7oWA_, 0.8344, 1.88, 0.307, 243, 225, 
3173, d4qz4G_, 0.8344, 1.87, 0.311, 241, 225, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3174, d4qw6G_, 0.8344, 1.87, 0.311, 241, 225, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3175, d4qvpG_, 0.8344, 1.88, 0.307, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3176, d4lqiG_, 0.8344, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3177, d3nzwU_, 0.8344, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3178, d3mg6G_, 0.8344, 1.88, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3179, d3hyeU_, 0.8344, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3180, d1vsyO_, 0.8344, 1.88, 0.307, 243, 225,  
3181, d5l67U_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3182, d5l67G_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3183, d5l66U_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3184, d5l65U_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3185, d5l65G_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3186, d5l64U_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3187, d5l62U_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3188, d5l62G_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3189, d5l5pU_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3190, d5l5fU_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3191, d5l5fG_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3192, d5l54U_, 0.8343, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3193, d5fgeU_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3194, d5fgeG_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3195, p5cgiG_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3196, p4y8uU_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3197, p4y8uG_, 0.8343, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3198, p4y8jU_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3199, p4y7yU_, 0.8343, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3200, d4qzwU_, 0.8343, 1.87, 0.311, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3201, d4qwrU_, 0.8343, 1.88, 0.311, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3202, d4qwrG_, 0.8343, 1.88, 0.311, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3203, d4qwjU_, 0.8343, 1.87, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3204, d4qluU_, 0.8343, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3205, d4qluG_, 0.8343, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3206, d4qlsU_, 0.8343, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3207, d4qlsG_, 0.8343, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3208, d3nzwG_, 0.8343, 1.89, 0.307, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3209, d3hyeG_, 0.8343, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3210, d3e47U_, 0.8343, 1.87, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3211, d2fnyU_, 0.8343, 1.87, 0.311, 243, 225,  
3212, d5l6cU_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3213, d5l6cG_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3214, d5l66G_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3215, d5l64G_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3216, d5l5wU_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3217, d5l5pG_, 0.8342, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3218, d5l54G_, 0.8342, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3219, p5l4gT_, 0.8342, 1.70, 0.317, 238, 224, 
3220, p5cghU_, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3221, p5cghG_, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3222, p4y8jG_, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3223, p4y82U_, 0.8342, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3224, p4y7yG_, 0.8342, 1.87, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3225, p4y74U_, 0.8342, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3226, d4qzwG_, 0.8342, 1.87, 0.311, 241, 225, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3227, d4qz7U_, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3228, d4qwjG_, 0.8342, 1.87, 0.307, 241, 225, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3229, d4qvwU_, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3230, d4qvwG_, 0.8342, 1.88, 0.307, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3231, d3wxrA_, 0.8342, 1.88, 0.307, 243, 225, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3232, d3okjU_, 0.8342, 1.89, 0.307, 243, 225, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3233, d3oeuG_, 0.8342, 1.88, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3234, d3e47G_, 0.8342, 1.87, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3235, d2fnyG_, 0.8342, 1.88, 0.311, 243, 225,  
3236, p5vfrL_, 0.8341, 1.72, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3237, d5l5xU_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3238, d5l5xG_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3239, d5l5wG_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3240, d5l5eU_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3241, d5l5eG_, 0.8341, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3242, p4y8qU_, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3243, p4y8qG_, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3244, p4y82G_, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3245, p4y74G_, 0.8341, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3246, d4r02U_, 0.8341, 1.99, 0.310, 241, 226, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3247, d4qzxU_, 0.8341, 1.88, 0.311, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3248, d4qzxG_, 0.8341, 1.88, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3249, d4qz7G_, 0.8341, 1.88, 0.307, 241, 225, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3250, d4qwxU_, 0.8341, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3251, d4qwxG_, 0.8341, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3252, d4qwiU_, 0.8341, 1.88, 0.311, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3253, p4qbyU_, 0.8341, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3254, d4inrG_, 0.8341, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3255, d4fzcU_, 0.8341, 1.88, 0.311, 243, 225, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3256, d3okjG_, 0.8341, 1.89, 0.307, 243, 225, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3257, d3d29U2, 0.8341, 1.90, 0.307, 241, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3258, d3d29G2, 0.8341, 1.90, 0.307, 241, 225, PROTEASOME INHIBITION BY FELLUTAMIDE B
3259, d2fakU_, 0.8341, 1.88, 0.307, 243, 225, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3260, p5t0gM_, 0.8340, 2.04, 0.295, 240, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3261, p5m32G_, 0.8340, 2.00, 0.358, 233, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3262, d5m2bU_, 0.8340, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3263, d5m2bG_, 0.8340, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3264, d5lajU_, 0.8340, 1.89, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3265, d5l5tU_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3266, d5l5tG_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3267, d5fgiU_, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3268, d5fgiG_, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3269, d5d0tU_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3270, d5d0tG_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3271, d5cz5U_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3272, d5cz5G_, 0.8340, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3273, p4y80U_, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3274, p4y80G_, 0.8340, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3275, p4y6vU_, 0.8340, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3276, p4y6vG_, 0.8340, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3277, p4y6aU_, 0.8340, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3278, d4qz2U_, 0.8340, 1.88, 0.311, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3279, d4qwiG_, 0.8340, 1.88, 0.311, 241, 225, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3280, p4qbyG_, 0.8340, 1.88, 0.307, 241, 225, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3281, d2fakG_, 0.8340, 1.89, 0.307, 243, 225, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3282, d5lajG_, 0.8339, 1.89, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3283, d5l5sU_, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3284, d5l5sG_, 0.8339, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3285, d5l5qU_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3286, d5l5qG_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3287, p4y84U_, 0.8339, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3288, p4y84G_, 0.8339, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3289, p4y7xU_, 0.8339, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3290, p4y7xG_, 0.8339, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3291, p4y6aG_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3292, p4y69U_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3293, p4y69G_, 0.8339, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3294, d4r18U_, 0.8339, 1.89, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3295, d4qz2G_, 0.8339, 1.88, 0.311, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3296, d4qlqU_, 0.8339, 1.89, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3297, d4qlqG_, 0.8339, 1.89, 0.311, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3298, d4ltcG_, 0.8339, 1.89, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3299, d4inuU_, 0.8339, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3300, d4intG_, 0.8339, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3301, d4fzcG_, 0.8339, 1.89, 0.311, 243, 225, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3302, d3sdiG_, 0.8339, 1.89, 0.307, 240, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3303, d2gplU_, 0.8339, 1.89, 0.311, 243, 225, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3304, d2f16U_, 0.8339, 1.88, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3305, d1g65G_, 0.8339, 1.89, 0.307, 243, 225, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3306, p5vfqF_, 0.8338, 1.72, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3307, d5l5zU_, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3308, d5l5vU_, 0.8338, 1.89, 0.307, 241, 225,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3309, d5l5vG_, 0.8338, 1.89, 0.307, 241, 225,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3310, d5l5jU_, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3311, d5l5jG_, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3312, d5fgdU_, 0.8338, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3313, d5fgdG_, 0.8338, 1.88, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3314, d5dkjU_, 0.8338, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3315, d4r18G_, 0.8338, 1.89, 0.307, 241, 225, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3316, d4qwkU_, 0.8338, 1.88, 0.311, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3317, d4qwfU_, 0.8338, 1.88, 0.311, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3318, d4qvqU_, 0.8338, 1.89, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3319, d4qvqG_, 0.8338, 1.89, 0.307, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3320, d4qlvU_, 0.8338, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3321, d4qlvG_, 0.8338, 1.89, 0.307, 241, 225, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3322, d2gplG_, 0.8338, 1.89, 0.311, 243, 225, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3323, p5vfqEA_, 0.8337, 1.73, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3324, p5mpbD_, 0.8337, 2.00, 0.358, 240, 229, 
3325, d5l68U_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3326, d5l5zG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3327, d5l5iU_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3328, d5l5iG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3329, d5dkjG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3330, d5bouU_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3331, d5bouG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3332, p4y8nU_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3333, p4y8nG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3334, p4y6zU_, 0.8337, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3335, p4y6zG_, 0.8337, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3336, d4rurU_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3337, d4rurG_, 0.8337, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3338, d4qwkG_, 0.8337, 1.88, 0.311, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3339, d4qwfG_, 0.8337, 1.88, 0.311, 241, 225, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3340, d4qw0U_, 0.8337, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3341, d4q1sG_, 0.8337, 1.90, 0.307, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3342, d4inuG_, 0.8337, 1.89, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3343, d3mg8G_, 0.8337, 1.89, 0.307, 243, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3344, d3dy3U_, 0.8337, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3345, d3dy3G_, 0.8337, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3346, d2f16G_, 0.8337, 1.89, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3347, d5l68G_, 0.8336, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3348, p4y8iU_, 0.8336, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3349, p4y8iG_, 0.8336, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3350, d4qw0G_, 0.8336, 1.89, 0.307, 241, 225, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3351, p4gk7U_, 0.8336, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3352, d3wxrG1, 0.8336, 1.86, 0.330, 236, 224, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3353, d5d0xU_, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3354, p4ya5U_, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3355, p4ya5G_, 0.8335, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3356, p4y78U_, 0.8335, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3357, p4y78G_, 0.8335, 1.88, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3358, d4qxjU_, 0.8335, 1.88, 0.311, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3359, d4qxjG_, 0.8335, 1.88, 0.311, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3360, d4qw4U_, 0.8335, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH CARFILZOMIB
3361, d4qw4G_, 0.8335, 1.88, 0.311, 241, 225, YCP IN COMPLEX WITH CARFILZOMIB
3362, d4qvvU_, 0.8335, 1.89, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3363, d4qvvG_, 0.8335, 1.89, 0.307, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3364, p4gk7G_, 0.8335, 1.88, 0.311, 243, 225, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3365, d5laiU_, 0.8334, 1.89, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3366, d5laiG_, 0.8334, 1.90, 0.307, 241, 225, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3367, d5l60U_, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3368, d5l5yU_, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3369, d5l5yG_, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3370, d5d0xG_, 0.8334, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3371, d4qz1U_, 0.8334, 1.88, 0.311, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3372, d4qz1G_, 0.8334, 1.88, 0.311, 241, 225, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3373, d3dy4U_, 0.8334, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3374, d3dy4G_, 0.8334, 1.91, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3375, p6avoG_, 0.8333, 1.73, 0.317, 234, 224, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3376, p5vfuLA_, 0.8333, 1.94, 0.296, 240, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3377, p5vftm_, 0.8333, 1.94, 0.296, 240, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3378, p5vfsEA_, 0.8333, 1.72, 0.317, 238, 224, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3379, d5l60G_, 0.8333, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3380, d4qvmU_, 0.8333, 1.89, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3381, p6avoL_, 0.8332, 1.73, 0.317, 234, 224, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3382, d5l69U_, 0.8332, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3383, p4x6zA_, 0.8332, 1.90, 0.307, 242, 225, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3384, d4qvmG_, 0.8332, 1.89, 0.307, 241, 225, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3385, d4hnpG_, 0.8332, 1.90, 0.307, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3386, d3unfS_, 0.8332, 1.72, 0.312, 238, 224, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3387, d2zcyU_, 0.8332, 1.91, 0.307, 243, 225, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3388, d2zcyG_, 0.8332, 1.92, 0.307, 243, 225, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3389, p5vfsF_, 0.8331, 1.72, 0.317, 238, 224, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3390, p5vfol_, 0.8331, 1.74, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3391, p5t0iI_, 0.8331, 2.38, 0.352, 250, 233, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3392, d5l69G_, 0.8331, 1.89, 0.307, 241, 225, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3393, p5l4gF_, 0.8331, 1.72, 0.317, 238, 224, 
3394, d5cz4U_, 0.8331, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3395, p4ya3U_, 0.8331, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3396, p4ya3G_, 0.8331, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3397, p4y81U_, 0.8331, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3398, p4y81G_, 0.8331, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3399, d4cr2G_, 0.8331, 2.14, 0.335, 245, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3400, d3unfE_, 0.8331, 1.72, 0.312, 238, 224, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3401, d3unbS_, 0.8331, 1.73, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3402, d1iruT_, 0.8331, 1.74, 0.317, 238, 224, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3403, d1iruF_, 0.8331, 1.74, 0.317, 238, 224, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3404, d5cz4G_, 0.8330, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3405, p4y8oU_, 0.8330, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3406, d4qwsU_, 0.8330, 1.89, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3407, d4hrdG_, 0.8330, 1.90, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3408, p3unbu_, 0.8330, 1.73, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3409, p5vfrm_, 0.8329, 2.03, 0.286, 240, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3410, p4y8oG_, 0.8329, 1.89, 0.311, 241, 225, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3411, d4qwsG_, 0.8329, 1.89, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3412, d1jd2G_, 0.8329, 1.90, 0.311, 243, 225, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3413, p6epdB_, 0.8328, 2.20, 0.603, 234, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3414, p5vfpDA_, 0.8328, 1.74, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3415, p5fghU_, 0.8328, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3416, p5fghG_, 0.8328, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3417, p4ya0U_, 0.8328, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3418, p3unhS_, 0.8328, 1.73, 0.312, 238, 224, MOUSE 20S IMMUNOPROTEASOME
3419, p3unhE_, 0.8328, 1.73, 0.312, 238, 224, MOUSE 20S IMMUNOPROTEASOME
3420, p5vfpF_, 0.8327, 1.74, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3421, p4ya0G_, 0.8327, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3422, d4hrcG_, 0.8327, 1.90, 0.311, 243, 225, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3423, d4r02G_, 0.8326, 1.91, 0.307, 241, 225, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3424, p6epeA_, 0.8325, 2.10, 0.354, 246, 229, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3425, d4qw3U_, 0.8325, 1.90, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3426, d4qw3G_, 0.8324, 1.90, 0.307, 241, 225, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3427, d3wxrU1, 0.8324, 1.88, 0.330, 236, 224, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3428, p3j9iU_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3429, p3j9iT_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3430, p3j9iS_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3431, p3j9iR_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3432, p3j9iQ_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3433, p3j9iP_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3434, p3j9iO_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3435, p3j9iG_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3436, p3j9iF_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3437, p3j9iE_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3438, p3j9iD_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3439, p3j9iC_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3440, p3j9iB_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3441, p3j9iA_, 0.8324, 1.67, 0.403, 224, 221, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3442, p5mp9a_, 0.8323, 1.98, 0.305, 241, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3443, d4r3oF_, 0.8323, 1.74, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
3444, d5dkiU_, 0.8322, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3445, d5dkiG_, 0.8322, 1.90, 0.307, 241, 225, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3446, d4r67F_, 0.8322, 1.75, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3447, d4r67T_, 0.8321, 1.75, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3448, p4r67h_, 0.8321, 1.75, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3449, d4r3oT_, 0.8321, 1.74, 0.317, 238, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
3450, p5mp9A_, 0.8320, 1.96, 0.305, 241, 226, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3451, d4qwgU_, 0.8320, 1.91, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3452, d4qwgG_, 0.8320, 1.91, 0.311, 241, 225, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3453, p5dsvJ_, 0.8317, 1.94, 0.290, 239, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3454, d5lf4E_, 0.8316, 1.69, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3455, p5lf0E_, 0.8316, 1.69, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3456, d3mg0G_, 0.8316, 1.92, 0.307, 243, 225, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3457, p5vftL_, 0.8315, 1.74, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3458, p5t0jM_, 0.8315, 1.91, 0.296, 240, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3459, p5vfuW_, 0.8314, 1.74, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3460, d5lf4S_, 0.8314, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3461, p5lf0S_, 0.8314, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3462, p5lf6E_, 0.8313, 1.70, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3463, d5lexS_, 0.8313, 1.70, 0.318, 235, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3464, p3uneu_, 0.8313, 1.76, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3465, p5leyE_, 0.8312, 1.70, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3466, d5lf7S_, 0.8311, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3467, d5lf7E_, 0.8311, 1.70, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3468, p3uneE_, 0.8311, 1.76, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3469, p5lf6S_, 0.8310, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3470, d5lf1E_, 0.8310, 1.70, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3471, d5lexE_, 0.8310, 1.70, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3472, p5wvkBA_, 0.8309, 1.99, 0.332, 244, 226, 
3473, d5lf3E_, 0.8309, 1.71, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3474, d5lf1S_, 0.8309, 1.70, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3475, d5le5S_, 0.8309, 1.70, 0.318, 237, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3476, p3uneS_, 0.8309, 1.76, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3477, p3unbg_, 0.8309, 1.76, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3478, d5lf3S_, 0.8308, 1.71, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3479, p5mpbU_, 0.8307, 2.01, 0.332, 243, 226, 
3480, p5leyS_, 0.8307, 1.71, 0.318, 235, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3481, d5le5E_, 0.8307, 1.71, 0.318, 233, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3482, p5vfuKA_, 0.8306, 1.77, 0.317, 238, 224, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3483, p5lezS_, 0.8306, 1.71, 0.318, 237, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3484, p5vftl_, 0.8305, 1.77, 0.317, 238, 224, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3485, p3uneg_, 0.8305, 1.76, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME
3486, p5lezE_, 0.8304, 1.71, 0.318, 233, 223, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3487, p3jcoPA_, 0.8304, 2.02, 0.341, 244, 226, 
3488, p5a5bG_, 0.8303, 2.07, 0.336, 245, 226, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3489, p4cr3G_, 0.8303, 2.07, 0.336, 245, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3490, d3unbE_, 0.8303, 1.77, 0.312, 238, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3491, p3jcoP_, 0.8303, 2.02, 0.341, 244, 226, 
3492, d1ya7F_, 0.8303, 1.64, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3493, p5wvkU_, 0.8300, 2.14, 0.330, 244, 227, 
3494, p5a0qP_, 0.8299, 1.10, 0.631, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3495, p5a0qB_, 0.8299, 1.10, 0.631, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3496, p5t0cX_, 0.8298, 1.78, 0.317, 238, 224, 
3497, p5t0cDB_, 0.8298, 1.78, 0.317, 238, 224, 
3498, p3jcoJA_, 0.8298, 1.95, 0.307, 243, 225, 
3499, d1yauF_, 0.8298, 1.54, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3500, p5t0hJ_, 0.8296, 2.03, 0.336, 239, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3501, p5mpaa_, 0.8296, 1.93, 0.311, 241, 225, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3502, p3jcoJ_, 0.8296, 1.95, 0.307, 243, 225, 
3503, d1ya7G_, 0.8296, 1.65, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3504, p5mpcG_, 0.8295, 2.43, 0.336, 243, 229, 
3505, p5mpcU_, 0.8294, 2.30, 0.342, 243, 228, 
3506, d1yauG_, 0.8294, 1.57, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3507, d1yauA_, 0.8293, 1.55, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3508, d1yauC_, 0.8292, 1.56, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3509, d1ya7C_, 0.8292, 1.65, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3510, d3jseG_, 0.8289, 1.65, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3511, d3jseF_, 0.8288, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3512, d3jseB_, 0.8287, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3513, d2ku2G1, 0.8287, 1.77, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3514, p5t0hM_, 0.8286, 2.39, 0.288, 240, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3515, d3jseA_, 0.8286, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3516, d2ku1D1, 0.8286, 1.91, 0.404, 233, 223, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3517, d1yauB_, 0.8286, 1.57, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3518, d3jseD_, 0.8285, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3519, d3jseC_, 0.8285, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3520, p5ln3G_, 0.8284, 2.06, 0.291, 242, 227, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3521, d3jseE_, 0.8284, 1.66, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3522, d2ku2F1, 0.8282, 1.82, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3523, d2ku2D1, 0.8282, 1.81, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3524, d2ku1F1, 0.8282, 1.81, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3525, d1ya7B_, 0.8282, 1.67, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3526, p5mpcR_, 0.8280, 2.05, 0.363, 240, 226, 
3527, d2ku1C1, 0.8280, 1.85, 0.401, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3528, p6epcC_, 0.8278, 2.71, 0.359, 249, 234, GROUND STATE 26S PROTEASOME (GS2)
3529, d1ya7D_, 0.8278, 1.67, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3530, d1ya7A_, 0.8278, 1.68, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3531, p5mpaf_, 0.8277, 1.64, 0.285, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3532, d5lexG_, 0.8277, 1.88, 0.368, 241, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3533, d1yauD_, 0.8277, 1.58, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3534, p5wviI_, 0.8275, 1.96, 0.350, 231, 226, 
3535, d1yarG_, 0.8275, 1.53, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3536, d1yarC_, 0.8275, 1.52, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3537, d1yarF_, 0.8272, 1.55, 0.411, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3538, d4g4sF_, 0.8271, 1.65, 0.285, 234, 221, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3539, d2ku2E1, 0.8271, 1.68, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3540, p6epfD_, 0.8269, 2.16, 0.330, 246, 230, GROUND STATE 26S PROTEASOME (GS1)
3541, d1yarD_, 0.8269, 1.53, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3542, p5wvkV_, 0.8268, 2.08, 0.310, 243, 226, 
3543, d4cr2A_, 0.8268, 2.03, 0.305, 243, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3544, d2ku1E1, 0.8268, 1.70, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3545, d5lf3G_, 0.8267, 1.89, 0.368, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3546, d2ku1G1, 0.8266, 1.72, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3547, p5mpbG_, 0.8265, 2.06, 0.336, 243, 226, 
3548, d5le5G_, 0.8263, 1.90, 0.368, 241, 223, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3549, d1yarB_, 0.8263, 1.55, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3550, d5lf7G_, 0.8262, 1.90, 0.368, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3551, d1z7qO1, 0.8262, 2.18, 0.300, 243, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3552, d5lf1G_, 0.8261, 1.90, 0.368, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3553, d1z7qA1, 0.8261, 2.18, 0.300, 243, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3554, p1fntO_, 0.8261, 2.02, 0.302, 238, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3555, p4cr4G_, 0.8260, 2.22, 0.335, 245, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3556, p5m32E_, 0.8259, 2.02, 0.311, 234, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3557, d5lf4G_, 0.8259, 1.90, 0.368, 241, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3558, d3jrmA_, 0.8259, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3559, p1fntA_, 0.8259, 2.02, 0.302, 238, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3560, p5vy3Y_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3561, p5vy3W_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3562, p5vy3U_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3563, p5vy3S_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3564, p5vy3Q_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3565, p5vy3O_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3566, p5vy3M_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3567, p5vy3K_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3568, p5vy3I_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3569, p5vy3G_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3570, p5vy3E_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3571, p5vy3C_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3572, p5vy3A_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3573, p5vy30_, 0.8258, 1.55, 0.411, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3574, p4zzgT_, 0.8258, 1.83, 0.284, 232, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3575, d3jrmG_, 0.8258, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3576, d3jrmC_, 0.8258, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3577, d3jrmB_, 0.8258, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3578, d3jrmF_, 0.8257, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3579, d3jrmD_, 0.8257, 1.70, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3580, d1yarA_, 0.8257, 1.56, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3581, p5nifT_, 0.8255, 1.84, 0.284, 232, 222, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3582, d3mg8S_, 0.8254, 1.84, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3583, d3jrmE_, 0.8254, 1.71, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3584, p6epeB_, 0.8253, 2.00, 0.612, 234, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3585, d1yauE_, 0.8253, 1.63, 0.414, 222, 220, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3586, d3dy3S_, 0.8252, 1.67, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3587, d3dy3E_, 0.8252, 1.67, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3588, p4zzgF_, 0.8251, 1.67, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3589, d3sdkE_, 0.8251, 1.85, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3590, p5vy4Y_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3591, p5vy4W_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3592, p5vy4U_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3593, p5vy4S_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3594, p5vy4Q_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3595, p5vy4O_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3596, p5vy4M_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3597, p5vy4K_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3598, p5vy4I_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3599, p5vy4G_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3600, p5vy4E_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3601, p5vy4C_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3602, p5vy4AA_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3603, p5vy4A_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3604, p5vy40_, 0.8250, 1.55, 0.416, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3605, p5mp9F_, 0.8250, 1.82, 0.284, 233, 222, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3606, d4hnpS_, 0.8250, 1.67, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3607, d4intE_, 0.8248, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3608, d4hnpE_, 0.8248, 1.67, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3609, d4fzgS_, 0.8248, 1.68, 0.285, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3610, d4fzgE_, 0.8248, 1.68, 0.285, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3611, d3bdmS_, 0.8248, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3612, d3bdmE_, 0.8248, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3613, d4intS_, 0.8247, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3614, d3gpjE_, 0.8247, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3615, p5nifF_, 0.8246, 1.68, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3616, p4gk7S_, 0.8246, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3617, p4gk7E_, 0.8246, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3618, d3gpjS_, 0.8246, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3619, d3dy4E_, 0.8246, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3620, d2zcyS_, 0.8246, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3621, d2zcyE_, 0.8246, 1.68, 0.285, 233, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3622, d4hrdS_, 0.8245, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3623, d4fzcE_, 0.8245, 1.68, 0.285, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3624, d3dy4S_, 0.8245, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3625, d3d29S_, 0.8245, 1.68, 0.285, 233, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
3626, d3d29E_, 0.8245, 1.68, 0.285, 233, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
3627, d4fzcS_, 0.8244, 1.69, 0.285, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3628, d3sdkS_, 0.8244, 1.68, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3629, p3jtlG_, 0.8244, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3630, p3jtlC_, 0.8244, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3631, p3jtlB_, 0.8244, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3632, d1z7qF1, 0.8244, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3633, d4hrdE_, 0.8243, 1.68, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3634, p3jtlD_, 0.8243, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3635, p3jtlA_, 0.8243, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3636, d1z7qT1, 0.8243, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3637, d3nzjS_, 0.8242, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3638, d3nzjE_, 0.8242, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3639, p3jtlF_, 0.8242, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3640, d4lqiS_, 0.8241, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3641, d4lqiE_, 0.8241, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3642, d3un8E_, 0.8241, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3643, d4eu2F_, 0.8240, 1.69, 0.285, 232, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3644, d3un8S_, 0.8240, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3645, d3sdiE_, 0.8240, 1.68, 0.285, 230, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3646, p3jtlE_, 0.8240, 1.74, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3647, p6bdfY_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3648, p6bdfW_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3649, p6bdfU_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3650, p6bdfS_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3651, p6bdfQ_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3652, p6bdfO_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3653, p6bdfM_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3654, p6bdfK_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3655, p6bdfI_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3656, p6bdfG_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3657, p6bdfE_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3658, p6bdfC_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3659, p6bdfA_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3660, p6bdf0_, 0.8239, 1.58, 0.416, 221, 219, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3661, d3oeuE_, 0.8239, 1.69, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3662, d3mg6S_, 0.8239, 1.70, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3663, d5lajS_, 0.8238, 1.69, 0.285, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3664, d5lajE_, 0.8238, 1.69, 0.285, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3665, d4j70S_, 0.8237, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3666, d4j70E_, 0.8237, 1.69, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3667, d3mg8E_, 0.8237, 1.70, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3668, d1yarE_, 0.8237, 1.59, 0.416, 221, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3669, d1ya7E_, 0.8237, 1.75, 0.412, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3670, d4r18S_, 0.8236, 1.70, 0.285, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3671, d4r18E_, 0.8236, 1.70, 0.285, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3672, d4jt0S_, 0.8236, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3673, d4jt0E_, 0.8236, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3674, d4jsqS_, 0.8236, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3675, d4jsqE_, 0.8236, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3676, p3un4E_, 0.8236, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3677, d3mg7E_, 0.8236, 1.87, 0.284, 233, 222, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3678, d3mg0S_, 0.8236, 1.70, 0.285, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3679, d3mg0E_, 0.8236, 1.69, 0.285, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3680, p5t0gL_, 0.8235, 1.85, 0.317, 238, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3681, d5l6cS_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3682, d5l6cE_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3683, d5l5zS_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3684, d5l5zE_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3685, d5l5uS_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3686, d5l5uE_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3687, d5l5tS_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3688, d5l5tE_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3689, d5l5sS_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3690, d5l5sE_, 0.8235, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3691, d5dkjS_, 0.8235, 1.69, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3692, d5dkjE_, 0.8235, 1.69, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3693, d4q1sE_, 0.8235, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3694, d4jsuS_, 0.8235, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3695, d4jsuE_, 0.8235, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3696, p3un4S_, 0.8235, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3697, d3mg7S_, 0.8235, 1.70, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3698, d1pmaO_, 0.8235, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3699, d1pmaD_, 0.8235, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3700, p1fntF_, 0.8235, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3701, p6epfG_, 0.8234, 2.15, 0.288, 245, 226, GROUND STATE 26S PROTEASOME (GS1)
3702, d5lttS_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3703, d5lttE_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3704, d5l69S_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3705, d5l69E_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3706, d5l67S_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3707, d5l67E_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3708, d5l62S_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3709, d5l62E_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3710, d5l61S_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3711, d5l61E_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3712, d5l60S_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3713, d5l60E_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3714, d5l5vS_, 0.8234, 1.70, 0.285, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3715, d5l5vE_, 0.8234, 1.70, 0.285, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3716, d5l5qS_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3717, d5l5qE_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3718, d5l5pS_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3719, d5l5pE_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3720, d5l5jS_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3721, d5l5jE_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3722, d5cz7S_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3723, d5cz7E_, 0.8234, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3724, p4x6zF_, 0.8234, 1.70, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3725, d4qw0S_, 0.8234, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3726, d4qw0E_, 0.8234, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3727, d4hrcE_, 0.8234, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3728, p1fntT_, 0.8234, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3729, d5l64S_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3730, d5l64E_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3731, d5l63S_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3732, d5l63E_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3733, d5l5oS_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3734, d5l5oE_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3735, d5l5iE_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3736, d5l5hS_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3737, d5l5hE_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3738, d5cz6S_, 0.8233, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3739, d4qvyS_, 0.8233, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3740, d4qvyE_, 0.8233, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3741, d4inrE_, 0.8233, 1.70, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3742, d3wxrF_, 0.8233, 1.70, 0.285, 232, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3743, d3mg6E_, 0.8233, 1.70, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3744, d2fakE_, 0.8233, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3745, d1rypF_, 0.8233, 1.69, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3746, d5l6bS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3747, d5l6bE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3748, d5l68S_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3749, d5l68E_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3750, d5l66S_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3751, d5l66E_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3752, d5l65S_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3753, d5l65E_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3754, d5l5yS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3755, d5l5xS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3756, d5l5xE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3757, d5l5wS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3758, d5l5wE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3759, d5l5iS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3760, d5l5fS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3761, d5l5fE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3762, d5l5eS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3763, d5l5aS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3764, d5l5aE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3765, d5fgaS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3766, d5fgaE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3767, d5dkiS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3768, d5dkiE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3769, d5d0tS_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3770, d5d0tE_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3771, d5cz6E_, 0.8232, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3772, p4x6zT_, 0.8232, 1.71, 0.285, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3773, d4qzzS_, 0.8232, 1.70, 0.285, 231, 221, YCP IN COMPLEX WITH OMURALIDE
3774, d4qzzE_, 0.8232, 1.70, 0.285, 231, 221, YCP IN COMPLEX WITH OMURALIDE
3775, d4qz6S_, 0.8232, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3776, d4qz6E_, 0.8232, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3777, d4qvvS_, 0.8232, 1.70, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3778, d4qvvE_, 0.8232, 1.70, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3779, d4ltcE_, 0.8232, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3780, d3shjE_, 0.8232, 1.70, 0.285, 233, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3781, d3nzwS_, 0.8232, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3782, d3nzwE_, 0.8232, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3783, d2fakS_, 0.8232, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3784, p6gopS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3785, p6gopE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3786, p5wviAA_, 0.8231, 2.00, 0.350, 231, 226, 
3787, d5l6aS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3788, d5l6aE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3789, d5l5yE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3790, d5l5eE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3791, d5l5dS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3792, d5l5dE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3793, p5fghS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3794, p5fghE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3795, d5fgfS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3796, d5fgfE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3797, d5fg9S_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3798, d5fg9E_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3799, d5d0xS_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3800, d5d0xE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3801, d5cgfE_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3802, p4y70S_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3803, p4y70E_, 0.8231, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3804, d4qvlS_, 0.8231, 1.70, 0.285, 231, 221, YCP IN COMPLEX WITH BORTEZOMIB
3805, d4qvlE_, 0.8231, 1.70, 0.285, 231, 221, YCP IN COMPLEX WITH BORTEZOMIB
3806, d4nnnS_, 0.8231, 1.70, 0.285, 231, 221, YCP IN COMPLEX WITH MG132
3807, d3shjS_, 0.8231, 1.70, 0.285, 233, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3808, d3oevE_, 0.8231, 1.70, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3809, d3hyeS_, 0.8231, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3810, d3hyeE_, 0.8231, 1.70, 0.285, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3811, d1pmaN_, 0.8231, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3812, d1pmaJ_, 0.8231, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3813, d1pmaH_, 0.8231, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3814, d1pmaF_, 0.8231, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3815, d5m2bS_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3816, d5m2bE_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3817, d5l5rS_, 0.8230, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3818, d5l5rE_, 0.8230, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3819, d5l5bS_, 0.8230, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3820, d5l5bE_, 0.8230, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3821, d5fg7S_, 0.8230, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3822, d5fg7E_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3823, d5czaS_, 0.8230, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3824, d5czaE_, 0.8230, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3825, d5cgfS_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3826, d5bouS_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3827, d5bouE_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3828, p4y9zS_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3829, p4y9zE_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3830, p4y8uS_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3831, p4y8uE_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3832, d4y8rS_, 0.8230, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3833, p4y7wS_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3834, p4y7wE_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3835, p4y69S_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3836, p4y69E_, 0.8230, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3837, d4r00S_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3838, d4r00E_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3839, d4qz5S_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3840, d4qz5E_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3841, d4qz3S_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3842, d4qz3E_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3843, d4qvwS_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3844, d4qvwE_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3845, d4qv6S_, 0.8230, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT
3846, d4qv6E_, 0.8230, 1.71, 0.285, 231, 221, YCP BETA5-A49V MUTANT
3847, d4qv0S_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3848, d4qv0E_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3849, d4quxS_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT
3850, d4quxE_, 0.8230, 1.70, 0.285, 231, 221, YCP BETA5-A49T-MUTANT
3851, d4nnnE_, 0.8230, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH MG132
3852, d3oeuS_, 0.8230, 1.71, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3853, d3gpwS_, 0.8230, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3854, d3gpwE_, 0.8230, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3855, d3gptE_, 0.8230, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3856, d2gplS_, 0.8230, 1.71, 0.285, 233, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3857, d2gplE_, 0.8230, 1.71, 0.285, 233, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3858, d5cz9S_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3859, d5cz9E_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3860, d5bxlS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3861, d5bxlE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3862, p4ya7S_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3863, p4ya7E_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3864, p4ya5S_, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3865, p4ya5E_, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3866, d4y9yS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3867, d4y9yE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3868, d4y8rE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3869, d4y8mS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3870, d4y8mE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3871, p4y8jS_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3872, p4y8jE_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3873, p4y7yS_, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3874, p4y7yE_, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3875, p4y74S_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3876, p4y74E_, 0.8229, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3877, p4y6vS_, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3878, p4y6vE_, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3879, p4y6aS_, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3880, p4y6aE_, 0.8229, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3881, d4qwjS_, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3882, d4qwjE_, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3883, d4qvpS_, 0.8229, 1.70, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3884, d4qvpE_, 0.8229, 1.70, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3885, d4qvmS_, 0.8229, 1.70, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3886, d4qvmE_, 0.8229, 1.70, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3887, d4qv8S_, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT
3888, d4qv8E_, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT
3889, d4qv7S_, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT
3890, d4qv7E_, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT
3891, d4quyS_, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT
3892, d4quyE_, 0.8229, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT
3893, d4nnwS_, 0.8229, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3894, d4nnwE_, 0.8229, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3895, d4ltcS_, 0.8229, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3896, d4inrS_, 0.8229, 1.71, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3897, d3nzxS_, 0.8229, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3898, d3nzxE_, 0.8229, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3899, d3mg4E_, 0.8229, 1.71, 0.285, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3900, d3gptS_, 0.8229, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3901, d1pmaM_, 0.8229, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3902, d1pmaL_, 0.8229, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3903, d1pmaG_, 0.8229, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3904, d1pmaE_, 0.8229, 1.59, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3905, p5mp9f_, 0.8228, 1.70, 0.285, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3906, d5laiE_, 0.8228, 1.71, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3907, d5jhrE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3908, d5fggS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3909, d5fggE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3910, d5fgeS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3911, d5fgeE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3912, d5fgdS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3913, d5fgdE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3914, p5cghS_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3915, p5cghE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3916, d4ya4E_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3917, d4ya1S_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3918, d4ya1E_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3919, p4y8nS_, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3920, p4y8nE_, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3921, p4y8iE_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3922, p4y80S_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3923, p4y80E_, 0.8228, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3924, d4rurS_, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3925, d4rurE_, 0.8228, 1.70, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3926, d4r02E_, 0.8228, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3927, d4qwuE_, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3928, d4qwiS_, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3929, d4qwiE_, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3930, d4qv9S_, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT
3931, d4qv9E_, 0.8228, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT
3932, d3e47S_, 0.8228, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3933, d3e47E_, 0.8228, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3934, d3c92Q1, 0.8228, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3935, d1pmaI_, 0.8228, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3936, d1pmaC_, 0.8228, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3937, d1pmaA_, 0.8228, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3938, d5laiS_, 0.8227, 1.71, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3939, d5jhsS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3940, d5jhsE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3941, d5jhrS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3942, d5fhsS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3943, d5fhsE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3944, d5fgiS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3945, d5fgiE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3946, d5d0wS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3947, d5d0wE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3948, d5cz8S_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3949, d5cz8E_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3950, p5cggS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3951, p5cggE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3952, d5bxnS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3953, d5bxnE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3954, d4z1lS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3955, d4z1lE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3956, d4ya4S_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3957, p4y8lS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3958, p4y8lE_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3959, p4y8iS_, 0.8227, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3960, d4qwuS_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3961, d4qwkS_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3962, d4qwkE_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3963, d4qw7S_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3964, d4qw7E_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3965, d4qw4S_, 0.8227, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
3966, d4qw4E_, 0.8227, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
3967, d4qw1E_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3968, d4qvqS_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3969, d4qvqE_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3970, d4qvnE_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3971, d4qv1S_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT
3972, d4qv1E_, 0.8227, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT
3973, p3jcpOA_, 0.8227, 1.72, 0.285, 233, 221, 
3974, p3jcpO_, 0.8227, 1.72, 0.285, 233, 221, 
3975, d3c92U1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3976, d3c92T1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3977, d3c92S1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3978, d3c92R1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3979, d3c92P1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3980, d3c92O1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3981, d3c92G1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3982, d3c92F1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3983, d3c92E1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3984, d3c92D1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3985, d3c92C1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3986, d3c92B1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3987, d3c92A1, 0.8227, 1.60, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3988, d2fnyE_, 0.8227, 1.71, 0.285, 233, 221,  
3989, d1g65E_, 0.8227, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3990, d5d0vS_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3991, d5d0vE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3992, d5d0sS_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3993, d5d0sE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3994, d5cz4S_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3995, d5cz4E_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3996, p4ya9S_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3997, p4ya9E_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3998, p4ya3S_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3999, p4ya3E_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
4000, p4ya0S_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4001, p4ya0E_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
4002, p4y8pS_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4003, p4y8pE_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4004, p4y78S_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4005, p4y78E_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
4006, p4y77E_, 0.8226, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4007, d4r17S_, 0.8226, 1.71, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4008, d4r17E_, 0.8226, 1.71, 0.285, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4009, d4r02S_, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
4010, d4qzwS_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4011, d4qzwE_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4012, d4qz4S_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4013, d4qz4E_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4014, d4qwrS_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4015, d4qwrE_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
4016, d4qw1S_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
4017, d4qvnS_, 0.8226, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
4018, d4no9S_, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4019, d4no9E_, 0.8226, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4020, d4eu2T_, 0.8226, 1.71, 0.285, 232, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4021, d3tddS_, 0.8226, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4022, d3tddE_, 0.8226, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4023, d2fnyS_, 0.8226, 1.71, 0.285, 233, 221,  
4024, d1pmaK_, 0.8226, 1.60, 0.406, 221, 219, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4025, d5cz5S_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4026, d5cz5E_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
4027, p4y7xS_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4028, p4y7xE_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
4029, p4y77S_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4030, p4y75S_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4031, p4y75E_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4032, p4y6zS_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4033, p4y6zE_, 0.8225, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4034, d4qz7S_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4035, d4qz7E_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4036, d4qw6S_, 0.8225, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4037, d4qw6E_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
4038, d4qw5S_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4039, d4qw5E_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
4040, d4qw3S_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4041, d4qw3E_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
4042, d4qv3E_, 0.8225, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT
4043, d4no1S_, 0.8225, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4044, d4no1E_, 0.8225, 1.71, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4045, d2f16E_, 0.8225, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4046, d5d0zS_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4047, d5d0zE_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
4048, p4y8qS_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4049, p4y8qE_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
4050, p4y8oS_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4051, p4y8oE_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4052, p4y8kS_, 0.8224, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4053, p4y8kE_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
4054, p4y82S_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4055, p4y82E_, 0.8224, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
4056, d4qwlS_, 0.8224, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4057, d4qwlE_, 0.8224, 1.72, 0.285, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
4058, d4qv4S_, 0.8224, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT
4059, d4qv4E_, 0.8224, 1.71, 0.285, 231, 221, YCP BETA5-M45T MUTANT
4060, d4qv3S_, 0.8224, 1.71, 0.285, 231, 221, YCP BETA5-M45V MUTANT
4061, d2f16S_, 0.8224, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4062, p5cgiS_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4063, p5cgiE_, 0.8223, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
4064, p4y81S_, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4065, p4y81E_, 0.8223, 1.71, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4066, d4qwfS_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4067, d4qwfE_, 0.8223, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4068, d4no8S_, 0.8223, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4069, d4no8E_, 0.8223, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
4070, d4hrcS_, 0.8223, 1.72, 0.285, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4071, d1rypT_, 0.8223, 1.71, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4072, p5vfoJ_, 0.8222, 2.04, 0.338, 239, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4073, d5l52S_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4074, d5l52E_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
4075, p4y8tS_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4076, p4y8tE_, 0.8222, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4077, d4qxjS_, 0.8222, 1.71, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4078, d4qxjE_, 0.8222, 1.72, 0.285, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4079, d4qlqS_, 0.8222, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4080, d4qlqE_, 0.8222, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4081, d3wxrT_, 0.8222, 1.72, 0.285, 232, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4082, p4y8sS_, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4083, p4y8sE_, 0.8221, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4084, d4qzxS_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4085, d4qzxE_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4086, d4qz1S_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4087, d4qz1E_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4088, d4qz0S_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4089, d4qz0E_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4090, d4qwxS_, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4091, d4qwxE_, 0.8221, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4092, d4qwsS_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4093, d4qwsE_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4094, d4qv5S_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT
4095, d4qv5E_, 0.8221, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT
4096, d4q1sS_, 0.8221, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4097, d4inuE_, 0.8221, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4098, d5l55S_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4099, d5l55E_, 0.8220, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4100, p5a0qS_, 0.8220, 1.31, 0.349, 215, 215, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4101, p5a0qE_, 0.8220, 1.31, 0.349, 215, 215, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4102, d4qz2S_, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4103, d4qz2E_, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4104, d4qwgS_, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4105, d4qwgE_, 0.8220, 1.72, 0.285, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4106, d3oevS_, 0.8220, 1.72, 0.285, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4107, d3c91U1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4108, d3c91T1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4109, d3c91S1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4110, d3c91R1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4111, d3c91Q1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4112, d3c91P1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4113, d3c91O1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4114, d3c91G1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4115, d3c91F1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4116, d3c91E1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4117, d3c91D1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4118, d3c91C1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4119, d3c91B1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4120, d3c91A1, 0.8220, 1.61, 0.406, 221, 219, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4121, d1g0uE_, 0.8220, 1.72, 0.285, 230, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4122, p5ln3D_, 0.8219, 2.22, 0.309, 232, 230, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4123, d4no6E_, 0.8219, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4124, d3mg4S_, 0.8219, 1.73, 0.285, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4125, p4y84S_, 0.8218, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4126, p4y84E_, 0.8218, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4127, d4no6S_, 0.8218, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4128, d3okjS_, 0.8218, 1.73, 0.285, 233, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4129, d3okjE_, 0.8218, 1.73, 0.285, 233, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4130, p5mpaF_, 0.8217, 1.87, 0.284, 233, 222, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4131, d5l54S_, 0.8217, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4132, d5l54E_, 0.8217, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4133, d5ahjS_, 0.8217, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4134, d5ahjE_, 0.8217, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4135, p4y8hS_, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4136, p4y8hE_, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4137, p4y8gS_, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4138, p4y8gE_, 0.8217, 1.72, 0.285, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4139, d4qlsS_, 0.8217, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4140, d4qlsE_, 0.8217, 1.72, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4141, d4inuS_, 0.8217, 1.72, 0.285, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4142, d3sdiS_, 0.8217, 1.72, 0.285, 230, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4143, d1g65S_, 0.8217, 1.73, 0.285, 233, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4144, p4ya2S_, 0.8215, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4145, p4ya2E_, 0.8215, 1.73, 0.285, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4146, d4qluS_, 0.8214, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4147, d4qluE_, 0.8214, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4148, d4qltS_, 0.8214, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4149, d4qltE_, 0.8214, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4150, p4qbyS_, 0.8214, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4151, p4qbyE_, 0.8214, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4152, p4v7oT_, 0.8213, 1.74, 0.285, 234, 221, 
4153, p4v7oBB_, 0.8213, 1.74, 0.285, 234, 221, 
4154, d3l5qW_, 0.8213, 1.74, 0.285, 234, 221,  
4155, d1vsyT_, 0.8213, 1.74, 0.285, 234, 221,  
4156, p5vfqD_, 0.8212, 2.05, 0.338, 239, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4157, p4v7oNA_, 0.8212, 1.75, 0.285, 234, 221, 
4158, p4v7oF_, 0.8212, 1.74, 0.285, 234, 221, 
4159, d3l5qK_, 0.8212, 1.74, 0.285, 234, 221,  
4160, d1vsyF_, 0.8212, 1.75, 0.285, 234, 221,  
4161, d4qlvS_, 0.8211, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4162, d4qlvE_, 0.8211, 1.73, 0.285, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4163, p6epfE_, 0.8210, 2.16, 0.323, 233, 226, GROUND STATE 26S PROTEASOME (GS1)
4164, p6epeC_, 0.8210, 2.30, 0.335, 249, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4165, p5a5bF_, 0.8207, 1.88, 0.284, 233, 222, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4166, p4cr3F_, 0.8207, 1.88, 0.284, 233, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4167, p5vfrJ_, 0.8204, 2.06, 0.338, 239, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4168, p4cr4A_, 0.8203, 2.23, 0.304, 243, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4169, p5wvkT_, 0.8202, 1.84, 0.284, 233, 222, 
4170, p5mpbF_, 0.8202, 1.91, 0.284, 231, 222, 
4171, d1jd2E_, 0.8201, 1.74, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4172, d1g0uS_, 0.8198, 1.75, 0.285, 230, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4173, p5t0hL_, 0.8187, 1.98, 0.317, 238, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4174, d1jd2Z_, 0.8187, 1.77, 0.285, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4175, p5mpbA_, 0.8186, 2.07, 0.307, 241, 225, 
4176, p6epeG_, 0.8184, 2.24, 0.295, 245, 227, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4177, p6epfF_, 0.8183, 1.98, 0.308, 238, 224, GROUND STATE 26S PROTEASOME (GS1)
4178, p5mpcO_, 0.8183, 2.06, 0.311, 241, 225, 
4179, p5fmgS_, 0.8180, 1.59, 0.332, 217, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4180, p5fmgE_, 0.8180, 1.59, 0.332, 217, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4181, p5t0jL_, 0.8179, 1.93, 0.317, 238, 224, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4182, p5fmgP_, 0.8177, 1.27, 0.528, 212, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4183, p5fmgB_, 0.8177, 1.27, 0.528, 212, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4184, d5lexU_, 0.8175, 2.01, 0.367, 235, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4185, d5lf3U_, 0.8171, 2.00, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4186, d5lf7U_, 0.8169, 2.00, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4187, p5mpbT_, 0.8166, 1.91, 0.284, 233, 222, 
4188, d5lf1U_, 0.8166, 2.00, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4189, p5lf6U_, 0.8165, 2.01, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4190, p5t0iK_, 0.8162, 2.07, 0.320, 228, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4191, p6epeF_, 0.8161, 2.06, 0.308, 238, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4192, d5lf4U_, 0.8161, 2.01, 0.367, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4193, p6epcG_, 0.8158, 2.46, 0.284, 245, 229, GROUND STATE 26S PROTEASOME (GS2)
4194, p5wviX_, 0.8158, 2.22, 0.341, 245, 226, 
4195, p3jcoOA_, 0.8150, 1.84, 0.281, 233, 221, 
4196, p3jcoO_, 0.8150, 1.84, 0.281, 233, 221, 
4197, p5dsvC_, 0.8143, 1.82, 0.297, 234, 219, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4198, p6epcF_, 0.8140, 2.17, 0.307, 238, 225, GROUND STATE 26S PROTEASOME (GS2)
4199, p6epcE_, 0.8132, 2.24, 0.323, 233, 226, GROUND STATE 26S PROTEASOME (GS2)
4200, d4g4sD_, 0.8129, 1.52, 0.379, 220, 214, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4201, p6epdG_, 0.8117, 2.57, 0.281, 245, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4202, p5mpcA_, 0.8115, 2.16, 0.304, 241, 224, 
4203, p4v7oR_, 0.8112, 1.59, 0.353, 227, 215, 
4204, p4v7oLA_, 0.8112, 1.59, 0.353, 227, 215, 
4205, d3l5qU_, 0.8112, 1.59, 0.353, 227, 215,  
4206, d1vsyD_, 0.8112, 1.59, 0.353, 227, 215,  
4207, p4v7oZA_, 0.8111, 1.59, 0.353, 227, 215, 
4208, p4v7oD_, 0.8111, 1.59, 0.353, 227, 215, 
4209, d3l5qI_, 0.8111, 1.59, 0.353, 227, 215,  
4210, d1vsyR_, 0.8111, 1.59, 0.353, 227, 215,  
4211, d4cr2F_, 0.8100, 2.04, 0.284, 233, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4212, d5le5U_, 0.8099, 1.88, 0.372, 232, 218, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4213, p4v7oE_, 0.8093, 1.58, 0.318, 227, 214, 
4214, p4v7oAB_, 0.8093, 1.58, 0.318, 227, 214, 
4215, p4v7oMA_, 0.8092, 1.58, 0.318, 227, 214, 
4216, p4v7oS_, 0.8091, 1.58, 0.318, 227, 214, 
4217, p5vfpAA_, 0.8088, 1.77, 0.344, 232, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4218, p3ipmF_, 0.8086, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4219, p3ipmE_, 0.8086, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4220, p3ipmD_, 0.8086, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4221, p3ipmC_, 0.8086, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4222, p3ipmB_, 0.8086, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4223, p3ipmA_, 0.8086, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4224, p5vfqBA_, 0.8085, 1.78, 0.344, 232, 218, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4225, p3ipmG_, 0.8085, 1.96, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4226, p5vfoi_, 0.8084, 1.79, 0.344, 232, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4227, p5t0iM_, 0.8074, 2.40, 0.295, 240, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4228, p5vfri_, 0.8073, 1.79, 0.344, 232, 218, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4229, p5l4gA_, 0.8071, 1.69, 0.349, 221, 215, 
4230, p5gjqB_, 0.8069, 1.73, 0.349, 221, 215, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4231, p5l4gO_, 0.8065, 1.69, 0.349, 221, 215, 
4232, p5gjrS_, 0.8065, 1.72, 0.349, 221, 215, 
4233, p5gjqh_, 0.8065, 1.69, 0.349, 221, 215, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4234, p5gjrGA_, 0.8064, 1.71, 0.349, 221, 215, 
4235, p5mpbE_, 0.8060, 1.68, 0.321, 228, 215, 
4236, p5mpcF_, 0.8058, 2.09, 0.284, 231, 222, 
4237, p5a5bC_, 0.8054, 1.99, 0.355, 226, 220, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4238, p4cr3C_, 0.8054, 1.99, 0.355, 226, 220, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4239, p5a5bA_, 0.8051, 2.36, 0.310, 243, 226, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4240, p4cr3A_, 0.8051, 2.36, 0.310, 243, 226, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4241, p3unhU_, 0.8045, 1.74, 0.349, 220, 215, MOUSE 20S IMMUNOPROTEASOME
4242, p3unhG_, 0.8045, 1.74, 0.349, 220, 215, MOUSE 20S IMMUNOPROTEASOME
4243, p5fmgQ_, 0.8043, 1.62, 0.347, 220, 213, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4244, p5fmgC_, 0.8043, 1.62, 0.347, 220, 213, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4245, p4cr4F_, 0.8041, 2.09, 0.284, 233, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4246, p5t0jH_, 0.8039, 2.25, 0.596, 232, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4247, p6epcD_, 0.8034, 2.55, 0.330, 246, 230, GROUND STATE 26S PROTEASOME (GS2)
4248, p5fmgO_, 0.8030, 1.84, 0.312, 219, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4249, p5fmgA_, 0.8030, 1.84, 0.312, 219, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4250, p6epeE_, 0.8002, 2.57, 0.320, 233, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4251, p5vfrG_, 0.8001, 1.78, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4252, p5fmgT_, 0.8001, 1.61, 0.324, 219, 213, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4253, p5fmgF_, 0.8001, 1.61, 0.324, 219, 213, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4254, p5wvkX_, 0.7998, 2.15, 0.352, 225, 219, 
4255, p5wvkQ_, 0.7995, 2.17, 0.350, 225, 220, 
4256, p5vfoG_, 0.7991, 1.81, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4257, p5vfqA_, 0.7989, 1.80, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4258, p5vfqZ_, 0.7985, 1.81, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4259, p5vfog_, 0.7985, 1.81, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4260, p5vfsZ_, 0.7984, 1.83, 0.349, 220, 215, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4261, p5vfsA_, 0.7981, 1.83, 0.349, 220, 215, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4262, p5vfrg_, 0.7979, 1.81, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4263, p5vfpA_, 0.7979, 1.82, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4264, p5t0cYA_, 0.7971, 1.84, 0.349, 220, 215, 
4265, p5t0cS_, 0.7971, 1.84, 0.349, 220, 215, 
4266, p5m32U_, 0.7967, 1.75, 0.350, 218, 214, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4267, p5vfpY_, 0.7966, 1.84, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4268, p5vfuR_, 0.7958, 1.87, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4269, p5vftG_, 0.7958, 1.87, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4270, p6avoR_, 0.7951, 1.85, 0.352, 217, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4271, p6avoK_, 0.7943, 1.85, 0.352, 217, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4272, p5t0gG_, 0.7937, 1.87, 0.349, 220, 215, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4273, p5vfuFA_, 0.7928, 1.93, 0.349, 220, 215, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4274, p5vftg_, 0.7928, 1.93, 0.349, 220, 215, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4275, p6epdE_, 0.7925, 2.61, 0.322, 233, 227, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4276, p5a0qR_, 0.7924, 1.61, 0.341, 214, 211, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4277, p5a0qD_, 0.7924, 1.61, 0.341, 214, 211, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4278, p5wviZ_, 0.7920, 2.11, 0.285, 233, 221, 
4279, p5mpcD_, 0.7918, 1.81, 0.362, 224, 213, 
4280, p5wviG_, 0.7917, 2.11, 0.285, 233, 221, 
4281, p5t0jG_, 0.7916, 1.87, 0.344, 220, 215, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4282, p6epdF_, 0.7908, 2.36, 0.308, 238, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4283, p5ln3C_, 0.7900, 2.04, 0.349, 225, 218, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4284, p5fmgR_, 0.7871, 1.62, 0.388, 215, 209, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4285, p5fmgD_, 0.7871, 1.62, 0.388, 215, 209, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4286, p6epdD_, 0.7869, 2.67, 0.330, 246, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4287, p5fmgU_, 0.7858, 2.13, 0.231, 219, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4288, p5fmgG_, 0.7858, 2.13, 0.231, 219, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4289, p5t0jK_, 0.7840, 1.71, 0.318, 212, 211, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4290, p6epfA_, 0.7834, 1.98, 0.344, 222, 215, GROUND STATE 26S PROTEASOME (GS1)
4291, p5t0hG_, 0.7826, 2.03, 0.349, 220, 215, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4292, p5wviNA_, 0.7821, 2.13, 0.352, 222, 216, 
4293, p5m32S_, 0.7814, 1.79, 0.308, 218, 211, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4294, p5lezG_, 0.7814, 1.78, 0.357, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4295, p5lf0G_, 0.7809, 1.79, 0.357, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4296, p5leyG_, 0.7809, 1.79, 0.357, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4297, p6epcA_, 0.7808, 1.94, 0.349, 219, 212, GROUND STATE 26S PROTEASOME (GS2)
4298, p5lf6G_, 0.7800, 1.80, 0.357, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4299, p5mpbO_, 0.7798, 1.94, 0.296, 225, 213, 
4300, p5mpaA_, 0.7794, 2.00, 0.291, 224, 213, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4301, p6epdA_, 0.7792, 2.17, 0.352, 223, 216, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4302, d5ts0G_, 0.7790, 2.13, 0.181, 220, 215, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4303, p5t0iG_, 0.7787, 2.06, 0.340, 220, 215, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4304, p5t0iL_, 0.7785, 1.84, 0.316, 221, 212, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4305, p5a0qU_, 0.7781, 1.67, 0.304, 209, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4306, p5a0qG_, 0.7781, 1.67, 0.304, 209, 207, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4307, d5trgP_, 0.7775, 2.08, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4308, d5trsA_, 0.7757, 2.12, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4309, p6epeD_, 0.7755, 2.01, 0.324, 229, 213, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4310, d5thoS_, 0.7751, 2.29, 0.181, 221, 216, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4311, d5trgA_, 0.7744, 2.07, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4312, d5trrA_, 0.7738, 2.08, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4313, d5thoG_, 0.7738, 2.09, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4314, d5tryA_, 0.7737, 2.09, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4315, d5trsP_, 0.7737, 2.17, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4316, p5wviH_, 0.7732, 1.55, 0.335, 214, 206, 
4317, d5ts0A_, 0.7730, 2.10, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4318, d5thoA_, 0.7730, 2.10, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4319, d5trrP_, 0.7726, 2.22, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4320, d3mi0F_, 0.7726, 2.34, 0.182, 220, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4321, d5ts0T_, 0.7724, 2.12, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4322, d5tryS_, 0.7723, 2.19, 0.182, 219, 214, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4323, d5trsC_, 0.7723, 2.14, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4324, d5tryQ_, 0.7722, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4325, d5trsD_, 0.7722, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4326, d3mfeI_, 0.7722, 2.04, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4327, d3mkaA_, 0.7721, 2.38, 0.181, 222, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4328, d5ts0U_, 0.7720, 2.06, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4329, d5ts0Q_, 0.7720, 2.12, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4330, d3h6iQ_, 0.7718, 2.22, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4331, d5tryF_, 0.7716, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4332, d5trgS_, 0.7714, 2.15, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4333, d3mkaU_, 0.7714, 2.40, 0.181, 221, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4334, d5ts0B_, 0.7713, 2.03, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4335, p5lezU_, 0.7713, 1.90, 0.356, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4336, d5trrS_, 0.7712, 2.14, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4337, p5lf0U_, 0.7712, 1.91, 0.356, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4338, p2fhgW_, 0.7712, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4339, d5trgO_, 0.7711, 2.13, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4340, p2fhgU_, 0.7711, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4341, p2fhgQ_, 0.7711, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4342, p2fhgM_, 0.7711, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4343, p2fhgI_, 0.7711, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4344, p2fhgD_, 0.7711, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4345, p2fhgB_, 0.7711, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4346, p2fhgA_, 0.7711, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4347, p2fhg1_, 0.7711, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4348, d5ts0E_, 0.7710, 2.14, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4349, d5thoE_, 0.7710, 2.14, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4350, p2fhgS_, 0.7710, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4351, p2fhgO_, 0.7710, 2.31, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4352, p2fhgK_, 0.7709, 2.32, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4353, p5wviY_, 0.7708, 2.06, 0.291, 225, 213, 
4354, d5ts0C_, 0.7708, 2.09, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4355, d5ts0P_, 0.7707, 2.16, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4356, p5leyU_, 0.7707, 1.92, 0.356, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4357, d5trrT_, 0.7706, 2.08, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4358, d5trrE_, 0.7706, 2.08, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4359, d5trsU_, 0.7705, 2.02, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4360, d5trrU_, 0.7705, 2.01, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4361, d3mfeK_, 0.7705, 2.02, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4362, d5trsS_, 0.7704, 2.16, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4363, d3mkaF_, 0.7704, 2.30, 0.182, 221, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4364, d5tryP_, 0.7703, 2.12, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4365, d5thoO_, 0.7703, 2.15, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4366, d3mkaM_, 0.7703, 2.50, 0.181, 224, 216, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4367, d5trsE_, 0.7702, 2.09, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4368, d5ts0S_, 0.7701, 2.18, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4369, d5ts0D_, 0.7701, 2.10, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4370, d3h6iF_, 0.7701, 2.10, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4371, d2fhhW_, 0.7701, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4372, d2fhhO_, 0.7700, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4373, d2fhhD_, 0.7700, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4374, d3hfaB_, 0.7699, 1.92, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4375, d2fhhU_, 0.7699, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4376, d2fhhS_, 0.7699, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4377, d2fhhM_, 0.7699, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4378, d2fhhF_, 0.7699, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4379, d2fhhB_, 0.7699, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4380, d2fhhA_, 0.7699, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4381, d5ts0R_, 0.7698, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4382, d5trgU_, 0.7698, 2.03, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4383, d2fhhY_, 0.7698, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4384, d2fhhQ_, 0.7698, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4385, d2fhhK_, 0.7698, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4386, d2fhhI_, 0.7698, 2.33, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4387, d5tryU_, 0.7697, 2.03, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4388, d5trgE_, 0.7697, 2.16, 0.183, 218, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4389, d2fhh1_, 0.7697, 2.34, 0.181, 220, 215, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4390, d5trsB_, 0.7695, 2.05, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4391, d5trrC_, 0.7695, 2.09, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4392, d5thoU_, 0.7695, 2.04, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4393, d5trsT_, 0.7694, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4394, d5trrO_, 0.7694, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4395, d5tryE_, 0.7693, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4396, d5thoT_, 0.7692, 2.11, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4397, d5thoF_, 0.7692, 2.12, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4398, d5tryD_, 0.7691, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4399, d5thoR_, 0.7691, 2.12, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4400, d5thoC_, 0.7691, 2.12, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4401, d5tryR_, 0.7689, 2.11, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4402, d3mkaS_, 0.7689, 2.35, 0.187, 219, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4403, d3h6fQ_, 0.7688, 2.20, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4404, d5trgT_, 0.7687, 2.13, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4405, d3mkaB_, 0.7687, 2.37, 0.182, 220, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4406, d5trsO_, 0.7686, 2.14, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4407, d5trrD_, 0.7685, 2.06, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4408, d3mfeB_, 0.7685, 2.06, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4409, d5thoP_, 0.7683, 2.14, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4410, p5lzpD_, 0.7683, 2.13, 0.184, 217, 212, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4411, d3h6fW_, 0.7683, 2.18, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4412, d5trrG_, 0.7682, 2.06, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4413, d3mkaW_, 0.7682, 2.22, 0.184, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4414, d3h6iW_, 0.7682, 2.20, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4415, d3mkaK_, 0.7681, 2.40, 0.182, 221, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4416, d3h6fF_, 0.7681, 2.08, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4417, d5trgQ_, 0.7680, 2.16, 0.184, 217, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4418, d3h6iK_, 0.7679, 2.26, 0.184, 217, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4419, d5tryC_, 0.7676, 2.05, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4420, d5trsQ_, 0.7676, 2.09, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4421, d5trsG_, 0.7676, 2.08, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4422, d5thoQ_, 0.7676, 2.09, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4423, d2h6jB1, 0.7676, 2.29, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4424, d5ts0O_, 0.7675, 2.09, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4425, d5tryT_, 0.7675, 2.07, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4426, d3h6iA_, 0.7675, 2.08, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4427, d5trgD_, 0.7674, 2.30, 0.183, 223, 213, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4428, d3mkaO_, 0.7673, 2.29, 0.183, 218, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4429, d2h6jA1, 0.7673, 2.31, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4430, d2h6jG1, 0.7672, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4431, d1q5qF_, 0.7672, 2.30, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4432, d1q5qD_, 0.7672, 2.30, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4433, d1q5qC_, 0.7672, 2.30, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4434, d1q5qB_, 0.7672, 2.30, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4435, p5mpcT_, 0.7671, 1.79, 0.269, 213, 208, 
4436, d2h6jF1, 0.7671, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4437, d2h6jD1, 0.7671, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4438, d1q5qG_, 0.7671, 2.30, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4439, d1q5qE_, 0.7671, 2.30, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4440, d1q5qA_, 0.7671, 2.30, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME
4441, d5tryG_, 0.7670, 2.08, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4442, d3mkaQ_, 0.7670, 2.30, 0.183, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4443, d2h6jE1, 0.7670, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4444, d2h6jC1, 0.7670, 2.32, 0.182, 219, 214, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4445, d1q5rF_, 0.7670, 2.33, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4446, d1q5rD_, 0.7670, 2.33, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4447, d1q5rB_, 0.7670, 2.33, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4448, d5trrB_, 0.7669, 2.03, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4449, d1q5rG_, 0.7669, 2.33, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4450, d1q5rE_, 0.7669, 2.33, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4451, d1q5rC_, 0.7669, 2.33, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4452, d1q5rA_, 0.7669, 2.33, 0.182, 219, 214, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4453, d3h6fK_, 0.7667, 2.01, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4454, d5trgB_, 0.7666, 2.04, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4455, d5trgG_, 0.7664, 2.09, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4456, d5thoD_, 0.7664, 2.10, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4457, d3mkaY_, 0.7663, 2.25, 0.183, 224, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4458, d3mfeS_, 0.7662, 2.04, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4459, d3krdF_, 0.7662, 2.11, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4460, d3h6i1_, 0.7661, 2.03, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4461, d3h6f1_, 0.7660, 2.03, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4462, d3mkaD_, 0.7659, 2.28, 0.183, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4463, d3h6iI_, 0.7659, 2.02, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4464, d5thoB_, 0.7657, 2.05, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4465, d3h6iU_, 0.7656, 2.06, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4466, d3h6iM_, 0.7656, 2.17, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4467, d5trgC_, 0.7655, 2.11, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4468, d3mi0U_, 0.7655, 2.19, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4469, d5tryB_, 0.7653, 2.05, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4470, d5trsR_, 0.7653, 2.13, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4471, d3mi0O_, 0.7652, 2.20, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4472, d5trgF_, 0.7651, 2.06, 0.181, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4473, d3mka1_, 0.7650, 2.41, 0.183, 219, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4474, d3mi0M_, 0.7649, 2.19, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4475, d3h6fA_, 0.7649, 2.04, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4476, d5trrQ_, 0.7647, 2.08, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4477, d3mi0K_, 0.7647, 2.24, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4478, d5trsF_, 0.7644, 2.15, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4479, p5vfpD_, 0.7643, 1.96, 0.325, 219, 209, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4480, d3h6fS_, 0.7643, 2.08, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4481, d3krdY_, 0.7642, 2.18, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4482, d3mi0S_, 0.7639, 2.22, 0.185, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4483, p5ln3A_, 0.7637, 2.13, 0.349, 219, 212, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4484, d3mi01_, 0.7636, 2.16, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4485, d3h6iO_, 0.7636, 2.09, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4486, d3h6fO_, 0.7635, 2.09, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4487, d3hfaA_, 0.7633, 2.03, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4488, d3h6iS_, 0.7633, 2.09, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4489, d5trrR_, 0.7632, 2.09, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4490, p5lzp2_, 0.7632, 2.09, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4491, d3h6fI_, 0.7632, 2.02, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4492, p5lzp4_, 0.7631, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4493, d5ts0F_, 0.7630, 2.10, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4494, p5lzp0_, 0.7630, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4495, p5lzp6_, 0.7629, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4496, d3krdI_, 0.7629, 2.11, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4497, d5tryO_, 0.7628, 2.16, 0.185, 216, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4498, p5lzpY_, 0.7628, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4499, p5lzpW_, 0.7627, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4500, p5lzp8_, 0.7627, 2.10, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4501, d3hfa1_, 0.7627, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4502, d3hfaS_, 0.7626, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4503, d3hfaW_, 0.7625, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4504, d3mi0Y_, 0.7624, 2.14, 0.186, 216, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4505, d3hfaQ_, 0.7623, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4506, d3hfaM_, 0.7623, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4507, d3mi0W_, 0.7622, 2.31, 0.190, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4508, d3hfaU_, 0.7622, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4509, d3hfaO_, 0.7622, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4510, d3hfaK_, 0.7622, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4511, d3hfaI_, 0.7622, 2.06, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4512, d3hfaF_, 0.7622, 2.05, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4513, d5trgR_, 0.7621, 2.10, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4514, d3mfeY_, 0.7621, 1.98, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4515, d3h6iB_, 0.7620, 2.06, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4516, d3krdS_, 0.7619, 2.12, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4517, d3hfaY_, 0.7618, 2.07, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4518, d3h6fM_, 0.7618, 2.18, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4519, d3krd1_, 0.7617, 2.13, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4520, p5lzpJ_, 0.7616, 2.13, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4521, p5lzpH_, 0.7616, 2.17, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4522, d3mi0A_, 0.7616, 2.18, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4523, d3krdW_, 0.7616, 2.11, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4524, d5trrF_, 0.7615, 2.11, 0.186, 215, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4525, d3mi0I_, 0.7615, 2.34, 0.180, 216, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4526, d3h6fD_, 0.7615, 2.04, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4527, d3mi0Q_, 0.7611, 2.22, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4528, d3h6fB_, 0.7611, 2.07, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4529, d3mfeA_, 0.7608, 2.07, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4530, d3krdQ_, 0.7605, 2.10, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4531, d3krdK_, 0.7605, 2.19, 0.186, 215, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4532, d3h6fU_, 0.7605, 2.09, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4533, d3mi0D_, 0.7604, 2.10, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4534, p5lzpS_, 0.7603, 2.18, 0.186, 215, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4535, p5wviF_, 0.7602, 2.03, 0.335, 223, 209, 
4536, d3hfaD_, 0.7601, 2.03, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4537, d3h6iD_, 0.7599, 2.01, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4538, d3krdO_, 0.7598, 2.14, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4539, d3h6fY_, 0.7589, 2.04, 0.183, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4540, d3mfe1_, 0.7587, 2.02, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4541, d3krdU_, 0.7587, 2.12, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4542, d3mfeO_, 0.7585, 2.08, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4543, p5lzpQ_, 0.7583, 2.11, 0.187, 214, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4544, d3hf9I_, 0.7582, 1.97, 0.188, 212, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4545, p5lzpB_, 0.7581, 2.13, 0.187, 214, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4546, d3krdA_, 0.7581, 2.13, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4547, d3mkaI_, 0.7579, 2.26, 0.186, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4548, p5lzpM_, 0.7577, 2.14, 0.187, 214, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4549, p5ln3F_, 0.7575, 1.95, 0.312, 212, 208, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4550, p5wvkAA_, 0.7573, 1.75, 0.268, 210, 205, 
4551, d3krdM_, 0.7573, 2.14, 0.187, 214, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4552, p5t0jJ_, 0.7572, 2.19, 0.325, 222, 212, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4553, d3mfeD_, 0.7570, 2.06, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4554, d3krdB_, 0.7566, 2.09, 0.183, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4555, p5wviD_, 0.7565, 2.10, 0.290, 222, 210, 
4556, d3krdD_, 0.7564, 2.10, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4557, d3mfeQ_, 0.7560, 2.08, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4558, p6bgoI_, 0.7558, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4559, p6bgoH_, 0.7558, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4560, p6bgoG_, 0.7558, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4561, p6bgoF_, 0.7558, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4562, p6bgoE_, 0.7558, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4563, p6bgoD_, 0.7558, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4564, p6bgoC_, 0.7558, 2.26, 0.186, 215, 210, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4565, p6bglO_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4566, p6bglN_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4567, p6bglM_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4568, p6bglL_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4569, p6bglK_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4570, p6bglJ_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4571, p6bglI_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4572, p6bglH_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4573, p6bglG_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4574, p6bglF_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4575, p6bglE_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4576, p6bglD_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4577, p6bglC_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4578, p6bglA_, 0.7558, 2.26, 0.186, 215, 210, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4579, p3hf9y_, 0.7558, 1.95, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4580, d3h6iY_, 0.7558, 2.10, 0.187, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4581, p3hf9s_, 0.7556, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4582, d3mfeU_, 0.7554, 2.04, 0.188, 212, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4583, p3hf9b_, 0.7552, 1.97, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4584, p3hf9f_, 0.7551, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4585, p3hf9u_, 0.7549, 1.97, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4586, d3hf9K_, 0.7548, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4587, p3hf9i_, 0.7545, 1.97, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4588, d3hf9S_, 0.7544, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4589, d3hf9B_, 0.7543, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4590, p3hf9k_, 0.7542, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4591, d3mi0B_, 0.7540, 2.25, 0.183, 213, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4592, d3hf9A_, 0.7539, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4593, d3hf9U_, 0.7535, 2.00, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4594, p3hf9w_, 0.7534, 1.97, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4595, p3hf9d_, 0.7533, 1.98, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4596, d3hf91_, 0.7533, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4597, d3hf9Q_, 0.7531, 2.00, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4598, d3hf9O_, 0.7531, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4599, p3hf9a_, 0.7529, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4600, p3hf9o_, 0.7527, 1.99, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4601, d3hf9Y_, 0.7520, 1.96, 0.185, 210, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4602, p3hf9q_, 0.7520, 2.01, 0.189, 211, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4603, d3hf93_, 0.7508, 1.97, 0.185, 210, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4604, d3mfeW_, 0.7486, 1.91, 0.191, 209, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4605, p5t0iJ_, 0.7483, 2.30, 0.302, 222, 212, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4606, d3hf9D_, 0.7473, 2.04, 0.185, 210, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4607, p3hf9m_, 0.7435, 1.98, 0.187, 208, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4608, p2fhgF_, 0.7397, 2.08, 0.191, 209, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4609, p2fhgY_, 0.7396, 2.09, 0.191, 209, 204, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4610, p6bgoN_, 0.7377, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4611, p6bgoM_, 0.7377, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4612, p6bgoL_, 0.7377, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4613, p6bgoK_, 0.7377, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4614, p6bgoJ_, 0.7377, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4615, p6bgoA_, 0.7377, 1.96, 0.193, 207, 202, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4616, d3hf9M_, 0.7355, 1.87, 0.190, 205, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4617, p6bgoO_, 0.7343, 1.96, 0.194, 206, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4618, p5a0qO_, 0.7262, 1.66, 0.365, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4619, p5a0qA_, 0.7262, 1.66, 0.365, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4620, p5a0qT_, 0.7222, 1.60, 0.339, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4621, p5a0qF_, 0.7221, 1.60, 0.339, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4622, d3h4pl_, 0.7102, 2.19, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4623, p3h4pg_, 0.7101, 2.19, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4624, p3h4pa_, 0.7101, 2.19, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4625, d3h4pk_, 0.7099, 2.19, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4626, d3h4pj_, 0.7096, 2.20, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4627, p3h4pe_, 0.7096, 2.07, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4628, p3h4pb_, 0.7095, 2.20, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4629, p3h4pc_, 0.7094, 2.06, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4630, d3h4pn_, 0.7093, 2.06, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4631, p3h4pf_, 0.7093, 2.07, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4632, p3h4pd_, 0.7093, 2.21, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4633, d3h4pi_, 0.7092, 2.06, 0.250, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4634, d3h4ph_, 0.7089, 2.22, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4635, d3h4pm_, 0.7088, 2.21, 0.254, 202, 193, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4636, p6bdfZ_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4637, p6bdfX_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4638, p6bdfV_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4639, p6bdfT_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4640, p6bdfR_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4641, p6bdfP_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4642, p6bdfN_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4643, p6bdfL_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4644, p6bdfJ_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4645, p6bdfH_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4646, p6bdfF_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4647, p6bdfD_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4648, p6bdfB_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4649, p6bdf1_, 0.7064, 2.24, 0.187, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4650, p3j9iZ_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4651, p3j9iY_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4652, p3j9iX_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4653, p3j9iW_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4654, p3j9iV_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4655, p3j9iN_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4656, p3j9iM_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4657, p3j9iL_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4658, p3j9iK_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4659, p3j9iJ_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4660, p3j9iI_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4661, p3j9iH_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4662, p3j9i2_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4663, p3j9i1_, 0.7050, 2.28, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4664, p5vy4X_, 0.7044, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4665, p5vy4R_, 0.7044, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4666, p5vy4BA_, 0.7044, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4667, p5vy41_, 0.7044, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4668, p5vy4Z_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4669, p5vy4V_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4670, p5vy4T_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4671, p5vy4P_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4672, p5vy4N_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4673, p5vy4L_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4674, p5vy4J_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4675, p5vy4H_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4676, p5vy4F_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4677, p5vy4D_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4678, p5vy4B_, 0.7043, 2.27, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4679, d2h6jN1, 0.7038, 2.62, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4680, p5vy3Z_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4681, p5vy3X_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4682, p5vy3V_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4683, p5vy3T_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4684, p5vy3R_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4685, p5vy3P_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4686, p5vy3N_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4687, p5vy3L_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4688, p5vy3J_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4689, p5vy3H_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4690, p5vy3F_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4691, p5vy3D_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4692, p5vy3B_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4693, p5vy31_, 0.7037, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4694, d2h6jK1, 0.7037, 2.62, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4695, d2h6jJ1, 0.7037, 2.63, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4696, d1yauM_, 0.7037, 2.30, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4697, d2h6jM1, 0.7036, 2.62, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4698, d2h6jI1, 0.7033, 2.63, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4699, d2h6jL1, 0.7032, 2.63, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4700, d1yarM_, 0.7031, 2.30, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4701, d1q5rN_, 0.7031, 3.06, 0.177, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4702, d2h6jH1, 0.7030, 2.63, 0.191, 225, 199, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4703, d1q5rM_, 0.7030, 3.07, 0.177, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4704, d1q5rL_, 0.7030, 3.05, 0.172, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4705, d1q5rK_, 0.7030, 3.07, 0.177, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4706, d1q5rJ_, 0.7030, 3.07, 0.177, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4707, d1q5rI_, 0.7030, 3.07, 0.177, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4708, d1q5rH_, 0.7030, 3.06, 0.167, 251, 203, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4709, d3jrmM_, 0.7029, 2.37, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4710, d1yauJ_, 0.7029, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4711, d3jrmI_, 0.7028, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4712, d1ya7M_, 0.7028, 2.31, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4713, d3jrmK_, 0.7027, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4714, d3jrmJ_, 0.7027, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4715, d3jrmH_, 0.7027, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4716, d3c92M1, 0.7027, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4717, d3c9211, 0.7027, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4718, d3c91M1, 0.7027, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4719, d3c9111, 0.7027, 2.30, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4720, d1yauK_, 0.7027, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4721, d1yauI_, 0.7027, 2.30, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4722, d1ya7K_, 0.7027, 2.31, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4723, d1ya7I_, 0.7027, 2.31, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4724, d1pmaX_, 0.7027, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4725, d1pmaT_, 0.7027, 2.30, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4726, d3jseM_, 0.7026, 2.37, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4727, d3jrmN_, 0.7026, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4728, d3jrmL_, 0.7026, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4729, d1pmaY_, 0.7026, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4730, p3jtlJ_, 0.7025, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4731, d3c92W1, 0.7025, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4732, d3c92I1, 0.7025, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4733, d3c91W1, 0.7025, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4734, d3c91I1, 0.7025, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4735, d1yauH_, 0.7025, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4736, d1yarK_, 0.7025, 2.31, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4737, d1ya7H_, 0.7025, 2.31, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4738, d1pmaP_, 0.7025, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4739, p3jtlK_, 0.7024, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4740, d3jseK_, 0.7024, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4741, d3c92X1, 0.7024, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4742, d3c92N1, 0.7024, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4743, d3c92J1, 0.7024, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4744, d3c9221, 0.7024, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4745, d3c91X1, 0.7024, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4746, d3c91N1, 0.7024, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4747, d3c91J1, 0.7024, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4748, d3c9121, 0.7024, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4749, d1ya7J_, 0.7024, 2.32, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4750, d1pmaU_, 0.7024, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4751, d1pmaQ_, 0.7024, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4752, d1pma2_, 0.7024, 2.30, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4753, p3jtlL_, 0.7023, 2.32, 0.187, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4754, d1yarI_, 0.7023, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4755, d1pmaV_, 0.7023, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4756, d3jseL_, 0.7022, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4757, d3jseJ_, 0.7022, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4758, d3jseI_, 0.7022, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4759, d3jseH_, 0.7022, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4760, d3c92Z1, 0.7022, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4761, d3c92L1, 0.7022, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4762, d3c91Z1, 0.7022, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4763, d3c91L1, 0.7022, 2.31, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4764, d1ya7N_, 0.7022, 2.33, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4765, d1pmaS_, 0.7022, 2.31, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4766, d1pma1_, 0.7022, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4767, d3jseN_, 0.7021, 2.38, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4768, d3c92V1, 0.7020, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4769, d3c92H1, 0.7020, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4770, d3c91V1, 0.7020, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4771, d3c91H1, 0.7020, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4772, d1yauN_, 0.7020, 2.33, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4773, d1yauL_, 0.7020, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4774, d1pmaZ_, 0.7020, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4775, d1pmaW_, 0.7020, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4776, d1pmaB_, 0.7020, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4777, p3jtlM_, 0.7019, 2.39, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4778, d1ya7L_, 0.7019, 2.32, 0.187, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4779, p3jtlN_, 0.7018, 2.39, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4780, p3jtlH_, 0.7018, 2.39, 0.192, 203, 193, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4781, d1yarL_, 0.7018, 2.32, 0.187, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4782, d1yarJ_, 0.7016, 2.39, 0.192, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4783, d3mkaG_, 0.7015, 3.10, 0.172, 251, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4784, d3c92Y1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4785, d3c92K1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4786, d3c91Y1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4787, d3c91K1, 0.7015, 2.32, 0.187, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4788, d1pmaR_, 0.7015, 2.32, 0.187, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4789, d3mkaJ_, 0.7013, 3.11, 0.172, 252, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4790, d1yarH_, 0.7012, 2.40, 0.192, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4791, d3mkaT_, 0.7009, 3.10, 0.172, 250, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4792, p3jtlI_, 0.7009, 2.28, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4793, d1j2qN_, 0.7009, 2.32, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4794, d1j2qJ_, 0.7009, 2.32, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4795, d1j2qI_, 0.7009, 2.33, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4796, d1j2qM_, 0.7008, 2.32, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4797, d1j2qL_, 0.7008, 2.32, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4798, d1j2qK_, 0.7008, 2.32, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4799, d1j2qH_, 0.7008, 2.32, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4800, d3mkaN_, 0.7007, 3.13, 0.172, 252, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4801, d3mkaL_, 0.7005, 3.10, 0.172, 251, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4802, d3mkaC_, 0.7004, 3.11, 0.172, 250, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4803, d1yarN_, 0.7004, 2.30, 0.193, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4804, d3mfeF_, 0.6999, 2.02, 0.198, 212, 192, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4805, p2z5cC_, 0.6995, 1.24, 0.302, 189, 182, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4806, p2z5cF_, 0.6994, 1.24, 0.302, 189, 182, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4807, d3mkaP_, 0.6983, 2.87, 0.175, 250, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4808, d3mkaV_, 0.6982, 2.88, 0.175, 249, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4809, d3mkaH_, 0.6979, 3.00, 0.179, 249, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4810, d3mkaR_, 0.6977, 2.74, 0.176, 246, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4811, d3mka2_, 0.6976, 2.88, 0.175, 246, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4812, d3mkaE_, 0.6966, 2.89, 0.175, 248, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4813, d3gpjX_, 0.6960, 2.05, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4814, d3gpjJ_, 0.6960, 2.05, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4815, d3d29J_, 0.6960, 2.06, 0.188, 198, 191, PROTEASOME INHIBITION BY FELLUTAMIDE B
4816, d4intJ_, 0.6959, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4817, d3sdiJ_, 0.6959, 2.24, 0.182, 198, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4818, d3d29X_, 0.6959, 2.06, 0.188, 198, 191, PROTEASOME INHIBITION BY FELLUTAMIDE B
4819, d1g65X_, 0.6959, 2.24, 0.187, 198, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4820, d3bdmX_, 0.6958, 2.05, 0.188, 198, 191, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4821, d3bdmJ_, 0.6958, 2.05, 0.188, 198, 191, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
4822, d4intX_, 0.6957, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
4823, d4inrX_, 0.6957, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4824, d4inrJ_, 0.6957, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
4825, d3okjJ_, 0.6957, 2.06, 0.194, 198, 191, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4826, d3nzwX_, 0.6957, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4827, d3nzwJ_, 0.6957, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4828, d2zcyJ_, 0.6957, 2.05, 0.188, 198, 191, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4829, d4jsqX_, 0.6956, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4830, d4jsqJ_, 0.6956, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
4831, d3okjX_, 0.6956, 2.06, 0.194, 198, 191, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4832, d2zcyX_, 0.6956, 2.05, 0.188, 198, 191, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4833, d1g65J_, 0.6956, 2.24, 0.187, 198, 192, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4834, d4jsuX_, 0.6954, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4835, d4jsuJ_, 0.6954, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4836, d3nzxX_, 0.6954, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4837, d3nzxJ_, 0.6954, 2.06, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4838, d5trrI_, 0.6953, 2.51, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4839, d5trgK_, 0.6953, 2.51, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4840, d4inuX_, 0.6953, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4841, d4inuJ_, 0.6953, 2.25, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4842, p5lzpI_, 0.6952, 2.51, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4843, d3mi0L_, 0.6951, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4844, d3mg0X_, 0.6951, 2.24, 0.182, 198, 192, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4845, d3mg0J_, 0.6951, 2.06, 0.194, 198, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
4846, d3nzjX_, 0.6950, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4847, d3mfeM_, 0.6950, 1.88, 0.196, 194, 189, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4848, p3un4X_, 0.6949, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4849, p3un4J_, 0.6949, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
4850, d3nzjJ_, 0.6949, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
4851, p3ipmK_, 0.6949, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4852, d2f16X_, 0.6949, 2.25, 0.187, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4853, d2f16J_, 0.6949, 2.25, 0.187, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4854, d5ts0W_, 0.6948, 2.52, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4855, d5trrW_, 0.6948, 2.51, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4856, d5trrL_, 0.6948, 2.52, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4857, d4ltcX_, 0.6948, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4858, d4ltcJ_, 0.6948, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
4859, d4hrcX_, 0.6948, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4860, p3ipmM_, 0.6948, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4861, p3ipmL_, 0.6948, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4862, p3ipmJ_, 0.6948, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4863, p3ipmI_, 0.6948, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4864, p3ipmH_, 0.6948, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4865, d5trsW_, 0.6947, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4866, d5trgL_, 0.6947, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4867, d4jt0J_, 0.6947, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4868, d3sdiX_, 0.6947, 2.26, 0.182, 198, 192, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
4869, p3ipmN_, 0.6947, 2.39, 0.193, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4870, d5trgY_, 0.6946, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4871, d5trgI_, 0.6946, 2.52, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4872, d4q1sJ_, 0.6946, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4873, d4jt0X_, 0.6946, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
4874, d4hrdJ_, 0.6946, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4875, p5trrb_, 0.6945, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4876, p5lzpK_, 0.6945, 2.52, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4877, p5lzpC_, 0.6945, 2.52, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4878, d5trgV_, 0.6944, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4879, d5thoL_, 0.6944, 2.52, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4880, p4gk7X_, 0.6944, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4881, p4gk7J_, 0.6944, 2.26, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4882, d3gptX_, 0.6944, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4883, d3gptJ_, 0.6944, 2.26, 0.182, 198, 192, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4884, d5trrZ_, 0.6943, 2.53, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4885, d5thoW_, 0.6943, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4886, p5lzpE_, 0.6943, 2.52, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4887, d3wxrY_, 0.6943, 2.28, 0.177, 198, 192, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4888, d3mg4J_, 0.6943, 2.08, 0.188, 198, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4889, d3gpwJ_, 0.6943, 2.08, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4890, d3dy3X_, 0.6943, 2.07, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4891, d3dy3J_, 0.6943, 2.07, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
4892, d2fakJ_, 0.6943, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4893, d1g0uX_, 0.6943, 2.27, 0.187, 198, 192, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4894, d5trsL_, 0.6942, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4895, d5trgX_, 0.6942, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4896, p5lzpR_, 0.6942, 2.52, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4897, d4fzgX_, 0.6942, 2.27, 0.182, 198, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4898, d4fzgJ_, 0.6942, 2.27, 0.182, 198, 192, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
4899, d3un8J_, 0.6942, 2.28, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4900, d3hyeX_, 0.6942, 2.26, 0.187, 198, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4901, d3hyeJ_, 0.6942, 2.26, 0.187, 198, 192, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4902, d3hf9W_, 0.6942, 1.83, 0.197, 193, 188, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4903, d3gpwX_, 0.6942, 2.07, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4904, d2gplX_, 0.6942, 2.27, 0.182, 198, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4905, d2gplJ_, 0.6942, 2.27, 0.182, 198, 192, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
4906, d2fakX_, 0.6942, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
4907, d1jd2Q_, 0.6942, 2.09, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4908, d5trrY_, 0.6941, 2.52, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4909, d3un8X_, 0.6941, 2.28, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4910, d3dy4X_, 0.6941, 2.07, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4911, d3dy4J_, 0.6941, 2.07, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4912, d5ts0K_, 0.6940, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4913, d5trsY_, 0.6940, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4914, p5trra_, 0.6940, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4915, d4hrcJ_, 0.6940, 2.26, 0.177, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4916, d3mg8J_, 0.6940, 2.08, 0.194, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
4917, d1rypK_, 0.6940, 2.27, 0.187, 198, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4918, d5ts0I_, 0.6939, 2.53, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4919, p5trya_, 0.6939, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4920, d4lqiJ_, 0.6939, 2.09, 0.188, 198, 191, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4921, d3mi0E_, 0.6939, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4922, d3mi02_, 0.6939, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4923, d3hfaV_, 0.6939, 2.56, 0.173, 226, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4924, d3hfaL_, 0.6939, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4925, d3hfaG_, 0.6939, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4926, d3hfaC_, 0.6939, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4927, d1g0uJ_, 0.6939, 2.27, 0.182, 198, 192, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4928, d5ts0L_, 0.6938, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4929, d5tryW_, 0.6938, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4930, p5tryb_, 0.6938, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4931, d5trsI_, 0.6938, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4932, p5trga_, 0.6938, 2.53, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4933, d5thoV_, 0.6938, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4934, p5lzpT_, 0.6938, 2.53, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4935, p5lzpN_, 0.6938, 2.53, 0.173, 221, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4936, d4lqiX_, 0.6938, 2.27, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4937, d4hrdX_, 0.6938, 2.27, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
4938, d4hnpX_, 0.6938, 2.09, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4939, d4hnpJ_, 0.6938, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
4940, d3mi0N_, 0.6938, 2.54, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4941, d3mi0J_, 0.6938, 2.54, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4942, d3mg6J_, 0.6938, 2.10, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
4943, d3hfaZ_, 0.6938, 2.57, 0.173, 224, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4944, d3hfaT_, 0.6938, 2.57, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4945, d3hfaP_, 0.6938, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4946, d3hfaN_, 0.6938, 2.57, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4947, d3hfaE_, 0.6938, 2.57, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4948, d3hfa2_, 0.6938, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4949, d1rypY_, 0.6938, 2.27, 0.187, 198, 192, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
4950, d5thoI_, 0.6937, 2.61, 0.173, 222, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4951, p5lzpG_, 0.6937, 2.54, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4952, d3tddX_, 0.6937, 2.28, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4953, d3tddJ_, 0.6937, 2.28, 0.182, 198, 192, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4954, d3hfaX_, 0.6937, 2.57, 0.173, 224, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4955, d3hfaR_, 0.6937, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4956, d3hfaJ_, 0.6937, 2.57, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4957, d3hfaH_, 0.6937, 2.57, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4958, d5trrV_, 0.6936, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4959, p5thob_, 0.6936, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4960, p5lzpU_, 0.6936, 2.54, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4961, d4q1sX_, 0.6936, 2.27, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4962, d3mi0X_, 0.6936, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4963, d3e47X_, 0.6936, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4964, d3e47J_, 0.6936, 2.10, 0.188, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4965, d1jd2J_, 0.6936, 2.09, 0.194, 198, 191, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4966, d5tryZ_, 0.6935, 2.54, 0.173, 222, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4967, p5lzpO_, 0.6935, 2.54, 0.173, 223, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4968, d3shjX_, 0.6935, 2.27, 0.187, 198, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4969, d3shjJ_, 0.6935, 2.27, 0.187, 198, 192, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4970, d3oevJ_, 0.6935, 2.10, 0.188, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
4971, d2fnyX_, 0.6935, 2.10, 0.188, 198, 191,  
4972, d2fnyJ_, 0.6935, 2.10, 0.188, 198, 191,  
4973, p5ts0b_, 0.6934, 2.54, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4974, d5trsK_, 0.6934, 2.56, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4975, p5trsb_, 0.6934, 2.56, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4976, p5trsa_, 0.6934, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4977, d5thoZ_, 0.6934, 2.54, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4978, d5thoK_, 0.6934, 2.54, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4979, d3mi0T_, 0.6934, 2.55, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4980, d3mg4X_, 0.6934, 2.10, 0.188, 198, 191, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4981, d5tryL_, 0.6933, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4982, d5tryI_, 0.6933, 2.62, 0.173, 222, 197, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4983, d5thoY_, 0.6933, 2.53, 0.173, 223, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4984, p5lzpA_, 0.6933, 2.55, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4985, p4v7oGB_, 0.6933, 2.28, 0.177, 198, 192, 
4986, d4fzcJ_, 0.6933, 2.10, 0.188, 198, 191, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4987, d3sdkJ_, 0.6933, 2.11, 0.194, 198, 191, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
4988, d3mi0G_, 0.6933, 2.55, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4989, d1vsyY_, 0.6933, 2.28, 0.177, 198, 192,  
4990, p5ts0a_, 0.6932, 2.55, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4991, d5trsV_, 0.6932, 2.56, 0.173, 223, 196, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4992, p5lzpF_, 0.6932, 2.55, 0.173, 222, 196, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4993, d4j70J_, 0.6932, 2.28, 0.182, 198, 192, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4994, d4fzcX_, 0.6932, 2.10, 0.188, 198, 191, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4995, d3mi0H_, 0.6932, 2.55, 0.173, 222, 196, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4996, d1q5qN_, 0.6932, 2.49, 0.179, 224, 196, THE RHODOCOCCUS 20S PROTEASOME
4997, d1q5qM_, 0.6932, 2.49, 0.179, 224, 196, THE RHODOCOCCUS 20S PROTEASOME
4998, d1q5qK_, 0.6932, 2.49, 0.179, 224, 196, THE RHODOCOCCUS 20S PROTEASOME
4999, d1q5qH_, 0.6932, 2.49, 0.179, 224, 196, THE RHODOCOCCUS 20S PROTEASOME
5000, p6bgoZ_, 0.6931, 2.55, 0.173, 222, 196, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
